[[1, "cytokine-mediated signaling pathway (GO:0019221)", 2.7286236423086907e-11, 5.71693820385297, 139.06245628578603, ["IFITM3", "CSF3", "CSF1", "EBI3", "ITGB2", "IFI6", "IFI35", "IL2RG", "CXCL3", "TNF", "CXCL2", "IFIT3", "IL21R", "MAPK3", "STAT5A", "CCL22", "TNFSF14", "CCL20", "MX2", "IL36G", "IRAK3", "MMP9", "IL23A", "IL1B", "OAS3", "IRF9"], 3.8528165829398716e-08, 0, 0], [2, "cellular response to type I interferon (GO:0071357)", 1.464177081192166e-06, 14.372974657249689, 193.0896632498229, ["IFITM3", "OAS3", "MX2", "IFI6", "IFI35", "IFIT3", "IRF9"], 0.0006891393462144462, 0, 0], [3, "type I interferon signaling pathway (GO:0060337)", 1.464177081192166e-06, 14.372974657249689, 193.0896632498229, ["IFITM3", "OAS3", "MX2", "IFI6", "IFI35", "IFIT3", "IRF9"], 0.0006891393462144462, 0, 0], [4, "cellular response to cytokine stimulus (GO:0071345)", 4.730214179917003e-06, 4.234110603865394, 51.91671685262955, ["STAT5A", "CSF3", "CCL22", "CSF1", "CCL20", "EBI3", "ITGB2", "IL36G", "IRAK3", "IL2RG", "TNF", "MMP9", "CXCL2", "IL23A", "IL1B", "LGALS9"], 0.001338921184181615, 0, 0], [5, "inflammatory response (GO:0006954)", 5.387550029995573e-06, 6.079485878572637, 73.75279546003416, ["VNN1", "CCL22", "CCL20", "IL1B", "PLA2G4C", "ITGB2", "IL36G", "LGALS9", "CXCL3", "TNF", "CXCL2"], 0.001338921184181615, 0, 0], [6, "positive regulation of NIK/NF-kappaB signaling (GO:1901224)", 6.294586936242143e-06, 15.120397502866608, 181.0791665398428, ["TNFSF14", "IL23A", "IL1B", "IFI35", "LGALS9", "TNF"], 0.001338921184181615, 0, 0], [7, "positive regulation of macromolecule metabolic process (GO:0010604)", 6.637711253025003e-06, 4.630256671766106, 55.20536191757504, ["CSF1", "DTX3L", "IL36G", "TICAM1", "TNF", "KLF2", "OLFM1", "C1QTNF1", "IL1B", "HEY2", "LGALS9", "SLC26A9", "CD34", "MAPK3"], 0.001338921184181615, 0, 0], [8, "cellular response to lipopolysaccharide (GO:0071222)", 9.832809790590922e-06, 8.534632034632034, 98.40247946591765, ["IL1B", "TNIP3", "LY96", "IL36G", "TICAM1", "CXCL3", "TNF", "CXCL2"], 0.0016172203753129187, 0, 0], [9, "response to lipopolysaccharide (GO:0032496)", 1.0308061882306139e-05, 7.1989024390243905, 82.66200384903631, ["IL1B", "TNIP3", "LY96", "IL36G", "IRAK3", "LGALS9", "TICAM1", "CXCL3", "CXCL2"], 0.0016172203753129187, 0, 0], [10, "positive regulation of ERK1 and ERK2 cascade (GO:0070374)", 1.9340485448456808e-05, 6.620380068831363, 71.8530369897297, ["MARCO", "P2RY6", "CCL22", "CCL20", "LGALS9", "ROR2", "TNF", "RASGRP1", "MAPK3"], 0.002730876545322101, 0, 0], [11, "toll-like receptor 4 signaling pathway (GO:0034142)", 2.3509528369431942e-05, 29.306213017751478, 312.3486883584108, ["TNIP3", "ITGB2", "LY96", "LGALS9"], 0.003017768550694355, 0, 0], [12, "positive regulation of monocyte chemotactic protein-1 production (GO:0071639)", 3.450110255719514e-05, 69.96, 718.8053685670126, ["IL1B", "OAS3", "LGALS9"], 0.004059629734229961, 0, 0], [13, "regulation of ERK1 and ERK2 cascade (GO:0070372)", 4.4051126306311475e-05, 5.273651921214078, 52.8955706402432, ["MARCO", "P2RY6", "CCL22", "CCL20", "IL1B", "ROR2", "LGALS9", "TNF", "RASGRP1", "MAPK3"], 0.004784630026500908, 0, 0], [14, "positive regulation of NF-kappaB transcription factor activity (GO:0051092)", 6.230793021625576e-05, 6.491032776747063, 62.855408616050035, ["TRIML2", "IL1B", "TRIM14", "IRAK3", "LGALS9", "TICAM1", "TNF", "NFKB2"], 0.005997057412184823, 0, 0], [15, "cellular response to molecule of bacterial origin (GO:0071219)", 6.415020130959454e-05, 7.69929718875502, 74.33119649287488, ["IL1B", "TNIP3", "LY96", "IL36G", "TICAM1", "CXCL3", "CXCL2"], 0.005997057412184823, 0, 0], [16, "regulation of NIK/NF-kappaB signaling (GO:1901222)", 6.7955324783964e-05, 9.590386793979608, 92.03568187860228, ["TNFSF14", "IL23A", "IL1B", "IFI35", "LGALS9", "TNF"], 0.005997057412184823, 0, 0], [17, "regulation of monocyte chemotactic protein-1 production (GO:0071637)", 9.972841131117317e-05, 43.71838235294118, 402.7800776910224, ["IL1B", "OAS3", "LGALS9"], 0.008101483528434912, 0, 0], [18, "regulation of tumor necrosis factor production (GO:0032680)", 0.00010327670220384449, 7.103799814643188, 65.19937614626235, ["IL23A", "OAS3", "LY96", "IRAK3", "LGALS9", "RASGRP1", "CD34"], 0.008101483528434912, 0, 0], [19, "cellular response to oxygen-containing compound (GO:1901701)", 0.00012144670216190336, 4.2470916429249765, 38.29192714188225, ["P2RY6", "NCF1", "IL1B", "TNIP3", "IL36G", "LY96", "TICAM1", "CXCL3", "MMP9", "CXCL2", "MAPK3"], 0.009025407550137239, 0, 0], [20, "positive regulation of interferon-gamma production (GO:0032729)", 0.00013300178754737025, 11.318108974358974, 101.01579755887985, ["IL23A", "IL1B", "EBI3", "LGALS9", "RASGRP1"], 0.009091155572040047, 0, 0], [21, "toll-like receptor signaling pathway (GO:0002224)", 0.0001393843496299388, 8.344628390278267, 74.0859084209299, ["TNIP3", "ITGB2", "LY96", "IRAK3", "LGALS9", "TICAM1"], 0.009091155572040047, 0, 0], [22, "positive regulation of MAPK cascade (GO:0043410)", 0.00014164689984764946, 4.546151701059676, 40.28878384977993, ["MARCO", "P2RY6", "CCL22", "CCL20", "GPR37L1", "ROR2", "LGALS9", "TNF", "RASGRP1", "MAPK3"], 0.009091155572040047, 0, 0], [23, "positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725)", 0.00021584140511492314, 31.7903743315508, 268.34148969982266, ["IL23A", "IL1B", "RASGRP1"], 0.013250785392272672, 0, 0], [24, "positive regulation of osteoclast differentiation (GO:0045672)", 0.00026808936576931366, 29.139705882352942, 239.65048292709187, ["CSF1", "IL23A", "TNF"], 0.015686027970325044, 0, 0], [25, "regulation of p38MAPK cascade (GO:1900744)", 0.00028576547120654183, 14.19688004303389, 115.8513555161933, ["NCF1", "IL1B", "LGALS9", "RASGRP1"], 0.015686027970325044, 0, 0], [26, "positive regulation of intracellular signal transduction (GO:1902533)", 0.00029365827722059964, 3.193478980470043, 25.97286406144295, ["CSF3", "NCF1", "TNFSF14", "GPR37L1", "IFI35", "TICAM1", "TNF", "TRIML2", "IL23A", "IL1B", "TRIM14", "ROR2", "LGALS9", "HBEGF"], 0.015686027970325044, 0, 0], [27, "positive regulation of DNA-binding transcription factor activity (GO:0051091)", 0.0002999452940501248, 4.536122259956777, 36.79661757709515, ["CSF3", "TRIML2", "IL1B", "TRIM14", "IRAK3", "LGALS9", "TICAM1", "TNF", "NFKB2"], 0.015686027970325044, 0, 0], [28, "regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645)", 0.00032786274064216056, 26.89683257918552, 215.79101529138512, ["IL23A", "IL1B", "RASGRP1"], 0.015963523785749334, 0, 0], [29, "positive regulation of alpha-beta T cell proliferation (GO:0046641)", 0.00032786274064216056, 26.89683257918552, 215.79101529138512, ["IL23A", "EBI3", "LGALS9"], 0.015963523785749334, 0, 0], [30, "regulation of viral entry into host cell (GO:0046596)", 0.0003511303381284613, 13.384277261200339, 106.46326691869795, ["IFITM3", "TRIML2", "TRIM14", "LGALS9"], 0.015996760017102783, 0, 0], [31, "neutrophil chemotaxis (GO:0030593)", 0.0003512036547664209, 9.0485347985348, 71.97335139834395, ["CCL22", "CCL20", "ITGB2", "CXCL3", "CXCL2"], 0.015996760017102783, 0, 0], [32, "regulation of nitric oxide biosynthetic process (GO:0045428)", 0.00038753028688949645, 13.011834319526628, 102.21728224242763, ["IL1B", "TNF", "CD34", "KLF2"], 0.01709977390899903, 0, 0], [33, "granulocyte chemotaxis (GO:0071621)", 0.00042686834028423466, 8.648021708683473, 67.10030250314561, ["CCL22", "CCL20", "ITGB2", "CXCL3", "CXCL2"], 0.01772759107298057, 0, 0], [34, "response to molecule of bacterial origin (GO:0002237)", 0.00042686834028423466, 8.648021708683473, 67.10030250314561, ["IL1B", "LY96", "IRAK3", "LGALS9", "CXCL2"], 0.01772759107298057, 0, 0], [35, "positive regulation of protein metabolic process (GO:0051247)", 0.0004961645701772474, 6.499368236005054, 49.45111195377378, ["CSF1", "IL23A", "IL1B", "TNF", "RASGRP1", "KLF2"], 0.02001669637400781, 0, 0], [36, "neutrophil migration (GO:1990266)", 0.0005461259431670047, 8.165922619047619, 61.34780792921131, ["CCL22", "CCL20", "ITGB2", "CXCL3", "CXCL2"], 0.020682010978795372, 0, 0], [37, "positive regulation of tumor necrosis factor production (GO:0032760)", 0.0005461259431670047, 8.165922619047619, 61.34780792921131, ["IL23A", "OAS3", "LY96", "LGALS9", "RASGRP1"], 0.020682010978795372, 0, 0], [38, "regulation of neuroinflammatory response (GO:0150077)", 0.0005565980291743798, 21.850367647058825, 163.73938443084637, ["IL1B", "MMP9", "TNF"], 0.020682010978795372, 0, 0], [39, "lipopolysaccharide-mediated signaling pathway (GO:0031663)", 0.0006506730511606745, 20.56401384083045, 150.8885187494502, ["IL1B", "TICAM1", "TNF"], 0.02244702549334412, 0, 0], [40, "positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557)", 0.0006888243693150544, 7.734570802005012, 56.31173010247803, ["IL23A", "OAS3", "LY96", "LGALS9", "RASGRP1"], 0.02244702549334412, 0, 0], [41, "positive regulation of cytokine production (GO:0001819)", 0.0006950579350520425, 3.68135913166588, 26.769059457178095, ["C3", "IL23A", "IL1B", "EBI3", "LGALS9", "TICAM1", "TNF", "RASGRP1", "CD34", "NFKB2"], 0.02244702549334412, 0, 0], [42, "regulation of fever generation (GO:0031620)", 0.000731277034485715, 77.28654970760233, 558.0643953055676, ["IL1B", "TNF"], 0.02244702549334412, 0, 0], [43, "chronic inflammatory response (GO:0002544)", 0.000731277034485715, 77.28654970760233, 558.0643953055676, ["VNN1", "TNF"], 0.02244702549334412, 0, 0], [44, "positive regulation of glial cell proliferation (GO:0060252)", 0.000731277034485715, 77.28654970760233, 558.0643953055676, ["IL1B", "TNF"], 0.02244702549334412, 0, 0], [45, "positive regulation of heat generation (GO:0031652)", 0.000731277034485715, 77.28654970760233, 558.0643953055676, ["IL1B", "TNF"], 0.02244702549334412, 0, 0], [46, "response to salt stress (GO:0009651)", 0.000731277034485715, 77.28654970760233, 558.0643953055676, ["KMO", "TNF"], 0.02244702549334412, 0, 0], [47, "cellular response to mechanical stimulus (GO:0071260)", 0.000845748232922839, 10.404733727810651, 73.61649642408294, ["TNFSF14", "IL1B", "TNFRSF10A", "MAPK3"], 0.025408436274192526, 0, 0], [48, "regulation of interferon-gamma production (GO:0032649)", 0.0009043943710629337, 7.255291005291006, 50.84685721266007, ["IL23A", "IL1B", "EBI3", "LGALS9", "RASGRP1"], 0.026061323508997192, 0, 0], [49, "response to interleukin-1 (GO:0070555)", 0.0009043943710629337, 7.255291005291006, 50.84685721266007, ["CCL22", "CCL20", "IL1B", "IRAK3", "LGALS9"], 0.026061323508997192, 0, 0], [50, "negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240)", 0.0009917524046789655, 17.476764705882353, 120.86995263753771, ["IL1B", "IFI6", "TNF"], 0.0269298922193596, 0, 0], [51, "negative regulation of signal transduction in absence of ligand (GO:1901099)", 0.0009917524046789655, 17.476764705882353, 120.86995263753771, ["IL1B", "IFI6", "TNF"], 0.0269298922193596, 0, 0], [52, "regulation of mononuclear cell migration (GO:0071675)", 0.0009917524046789655, 17.476764705882353, 120.86995263753771, ["CSF1", "TNF", "MAPK3"], 0.0269298922193596, 0, 0], [53, "positive regulation of gene expression (GO:0010628)", 0.0010271296305251261, 3.069697370159905, 21.12254810775981, ["OLFM1", "C1QTNF1", "CSF1", "IL1B", "HEY2", "IL36G", "LGALS9", "SLC26A9", "TICAM1", "TNF", "CD34", "MAPK3"], 0.027018201203948, 0, 0], [54, "negative regulation of cytokine production (GO:0001818)", 0.0010551763958043055, 4.735421686746988, 32.45680435055313, ["HERC5", "IL23A", "UBE2L6", "IRAK3", "LGALS9", "TNF", "CD34"], 0.027018201203948, 0, 0], [55, "positive regulation of fever generation (GO:0031622)", 0.0010906780939270793, 57.961988304093566, 395.3561528627805, ["IL1B", "TNF"], 0.027018201203948, 0, 0], [56, "positive regulation of histone phosphorylation (GO:0033129)", 0.0010906780939270793, 57.961988304093566, 395.3561528627805, ["IL1B", "MAPK3"], 0.027018201203948, 0, 0], [57, "ISG15-protein conjugation (GO:0032020)", 0.0010906780939270793, 57.961988304093566, 395.3561528627805, ["HERC5", "UBE2L6"], 0.027018201203948, 0, 0], [58, "positive regulation of chemokine production (GO:0032722)", 0.0011379464378541897, 9.553435575413598, 64.7582497589396, ["IL1B", "OAS3", "LGALS9", "TNF"], 0.02723356559745959, 0, 0], [59, "positive regulation of phagocytosis (GO:0050766)", 0.0011379464378541897, 9.553435575413598, 64.7582497589396, ["C3", "IL1B", "IL2RG", "TNF"], 0.02723356559745959, 0, 0], [60, "innate immune response (GO:0045087)", 0.0012960634223348224, 3.6586614500957295, 24.32433166069365, ["IFITM3", "C3", "PGLYRP4", "VNN1", "NCF1", "TRIML2", "IFI6", "TRIM14", "WFDC5"], 0.030500692538946154, 0, 0], [61, "chemokine-mediated signaling pathway (GO:0070098)", 0.0013989322570344095, 9.000910332271278, 59.15439680758923, ["CCL22", "CCL20", "CXCL3", "CXCL2"], 0.03166255194735305, 0, 0], [62, "positive regulation of cellular catabolic process (GO:0031331)", 0.0014374223161502692, 5.240718562874251, 34.29999898201208, ["DTX3L", "TRIML2", "IL1B", "TRIM14", "TICAM1", "TNF"], 0.03166255194735305, 0, 0], [63, "positive regulation of protein phosphorylation (GO:0001934)", 0.0014997759631962095, 3.308125010621484, 21.51088287199117, ["C3", "MARCO", "CSF3", "CSF1", "IL1B", "APLNR", "TNF", "RASGRP1", "MMP9", "MAPK3"], 0.03166255194735305, 0, 0], [64, "regulation of calcidiol 1-monooxygenase activity (GO:0060558)", 0.0015182716250434199, 46.3672514619883, 300.9319323525674, ["IL1B", "TNF"], 0.03166255194735305, 0, 0], [65, "negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128)", 0.0015182716250434199, 46.3672514619883, 300.9319323525674, ["LY96", "TICAM1"], 0.03166255194735305, 0, 0], [66, "positive regulation of gliogenesis (GO:0014015)", 0.0015182716250434199, 46.3672514619883, 300.9319323525674, ["IL1B", "TNF"], 0.03166255194735305, 0, 0], [67, "intermediate filament bundle assembly (GO:0045110)", 0.0015182716250434199, 46.3672514619883, 300.9319323525674, ["NEFM", "NEFH"], 0.03166255194735305, 0, 0], [68, "negative regulation of macromolecule metabolic process (GO:0010605)", 0.0015248254478895235, 4.428838348044585, 28.72489340815606, ["OLFM1", "HEY2", "APLNR", "LGALS9", "PARP14", "TNF", "CD34"], 0.03166255194735305, 0, 0], [69, "cellular response to cadmium ion (GO:0071276)", 0.0015969630584689977, 14.561029411764705, 93.76795550233355, ["NCF1", "MMP9", "MAPK3"], 0.032213026265117496, 0, 0], [70, "positive regulation of nitric oxide biosynthetic process (GO:0045429)", 0.0015969630584689977, 14.561029411764705, 93.76795550233355, ["IL1B", "TNF", "KLF2"], 0.032213026265117496, 0, 0], [71, "positive regulation of phosphorylation (GO:0042327)", 0.0016537018579142347, 3.875225726654298, 24.819809166346133, ["C3", "MARCO", "IL1B", "ROR2", "TNF", "RASGRP1", "MMP9", "MAPK3"], 0.03288770455457605, 0, 0], [72, "regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239)", 0.0017773040502781071, 13.977882352941176, 88.51714349164372, ["IL1B", "IFI6", "TNF"], 0.03437744272592722, 0, 0], [73, "positive regulation of nitric oxide metabolic process (GO:1904407)", 0.0017773040502781071, 13.977882352941176, 88.51714349164372, ["IL1B", "TNF", "KLF2"], 0.03437744272592722, 0, 0], [74, "cellular response to chemokine (GO:1990869)", 0.0018082506675976588, 8.35629754860524, 52.77332295776591, ["CCL22", "CCL20", "CXCL3", "CXCL2"], 0.03450337760334992, 0, 0], [75, "response to cytokine (GO:0034097)", 0.0019681702360914302, 4.9109281437125745, 30.59827926122385, ["IFITM3", "CSF3", "IL1B", "MX2", "IRAK3", "LGALS9"], 0.035527062945394074, 0, 0], [76, "response to cadmium ion (GO:0046686)", 0.0019698643960480823, 13.439592760180995, 83.7258482836087, ["NCF1", "MMP9", "MAPK3"], 0.035527062945394074, 0, 0], [77, "cellular response to interleukin-21 (GO:0098757)", 0.0020128647561129787, 38.63742690058479, 239.8687314915621, ["IL21R", "IL2RG"], 0.035527062945394074, 0, 0], [78, "regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127)", 0.0020128647561129787, 38.63742690058479, 239.8687314915621, ["LY96", "TICAM1"], 0.035527062945394074, 0, 0], [79, "interleukin-21-mediated signaling pathway (GO:0038114)", 0.0020128647561129787, 38.63742690058479, 239.8687314915621, ["IL21R", "IL2RG"], 0.035527062945394074, 0, 0], [80, "vascular associated smooth muscle cell differentiation (GO:0035886)", 0.0020128647561129787, 38.63742690058479, 239.8687314915621, ["HEY2", "APLNR"], 0.035527062945394074, 0, 0], [81, "regulation of protein phosphorylation (GO:0001932)", 0.002259728925449625, 3.677519379844961, 22.405325131833937, ["C3", "MARCO", "IL1B", "ITGB2", "TNF", "RASGRP1", "MMP9", "MAPK3"], 0.03939181781154161, 0, 0], [82, "regulation of phosphatidylinositol 3-kinase signaling (GO:0014066)", 0.002291769747756061, 5.8127062706270625, 35.33213366533303, ["CSF3", "NCF1", "ROR2", "TNF", "MAPK3"], 0.03946315711989705, 0, 0], [83, "MyD88-independent toll-like receptor signaling pathway (GO:0002756)", 0.002392768780111546, 12.478361344537815, 75.31070536104531, ["TNIP3", "LY96", "TICAM1"], 0.040705897801415696, 0, 0], [84, "regulation of endothelial cell development (GO:1901550)", 0.0025732799260982397, 33.11612364243943, 197.4573364181925, ["IL1B", "TNF"], 0.04070983328714405, 0, 0], [85, "negative regulation of protein-containing complex disassembly (GO:0043242)", 0.0025732799260982397, 33.11612364243943, 197.4573364181925, ["IRAK3", "TNF"], 0.04070983328714405, 0, 0], [86, "regulation of gap junction assembly (GO:1903596)", 0.0025732799260982397, 33.11612364243943, 197.4573364181925, ["IL1B", "APLNR"], 0.04070983328714405, 0, 0], [87, "cellular response to interleukin-9 (GO:0071355)", 0.0025732799260982397, 33.11612364243943, 197.4573364181925, ["STAT5A", "IL2RG"], 0.04070983328714405, 0, 0], [88, "regulation of glial cell proliferation (GO:0060251)", 0.0025732799260982397, 33.11612364243943, 197.4573364181925, ["IL1B", "TNF"], 0.04070983328714405, 0, 0], [89, "interleukin-9-mediated signaling pathway (GO:0038113)", 0.0025732799260982397, 33.11612364243943, 197.4573364181925, ["STAT5A", "IL2RG"], 0.04070983328714405, 0, 0], [90, "positive regulation of immune effector process (GO:0002699)", 0.002623650728845686, 12.047464503042596, 71.60035276747669, ["IL23A", "IL1B", "LGALS9"], 0.04070983328714405, 0, 0], [91, "positive regulation of interleukin-10 production (GO:0032733)", 0.002623650728845686, 12.047464503042596, 71.60035276747669, ["IL23A", "LGALS9", "CD34"], 0.04070983328714405, 0, 0], [92, "positive regulation of protein modification process (GO:0031401)", 0.002653302757678234, 3.996856993190152, 23.709156205861028, ["C3", "MARCO", "IL1B", "TNF", "RASGRP1", "MMP9", "MAPK3"], 0.04072242928088768, 0, 0], [93, "positive regulation of histone modification (GO:0031058)", 0.0028678282231969165, 11.645294117647058, 68.17388376188518, ["IL1B", "APLNR", "MAPK3"], 0.0435416500124091, 0, 0], [94, "cellular response to lipid (GO:0071396)", 0.003016216191033543, 3.9015969538531485, 22.643901709468864, ["IL1B", "TNIP3", "IL36G", "LY96", "TICAM1", "CXCL3", "CXCL2"], 0.045307417678078325, 0, 0], [95, "positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742)", 0.003125546139385553, 11.269070208728653, 65.00164502557183, ["NCF1", "MMP9", "HBEGF"], 0.04645548577697264, 0, 0], [96, "negative regulation of viral process (GO:0048525)", 0.00318038235360875, 7.086605701990317, 40.75332504140195, ["IFITM3", "OAS3", "TRIM14", "TNF"], 0.04655749340505608, 0, 0], [97, "regulation of histone phosphorylation (GO:0033127)", 0.0031983547169195745, 28.97514619883041, 166.46565577927367, ["IL1B", "MAPK3"], 0.04655749340505608, 0, 0], [98, "myeloid leukocyte differentiation (GO:0002573)", 0.0033478568787187, 6.980482204362802, 39.78480372377512, ["CSF3", "CSF1", "LGALS9", "MMP9"], 0.04823385931064257, 0, 0], [99, "negative regulation of neurogenesis (GO:0050768)", 0.003397040047198756, 10.916360294117647, 62.05787956074492, ["LINGO1", "IL1B", "TNF"], 0.04823385931064257, 0, 0], [100, "regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122)", 0.003415995701886868, 3.810726778080062, 21.642208236266455, ["TRIML2", "IL1B", "TNIP3", "TRIM14", "LGALS9", "TICAM1", "TNF"], 0.04823385931064257, 0, 0], [101, "negative regulation of toll-like receptor signaling pathway (GO:0034122)", 0.003682536381138811, 10.585026737967915, 59.320114960938064, ["LY96", "IRAK3", "TICAM1"], 0.04989419689366647, 0, 0], [102, "regulation of osteoclast differentiation (GO:0045670)", 0.003682536381138811, 10.585026737967915, 59.320114960938064, ["CSF1", "IL23A", "TNF"], 0.04989419689366647, 0, 0], [103, "positive regulation of myeloid leukocyte differentiation (GO:0002763)", 0.003682536381138811, 10.585026737967915, 59.320114960938064, ["CSF1", "IL23A", "TNF"], 0.04989419689366647, 0, 0], [104, "macrophage activation (GO:0042116)", 0.003682536381138811, 10.585026737967915, 59.320114960938064, ["ITGB2", "IFI35", "TNF"], 0.04989419689366647, 0, 0], [105, "regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267)", 0.0038869416843507875, 25.75438596491228, 142.94025790855406, ["LGALS9", "MMP9"], 0.04989419689366647, 0, 0], [106, "cellular response to interleukin-2 (GO:0071352)", 0.0038869416843507875, 25.75438596491228, 142.94025790855406, ["STAT5A", "IL2RG"], 0.04989419689366647, 0, 0], [107, "negative regulation of sprouting angiogenesis (GO:1903671)", 0.0038869416843507875, 25.75438596491228, 142.94025790855406, ["ADAMTS9", "KLF2"], 0.04989419689366647, 0, 0], [108, "positive regulation of epidermal growth factor-activated receptor activity (GO:0045741)", 0.0038869416843507875, 25.75438596491228, 142.94025790855406, ["NCF1", "HBEGF"], 0.04989419689366647, 0, 0], [109, "interleukin-2-mediated signaling pathway (GO:0038110)", 0.0038869416843507875, 25.75438596491228, 142.94025790855406, ["STAT5A", "IL2RG"], 0.04989419689366647, 0, 0], [110, "positive regulation of transforming growth factor beta production (GO:0071636)", 0.0038869416843507875, 25.75438596491228, 142.94025790855406, ["LGALS9", "CD34"], 0.04989419689366647, 0, 0], [111, "cellular response to interferon-gamma (GO:0071346)", 0.004054085364089783, 5.057214696223317, 27.85529114530709, ["CCL22", "CCL20", "OAS3", "LGALS9", "IRF9"], 0.0514092899401848, 0, 0], [112, "positive regulation of immune response (GO:0050778)", 0.004077790703470749, 6.585882156846404, 36.23684035209868, ["IL23A", "ITGB2", "IFI35", "LGALS9"], 0.0514092899401848, 0, 0], [113, "positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068)", 0.004480132092886452, 6.404798573397098, 34.637808764987156, ["CSF3", "NCF1", "ROR2", "TNF"], 0.05457271971917211, 0, 0], [114, "defense response to symbiont (GO:0140546)", 0.004497821855946495, 4.928971588635454, 26.636961113148434, ["IFITM3", "OAS3", "MX2", "IFI6", "IFIT3"], 0.05457271971917211, 0, 0], [115, "regulation of natural killer cell activation (GO:0032814)", 0.004637908191431057, 23.177777777777777, 124.54559964711954, ["IL23A", "TICAM1"], 0.05457271971917211, 0, 0], [116, "positive regulation of leukocyte proliferation (GO:0070665)", 0.004637908191431057, 23.177777777777777, 124.54559964711954, ["CSF1", "MAPK3"], 0.05457271971917211, 0, 0], [117, "positive regulation of myeloid leukocyte mediated immunity (GO:0002888)", 0.004637908191431057, 23.177777777777777, 124.54559964711954, ["ITGB2", "TICAM1"], 0.05457271971917211, 0, 0], [118, "positive regulation of neuroinflammatory response (GO:0150078)", 0.004637908191431057, 23.177777777777777, 124.54559964711954, ["IL1B", "TNF"], 0.05457271971917211, 0, 0], [119, "smooth muscle cell differentiation (GO:0051145)", 0.004637908191431057, 23.177777777777777, 124.54559964711954, ["HEY2", "APLNR"], 0.05457271971917211, 0, 0], [120, "positive regulation of T-helper 1 type immune response (GO:0002827)", 0.004637908191431057, 23.177777777777777, 124.54559964711954, ["IL23A", "IL1B"], 0.05457271971917211, 0, 0], [121, "MAPK cascade (GO:0000165)", 0.0049673532950382775, 3.2101900359527478, 17.029634771015218, ["IL1B", "LGALS9", "IL2RG", "TNF", "RASGRP1", "GRIN1", "HBEGF", "MAPK3"], 0.057966139277636754, 0, 0], [122, "negative regulation of extrinsic apoptotic signaling pathway (GO:2001237)", 0.005132482124475969, 6.151043288695111, 32.42932062618239, ["IL1B", "IFI6", "TNFRSF10A", "TNF"], 0.05891922568910625, 0, 0], [123, "response to interferon-gamma (GO:0034341)", 0.005132482124475969, 6.151043288695111, 32.42932062618239, ["IFITM3", "CCL22", "CCL20", "LGALS9"], 0.05891922568910625, 0, 0], [124, "regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341)", 0.00545013624169113, 21.06964380648591, 109.81739962063325, ["OAS3", "TNF"], 0.05965575483153392, 0, 0], [125, "cellular response to interleukin-15 (GO:0071350)", 0.00545013624169113, 21.06964380648591, 109.81739962063325, ["STAT5A", "IL2RG"], 0.05965575483153392, 0, 0], [126, "regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994)", 0.00545013624169113, 21.06964380648591, 109.81739962063325, ["ITGB2", "TNF"], 0.05965575483153392, 0, 0], [127, "positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824)", 0.00545013624169113, 21.06964380648591, 109.81739962063325, ["IL23A", "IL1B"], 0.05965575483153392, 0, 0], [128, "regulation of T cell differentiation in thymus (GO:0033081)", 0.00545013624169113, 21.06964380648591, 109.81739962063325, ["VNN1", "TOX"], 0.05965575483153392, 0, 0], [129, "interleukin-15-mediated signaling pathway (GO:0035723)", 0.00545013624169113, 21.06964380648591, 109.81739962063325, ["STAT5A", "IL2RG"], 0.05965575483153392, 0, 0], [130, "positive regulation of epithelial to mesenchymal transition (GO:0010718)", 0.005701137915144384, 8.953846153846154, 46.26532435509357, ["OLFM1", "IL1B", "PDPN"], 0.061923128739875925, 0, 0], [131, "regulation of gene expression (GO:0010468)", 0.005815608703526951, 2.05398437262473, 10.57228853356875, ["CSF1", "NFYA", "IL36G", "TICAM1", "PARP14", "TNF", "NFKB2", "OLFM1", "C1QTNF1", "TRIML2", "IL1B", "HEY2", "APLNR", "TRIM14", "LGALS9", "SLC26A9", "CD34", "MAPK3"], 0.06268427091129812, 0, 0], [132, "defense response to virus (GO:0051607)", 0.006035660310469209, 4.5803106398809526, 23.40570806902802, ["IFITM3", "OAS3", "MX2", "IFI6", "IFIT3"], 0.06456327544229185, 0, 0], [133, "natural killer cell activation (GO:0030101)", 0.0060902598536974936, 8.729558823529413, 44.530042870748964, ["IL21R", "TOX", "RASGRP1"], 0.06465749558963053, 0, 0], [134, "aorta development (GO:0035904)", 0.006322522312669346, 19.31286549707602, 97.79334127916395, ["APLNR", "ADAMTS9"], 0.06469131525716751, 0, 0], [135, "negative regulation of viral transcription (GO:0032897)", 0.006322522312669346, 19.31286549707602, 97.79334127916395, ["IFITM3", "TRIM14"], 0.06469131525716751, 0, 0], [136, "regulation of vasculogenesis (GO:2001212)", 0.006322522312669346, 19.31286549707602, 97.79334127916395, ["HEY2", "CD34"], 0.06469131525716751, 0, 0], [137, "positive regulation of macrophage chemotaxis (GO:0010759)", 0.006322522312669346, 19.31286549707602, 97.79334127916395, ["CSF1", "MAPK3"], 0.06469131525716751, 0, 0], [138, "positive regulation of transmembrane transport (GO:0034764)", 0.006322522312669346, 19.31286549707602, 97.79334127916395, ["C3", "ACSL5"], 0.06469131525716751, 0, 0], [139, "negative regulation of angiogenesis (GO:0016525)", 0.00689514389591373, 5.630284451415128, 28.021576064747066, ["ECSCR", "TNF", "ADAMTS9", "KLF2"], 0.0700427566980589, 0, 0], [140, "positive regulation of response to external stimulus (GO:0032103)", 0.007246147613400754, 4.373889481165601, 21.551401410015742, ["IL23A", "IL1B", "LY96", "IFI35", "TNF"], 0.07013496343639888, 0, 0], [141, "positive regulation of acute inflammatory response (GO:0002675)", 0.007253977195795924, 17.826360773729196, 87.81631438144224, ["IL1B", "TNF"], 0.07013496343639888, 0, 0], [142, "positive regulation of heterotypic cell-cell adhesion (GO:0034116)", 0.007253977195795924, 17.826360773729196, 87.81631438144224, ["IL1B", "TNF"], 0.07013496343639888, 0, 0], [143, "positive regulation of membrane protein ectodomain proteolysis (GO:0051044)", 0.007253977195795924, 17.826360773729196, 87.81631438144224, ["IL1B", "TNF"], 0.07013496343639888, 0, 0], [144, "positive regulation of natural killer cell activation (GO:0032816)", 0.007253977195795924, 17.826360773729196, 87.81631438144224, ["IL23A", "TICAM1"], 0.07013496343639888, 0, 0], [145, "macrophage differentiation (GO:0030225)", 0.007253977195795924, 17.826360773729196, 87.81631438144224, ["CSF1", "MMP9"], 0.07013496343639888, 0, 0], [146, "T cell proliferation (GO:0042098)", 0.007253977195795924, 17.826360773729196, 87.81631438144224, ["TNFSF14", "RASGRP1"], 0.07013496343639888, 0, 0], [147, "negative regulation of tumor necrosis factor production (GO:0032720)", 0.007351256790784019, 8.119288645690835, 39.88912318486773, ["IRAK3", "LGALS9", "CD34"], 0.07013496343639888, 0, 0], [148, "positive regulation of smooth muscle cell proliferation (GO:0048661)", 0.007351256790784019, 8.119288645690835, 39.88912318486773, ["P2RY6", "TNF", "MMP9"], 0.07013496343639888, 0, 0], [149, "positive regulation of inflammatory response (GO:0050729)", 0.007463705961976671, 5.497250261051166, 26.9239002517841, ["IL23A", "IL1B", "IFI35", "TNF"], 0.0707298846866514, 0, 0], [150, "positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996)", 0.008243425829305352, 16.552213868003342, 79.42313773345755, ["ITGB2", "TNF"], 0.07633448570562001, 0, 0], [151, "necroptotic process (GO:0070266)", 0.008243425829305352, 16.552213868003342, 79.42313773345755, ["LY96", "TICAM1"], 0.07633448570562001, 0, 0], [152, "negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556)", 0.008271371326458827, 7.75764705882353, 37.19756827591976, ["IRAK3", "LGALS9", "CD34"], 0.07633448570562001, 0, 0], [153, "regulation of interleukin-10 production (GO:0032653)", 0.008271371326458827, 7.75764705882353, 37.19756827591976, ["IL23A", "LGALS9", "CD34"], 0.07633448570562001, 0, 0], [154, "negative regulation of catabolic process (GO:0009895)", 0.008755652530847998, 7.588618925831202, 35.95529979150795, ["IL1B", "IRAK3", "TNF"], 0.07976117015198306, 0, 0], [155, "regulation of stress-activated MAPK cascade (GO:0032872)", 0.008755652530847998, 7.588618925831202, 35.95529979150795, ["LGALS9", "RASGRP1", "MAPK3"], 0.07976117015198306, 0, 0], [156, "regulation of cellular component movement (GO:0051270)", 0.009256239445322821, 7.4267834793491865, 34.77559741127963, ["PDPN", "ZSWIM4", "HBEGF"], 0.08097041783482231, 0, 0], [157, "negative regulation of chemokine production (GO:0032682)", 0.009289807145354968, 15.44795321637427, 72.27846258692112, ["OAS3", "LGALS9"], 0.08097041783482231, 0, 0], [158, "negative regulation of cytokine production involved in immune response (GO:0002719)", 0.009289807145354968, 15.44795321637427, 72.27846258692112, ["IRAK3", "TNF"], 0.08097041783482231, 0, 0], [159, "aorta morphogenesis (GO:0035909)", 0.009289807145354968, 15.44795321637427, 72.27846258692112, ["HEY2", "ADAMTS9"], 0.08097041783482231, 0, 0], [160, "regulation of establishment of endothelial barrier (GO:1903140)", 0.009289807145354968, 15.44795321637427, 72.27846258692112, ["IL1B", "TNF"], 0.08097041783482231, 0, 0], [161, "positive regulation of cytokine production involved in inflammatory response (GO:1900017)", 0.009289807145354968, 15.44795321637427, 72.27846258692112, ["TICAM1", "TNF"], 0.08097041783482231, 0, 0], [162, "modified amino acid transport (GO:0072337)", 0.009289807145354968, 15.44795321637427, 72.27846258692112, ["PDPN", "CTNS"], 0.08097041783482231, 0, 0], [163, "regulation of interleukin-12 production (GO:0032655)", 0.009773240857056827, 7.271691176470588, 33.65416594662001, ["IL23A", "IRAK3", "LGALS9"], 0.08466144840591558, 0, 0], [164, "regulation of MAP kinase activity (GO:0043405)", 0.010044746910230593, 5.022332506203474, 23.106272666744232, ["IL1B", "IRAK3", "TNF", "RASGRP1"], 0.0859017796368232, 0, 0], [165, "negative regulation of lipid catabolic process (GO:0050995)", 0.010392073899679458, 14.48172514619883, 66.1338663901299, ["IL1B", "TNF"], 0.0859017796368232, 0, 0], [166, "regulation of platelet aggregation (GO:0090330)", 0.010392073899679458, 14.48172514619883, 66.1338663901299, ["C1QTNF1", "PDPN"], 0.0859017796368232, 0, 0], [167, "regulation of protein-containing complex disassembly (GO:0043244)", 0.010392073899679458, 14.48172514619883, 66.1338663901299, ["IRAK3", "TNF"], 0.0859017796368232, 0, 0], [168, "regulation of transforming growth factor beta production (GO:0071634)", 0.010392073899679458, 14.48172514619883, 66.1338663901299, ["LGALS9", "CD34"], 0.0859017796368232, 0, 0], [169, "response to interferon-alpha (GO:0035455)", 0.010392073899679458, 14.48172514619883, 66.1338663901299, ["IFITM3", "MX2"], 0.0859017796368232, 0, 0], [170, "programmed necrotic cell death (GO:0097300)", 0.010392073899679458, 14.48172514619883, 66.1338663901299, ["LY96", "TICAM1"], 0.0859017796368232, 0, 0], [171, "positive regulation of defense response (GO:0031349)", 0.010403119205309326, 4.968651642956062, 22.68512235746034, ["IL23A", "IL1B", "IFI35", "TNF"], 0.0859017796368232, 0, 0], [172, "cellular response to interleukin-1 (GO:0071347)", 0.011283134234769916, 3.904166666666667, 17.508025426436667, ["CCL22", "CCL20", "IL1B", "IRAK3", "MAPK3"], 0.09009646323879053, 0, 0], [173, "negative regulation of viral genome replication (GO:0045071)", 0.011423720826488761, 6.842906574394464, 30.601911432913134, ["IFITM3", "OAS3", "TNF"], 0.09009646323879053, 0, 0], [174, "positive regulation of leukocyte chemotaxis (GO:0002690)", 0.011423720826488761, 6.842906574394464, 30.601911432913134, ["CSF1", "LGALS9", "MAPK3"], 0.09009646323879053, 0, 0], [175, "atrioventricular valve morphogenesis (GO:0003181)", 0.011549192525652327, 13.629170966632268, 60.80163643589166, ["OLFM1", "HEY2"], 0.09009646323879053, 0, 0], [176, "carbohydrate derivative catabolic process (GO:1901136)", 0.011549192525652327, 13.629170966632268, 60.80163643589166, ["BPGM", "ADAMTS9"], 0.09009646323879053, 0, 0], [177, "negative regulation of nervous system development (GO:0051961)", 0.011549192525652327, 13.629170966632268, 60.80163643589166, ["IL1B", "TNF"], 0.09009646323879053, 0, 0], [178, "cellular response to interleukin-7 (GO:0098761)", 0.011549192525652327, 13.629170966632268, 60.80163643589166, ["STAT5A", "IL2RG"], 0.09009646323879053, 0, 0], [179, "regulation of glucose transmembrane transport (GO:0010827)", 0.011549192525652327, 13.629170966632268, 60.80163643589166, ["C3", "IL1B"], 0.09009646323879053, 0, 0], [180, "positive regulation of macrophage migration (GO:1905523)", 0.011549192525652327, 13.629170966632268, 60.80163643589166, ["CSF1", "MAPK3"], 0.09009646323879053, 0, 0], [181, "interleukin-7-mediated signaling pathway (GO:0038111)", 0.011549192525652327, 13.629170966632268, 60.80163643589166, ["STAT5A", "IL2RG"], 0.09009646323879053, 0, 0], [182, "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154)", 0.012007336899450013, 6.710972850678733, 29.67751518260261, ["IFI6", "TNF", "MMP9"], 0.09264677432799683, 0, 0], [183, "negative regulation of cytokine-mediated signaling pathway (GO:0001960)", 0.012007336899450013, 6.710972850678733, 29.67751518260261, ["OAS3", "IRAK3", "PARP14"], 0.09264677432799683, 0, 0], [184, "positive regulation of cell motility (GO:2000147)", 0.012639122578669719, 3.2773151371675255, 14.325007829742932, ["CSF1", "IL1B", "PDPN", "ROR2", "MMP9", "HBEGF"], 0.0948280098700465, 0, 0], [185, "cardiac epithelial to mesenchymal transition (GO:0060317)", 0.012760142971181894, 12.871345029239766, 56.13745486008712, ["OLFM1", "HEY2"], 0.0948280098700465, 0, 0], [186, "regulation of granulocyte chemotaxis (GO:0071622)", 0.012760142971181894, 12.871345029239766, 56.13745486008712, ["CSF1", "MAPK3"], 0.0948280098700465, 0, 0], [187, "positive regulation of alpha-beta T cell activation (GO:0046635)", 0.012760142971181894, 12.871345029239766, 56.13745486008712, ["IL23A", "EBI3"], 0.0948280098700465, 0, 0], [188, "positive regulation of nitrogen compound metabolic process (GO:0051173)", 0.012760142971181894, 12.871345029239766, 56.13745486008712, ["TNF", "KLF2"], 0.0948280098700465, 0, 0], [189, "positive regulation of peptidyl-lysine acetylation (GO:2000758)", 0.012760142971181894, 12.871345029239766, 56.13745486008712, ["IL1B", "MAPK3"], 0.0948280098700465, 0, 0], [190, "modulation by symbiont of entry into host (GO:0052372)", 0.012760142971181894, 12.871345029239766, 56.13745486008712, ["TRIML2", "TRIM14"], 0.0948280098700465, 0, 0], [191, "regulation of phagocytosis (GO:0050764)", 0.01385962979711768, 6.343957219251337, 27.14436552378812, ["IL1B", "IL2RG", "TNF"], 0.10154755381284553, 0, 0], [192, "positive regulation of protein binding (GO:0032092)", 0.01385962979711768, 6.343957219251337, 27.14436552378812, ["CSF3", "DTX3L", "MMP9"], 0.10154755381284553, 0, 0], [193, "purinergic nucleotide receptor signaling pathway (GO:0035590)", 0.014023918550640849, 12.19329024315174, 52.0286589869924, ["C3", "IL1B"], 0.10154755381284553, 0, 0], [194, "regulation of lipid catabolic process (GO:0050994)", 0.014023918550640849, 12.19329024315174, 52.0286589869924, ["IL1B", "TNF"], 0.10154755381284553, 0, 0], [195, "positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707)", 0.014023918550640849, 12.19329024315174, 52.0286589869924, ["P2RY6", "MMP9"], 0.10154755381284553, 0, 0], [196, "response to reactive oxygen species (GO:0000302)", 0.014511092267689221, 6.230357142857143, 26.37211700317894, ["NCF1", "MMP9", "MAPK3"], 0.1040084379795796, 0, 0], [197, "positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531)", 0.014511092267689221, 6.230357142857143, 26.37211700317894, ["IL23A", "PARP14", "TNF"], 0.1040084379795796, 0, 0], [198, "regulation of MAPK cascade (GO:0043408)", 0.014811739337954852, 3.635388938183969, 15.313476841324801, ["IL1B", "GPR37L1", "ROR2", "RASGRP1", "MAPK3"], 0.10562715123834471, 0, 0], [199, "Notch signaling pathway (GO:0007219)", 0.015179664476704345, 6.120743034055727, 25.632439171672065, ["DTX3L", "HEY2", "DTX2"], 0.10579409824987991, 0, 0], [200, "regulation of lipid storage (GO:0010883)", 0.015339525786894424, 11.583040935672514, 48.386096326206, ["C3", "TNF"], 0.10579409824987991, 0, 0], [201, "regulation of macrophage chemotaxis (GO:0010758)", 0.015339525786894424, 11.583040935672514, 48.386096326206, ["CSF1", "MAPK3"], 0.10579409824987991, 0, 0], [202, "regulation of membrane protein ectodomain proteolysis (GO:0051043)", 0.015339525786894424, 11.583040935672514, 48.386096326206, ["IL1B", "TNF"], 0.10579409824987991, 0, 0], [203, "positive regulation of neural precursor cell proliferation (GO:2000179)", 0.015339525786894424, 11.583040935672514, 48.386096326206, ["TOX", "NES"], 0.10579409824987991, 0, 0], [204, "microglial cell activation (GO:0001774)", 0.015339525786894424, 11.583040935672514, 48.386096326206, ["ITGB2", "TNF"], 0.10579409824987991, 0, 0], [205, "regulation of interleukin-6 production (GO:0032675)", 0.015359624745910327, 4.403483309143686, 18.389003465734625, ["IL1B", "IRAK3", "LGALS9", "TNF"], 0.10579409824987991, 0, 0], [206, "positive regulation of interleukin-8 production (GO:0032757)", 0.015865394473954818, 6.014908722109533, 24.923465943454882, ["IL1B", "LGALS9", "TNF"], 0.10874726697681651, 0, 0], [207, "regulation of neurogenesis (GO:0050767)", 0.016568324920600713, 5.912662013958125, 24.243466589662333, ["IL1B", "HEY2", "TNF"], 0.11126815932363315, 0, 0], [208, "I-kappaB kinase/NF-kappaB signaling (GO:0007249)", 0.016568324920600713, 5.912662013958125, 24.243466589662333, ["LY96", "TICAM1", "TNF"], 0.11126815932363315, 0, 0], [209, "positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123)", 0.016635438298817876, 3.524992828456684, 14.439146200867302, ["TRIML2", "TRIM14", "LGALS9", "TICAM1", "TNF"], 0.11126815932363315, 0, 0], [210, "regulation of neural precursor cell proliferation (GO:2000177)", 0.016705984261055403, 11.030910609857978, 45.1383569857974, ["TOX", "NES"], 0.11126815932363315, 0, 0], [211, "ERK1 and ERK2 cascade (GO:0070371)", 0.016705984261055403, 11.030910609857978, 45.1383569857974, ["LGALS9", "MAPK3"], 0.11126815932363315, 0, 0], [212, "positive regulation of histone acetylation (GO:0035066)", 0.016705984261055403, 11.030910609857978, 45.1383569857974, ["IL1B", "MAPK3"], 0.11126815932363315, 0, 0], [213, "cellular response to reactive oxygen species (GO:0034614)", 0.017288493198930412, 5.813823529411764, 23.590833895011638, ["NCF1", "MMP9", "MAPK3"], 0.11409179509234103, 0, 0], [214, "response to lipid (GO:0033993)", 0.0172915326839667, 4.242495965572888, 17.214090027113542, ["IL1B", "LY96", "IRAK3", "LGALS9"], 0.11409179509234103, 0, 0], [215, "antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844)", 0.018025931528963177, 5.7182256509161045, 22.9640735206309, ["PGLYRP4", "CXCL3", "CXCL2"], 0.11737947232147221, 0, 0], [216, "negative regulation of lipid metabolic process (GO:0045833)", 0.01812232646323013, 10.528973950026582, 42.227614474226755, ["IL1B", "TNF"], 0.11737947232147221, 0, 0], [217, "positive regulation of p38MAPK cascade (GO:1900745)", 0.01812232646323013, 10.528973950026582, 42.227614474226755, ["NCF1", "IL1B"], 0.11737947232147221, 0, 0], [218, "protein kinase B signaling (GO:0043491)", 0.01812232646323013, 10.528973950026582, 42.227614474226755, ["IL1B", "TNF"], 0.11737947232147221, 0, 0], [219, "ion transport (GO:0006811)", 0.01831180733918453, 4.166314454775994, 16.666129484588478, ["CTNS", "SLC26A9", "CNGB1", "GRIN1"], 0.1180651687804957, 0, 0], [220, "embryonic organ development (GO:0048568)", 0.01955272208272212, 5.5361344537815125, 21.782700303894654, ["HEY2", "TNF", "NES"], 0.12292305726669815, 0, 0], [221, "positive regulation of T cell proliferation (GO:0042102)", 0.01955272208272212, 5.5361344537815125, 21.782700303894654, ["IL23A", "IL1B", "EBI3"], 0.12292305726669815, 0, 0], [222, "negative regulation of cell junction assembly (GO:1901889)", 0.019587597652271305, 10.07068395626748, 39.606576870100476, ["IL1B", "TNF"], 0.12292305726669815, 0, 0], [223, "regulation of heterotypic cell-cell adhesion (GO:0034114)", 0.019587597652271305, 10.07068395626748, 39.606576870100476, ["IL1B", "TNF"], 0.12292305726669815, 0, 0], [224, "response to dsRNA (GO:0043331)", 0.019587597652271305, 10.07068395626748, 39.606576870100476, ["IRAK3", "TICAM1"], 0.12292305726669815, 0, 0], [225, "positive regulation of vascular endothelial growth factor production (GO:0010575)", 0.019587597652271305, 10.07068395626748, 39.606576870100476, ["C3", "IL1B"], 0.12292305726669815, 0, 0], [226, "regulation of epidermal growth factor receptor signaling pathway (GO:0042058)", 0.02034211394021591, 5.449356617647059, 21.22558168729639, ["IFI6", "MMP9", "HBEGF"], 0.12653332547834745, 0, 0], [227, "regulation of viral genome replication (GO:0045069)", 0.02034211394021591, 5.449356617647059, 21.22558168729639, ["IFITM3", "OAS3", "TNF"], 0.12653332547834745, 0, 0], [228, "negative regulation of cell development (GO:0010721)", 0.02110085569914013, 9.650584795321638, 37.236218657552925, ["IL1B", "TNF"], 0.12983558140222975, 0, 0], [229, "regulation of viral life cycle (GO:1903900)", 0.02110085569914013, 9.650584795321638, 37.236218657552925, ["TRIML2", "TRIM14"], 0.12983558140222975, 0, 0], [230, "regulation of tyrosine phosphorylation of STAT protein (GO:0042509)", 0.02114885532755867, 5.365248868778281, 20.689309029358768, ["IL23A", "PARP14", "TNF"], 0.12983558140222975, 0, 0], [231, "negative regulation of gene expression (GO:0010629)", 0.02223957547672592, 2.612048192771084, 9.941146933724283, ["OLFM1", "HEY2", "APLNR", "LGALS9", "PARP14", "TNF", "CD34"], 0.13594060854171863, 0, 0], [232, "positive regulation of signal transduction (GO:0009967)", 0.022581864553167085, 2.859792609902147, 10.840353169376357, ["C3", "P2RY6", "IL1B", "LY96", "KLF2", "GRIN1"], 0.13674176655501652, 0, 0], [233, "regulation of epidermal growth factor-activated receptor activity (GO:0007176)", 0.02266117094466988, 9.264093567251463, 35.08407052096717, ["NCF1", "HBEGF"], 0.13674176655501652, 0, 0], [234, "regulation of vascular endothelial growth factor production (GO:0010574)", 0.02266117094466988, 9.264093567251463, 35.08407052096717, ["C3", "IL1B"], 0.13674176655501652, 0, 0], [235, "negative regulation of oxidative stress-induced cell death (GO:1903202)", 0.024267626061163804, 8.907332433648223, 33.122913968223706, ["VNN1", "GPR37L1"], 0.14397431932085417, 0, 0], [236, "positive regulation of defense response to virus by host (GO:0002230)", 0.024267626061163804, 8.907332433648223, 33.122913968223706, ["DTX3L", "IL23A"], 0.14397431932085417, 0, 0], [237, "positive regulation of monooxygenase activity (GO:0032770)", 0.024267626061163804, 8.907332433648223, 33.122913968223706, ["IL1B", "TNF"], 0.14397431932085417, 0, 0], [238, "ventricular septum morphogenesis (GO:0060412)", 0.024267626061163804, 8.907332433648223, 33.122913968223706, ["HEY2", "APLNR"], 0.14397431932085417, 0, 0], [239, "positive regulation of cell differentiation (GO:0045597)", 0.0249810512399601, 2.790846877673225, 10.297213832198974, ["OLFM1", "CSF3", "CSF1", "IL1B", "PDPN", "CD34"], 0.14758679644696093, 0, 0], [240, "positive regulation of JNK cascade (GO:0046330)", 0.02544293149128422, 4.980756302521009, 18.285936858095855, ["NCF1", "IL1B", "RASGRP1"], 0.14968924694038885, 0, 0], [241, "negative regulation of wound healing (GO:0061045)", 0.025919315910968337, 8.576998050682262, 31.329773724655823, ["TNF", "CD34"], 0.15060935829747857, 0, 0], [242, "positive regulation of leukocyte migration (GO:0002687)", 0.025919315910968337, 8.576998050682262, 31.329773724655823, ["CSF1", "TNF"], 0.15060935829747857, 0, 0], [243, "MyD88-dependent toll-like receptor signaling pathway (GO:0002755)", 0.025919315910968337, 8.576998050682262, 31.329773724655823, ["LY96", "IRAK3"], 0.15060935829747857, 0, 0], [244, "positive regulation of T cell activation (GO:0050870)", 0.027281953013143467, 4.841911764705882, 17.43828978641221, ["IL23A", "IL1B", "LGALS9"], 0.15659787357197977, 0, 0], [245, "artery morphogenesis (GO:0048844)", 0.027615347393359038, 8.270258980785297, 29.685131918889, ["HEY2", "ADAMTS9"], 0.15659787357197977, 0, 0], [246, "regulation of natural killer cell mediated cytotoxicity (GO:0042269)", 0.027615347393359038, 8.270258980785297, 29.685131918889, ["LGALS9", "RASGRP1"], 0.15659787357197977, 0, 0], [247, "plasma membrane invagination (GO:0099024)", 0.027615347393359038, 8.270258980785297, 29.685131918889, ["MARCO", "ITGB2"], 0.15659787357197977, 0, 0], [248, "extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625)", 0.027615347393359038, 8.270258980785297, 29.685131918889, ["TNFRSF10A", "TNF"], 0.15659787357197977, 0, 0], [249, "TRIF-dependent toll-like receptor signaling pathway (GO:0035666)", 0.027615347393359038, 8.270258980785297, 29.685131918889, ["LY96", "TICAM1"], 0.15659787357197977, 0, 0], [250, "regulation of epithelial to mesenchymal transition (GO:0010717)", 0.02822741437471467, 4.7753424657534245, 17.035851027733788, ["OLFM1", "IL1B", "PDPN"], 0.15816313133768695, 0, 0], [251, "chloride transport (GO:0006821)", 0.02822741437471467, 4.7753424657534245, 17.035851027733788, ["GABRR2", "SLC26A9", "CLCN1"], 0.15816313133768695, 0, 0], [252, "positive regulation of interleukin-6 production (GO:0032755)", 0.02822741437471467, 4.7753424657534245, 17.035851027733788, ["IL1B", "LGALS9", "TNF"], 0.15816313133768695, 0, 0], [253, "positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)", 0.029180936612638146, 3.586162949476559, 12.674359246671418, ["CSF3", "IL23A", "PARP14", "TNF"], 0.16128028454234697, 0, 0], [254, "negative regulation of interleukin-6 production (GO:0032715)", 0.02935483932534219, 7.984674329501916, 28.172309373398363, ["IRAK3", "TNF"], 0.16128028454234697, 0, 0], [255, "regulation of developmental growth (GO:0048638)", 0.02935483932534219, 7.984674329501916, 28.172309373398363, ["STAT5A", "OLFM1"], 0.16128028454234697, 0, 0], [256, "positive regulation of leukocyte cell-cell adhesion (GO:1903039)", 0.02935483932534219, 7.984674329501916, 28.172309373398363, ["ITGB2", "TNF"], 0.16128028454234697, 0, 0], [257, "positive regulation of mononuclear cell migration (GO:0071677)", 0.02935483932534219, 7.984674329501916, 28.172309373398363, ["LGALS9", "TNF"], 0.16128028454234697, 0, 0], [258, "positive regulation of cell migration (GO:0030335)", 0.02981049503891914, 2.672616743698914, 9.388621367680129, ["CSF1", "IL1B", "PDPN", "ROR2", "MMP9", "HBEGF"], 0.16314891083315436, 0, 0], [259, "regulation of cellular biosynthetic process (GO:0031326)", 0.03113692228456005, 7.71812865497076, 26.77697418002294, ["C3", "CTNS"], 0.1690974394838415, 0, 0], [260, "endodermal cell differentiation (GO:0035987)", 0.03113692228456005, 7.71812865497076, 26.77697418002294, ["ITGB2", "MMP9"], 0.1690974394838415, 0, 0], [261, "regulation of histone acetylation (GO:0035065)", 0.03296073849644028, 7.468779475570647, 25.486748153450815, ["IL1B", "MAPK3"], 0.17696031466529916, 0, 0], [262, "regulation of sprouting angiogenesis (GO:1903670)", 0.03296073849644028, 7.468779475570647, 25.486748153450815, ["ADAMTS9", "KLF2"], 0.17696031466529916, 0, 0], [263, "vasculogenesis (GO:0001570)", 0.03296073849644028, 7.468779475570647, 25.486748153450815, ["HEY2", "APLNR"], 0.17696031466529916, 0, 0], [264, "regulation of interleukin-8 production (GO:0032677)", 0.03321310649076322, 4.468099547511312, 15.213033179952701, ["IL1B", "LGALS9", "TNF"], 0.17763979683696088, 0, 0], [265, "regulation of inflammatory response (GO:0050727)", 0.033629164605693325, 2.906005685856432, 9.858222081473349, ["IL23A", "IL1B", "IFI35", "TNF", "MMP9"], 0.1791863412197697, 0, 0], [266, "regulation of activated T cell proliferation (GO:0046006)", 0.03482544167807793, 7.2350146198830405, 24.29088928416562, ["IL23A", "LGALS9"], 0.18260409148373424, 0, 0], [267, "positive regulation of calcium ion transport into cytosol (GO:0010524)", 0.03482544167807793, 7.2350146198830405, 24.29088928416562, ["APLNR", "GRIN1"], 0.18260409148373424, 0, 0], [268, "positive regulation of interleukin-12 production (GO:0032735)", 0.03482544167807793, 7.2350146198830405, 24.29088928416562, ["IL23A", "LGALS9"], 0.18260409148373424, 0, 0], [269, "positive regulation of release of sequestered calcium ion into cytosol (GO:0051281)", 0.03482544167807793, 7.2350146198830405, 24.29088928416562, ["P2RY6", "APLNR"], 0.18260409148373424, 0, 0], [270, "bicarbonate transport (GO:0015701)", 0.03673019691757393, 7.015417331206805, 23.180033673925838, ["SLC26A9", "CA14"], 0.18260409148373424, 0, 0], [271, "cellular response to virus (GO:0098586)", 0.03673019691757393, 7.015417331206805, 23.180033673925838, ["IFI6", "LGALS9"], 0.18260409148373424, 0, 0], [272, "response to exogenous dsRNA (GO:0043330)", 0.03673019691757393, 7.015417331206805, 23.180033673925838, ["IRAK3", "TICAM1"], 0.18260409148373424, 0, 0], [273, "positive regulation of lymphocyte activation (GO:0051251)", 0.03673019691757393, 7.015417331206805, 23.180033673925838, ["IL23A", "TICAM1"], 0.18260409148373424, 0, 0], [274, "regulation of neuron death (GO:1901214)", 0.03862581613067791, 4.197873848334514, 13.659186394981212, ["CSF1", "ITGB2", "CD34"], 0.18260409148373424, 0, 0], [275, "regulation of defense response to virus by host (GO:0050691)", 0.038674180538602526, 6.8087375300997595, 22.14598442629385, ["DTX3L", "IL23A"], 0.18260409148373424, 0, 0], [276, "endoderm formation (GO:0001706)", 0.038674180538602526, 6.8087375300997595, 22.14598442629385, ["ITGB2", "MMP9"], 0.18260409148373424, 0, 0], [277, "positive regulation of cytokine-mediated signaling pathway (GO:0001961)", 0.038674180538602526, 6.8087375300997595, 22.14598442629385, ["CSF1", "PARP14"], 0.18260409148373424, 0, 0], [278, "positive regulation of T cell mediated immunity (GO:0002711)", 0.038674180538602526, 6.8087375300997595, 22.14598442629385, ["IL23A", "IL1B"], 0.18260409148373424, 0, 0], [279, "phagocytosis, engulfment (GO:0006911)", 0.04065657997306811, 6.613868003341688, 21.181537867504435, ["MARCO", "ITGB2"], 0.18260409148373424, 0, 0], [280, "regulation of vascular associated smooth muscle cell proliferation (GO:1904705)", 0.04065657997306811, 6.613868003341688, 21.181537867504435, ["P2RY6", "MMP9"], 0.18260409148373424, 0, 0], [281, "positive regulation of signaling receptor activity (GO:2000273)", 0.04065657997306811, 6.613868003341688, 21.181537867504435, ["NCF1", "HBEGF"], 0.18260409148373424, 0, 0], [282, "regulation of type I interferon production (GO:0032479)", 0.04207575831140036, 4.050820793433653, 12.834148746988943, ["HERC5", "UBE2L6", "NFKB2"], 0.18260409148373424, 0, 0], [283, "pulmonary artery morphogenesis (GO:0061156)", 0.04251217773219479, 28.8125, 90.98885818439754, ["HEY2"], 0.18260409148373424, 0, 0], [284, "negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001268)", 0.04251217773219479, 28.8125, 90.98885818439754, ["MMP9"], 0.18260409148373424, 0, 0], [285, "reelin-mediated signaling pathway (GO:0038026)", 0.04251217773219479, 28.8125, 90.98885818439754, ["STAT5A"], 0.18260409148373424, 0, 0], [286, "cadmium ion transmembrane transport (GO:0070574)", 0.04251217773219479, 28.8125, 90.98885818439754, ["SLC11A2"], 0.18260409148373424, 0, 0], [287, "cadmium ion transport (GO:0015691)", 0.04251217773219479, 28.8125, 90.98885818439754, ["SLC11A2"], 0.18260409148373424, 0, 0], [288, "negative regulation of macrophage cytokine production (GO:0010936)", 0.04251217773219479, 28.8125, 90.98885818439754, ["IRAK3"], 0.18260409148373424, 0, 0], [289, "negative regulation of mast cell activation involved in immune response (GO:0033007)", 0.04251217773219479, 28.8125, 90.98885818439754, ["LGALS9"], 0.18260409148373424, 0, 0], [290, "negative regulation of myosin-light-chain-phosphatase activity (GO:0035509)", 0.04251217773219479, 28.8125, 90.98885818439754, ["TNF"], 0.18260409148373424, 0, 0], [291, "caveolin-mediated endocytosis (GO:0072584)", 0.04251217773219479, 28.8125, 90.98885818439754, ["MAPK3"], 0.18260409148373424, 0, 0], [292, "regulation of cyclase activity (GO:0031279)", 0.04251217773219479, 28.8125, 90.98885818439754, ["MAPK3"], 0.18260409148373424, 0, 0], [293, "cellular response to nicotine (GO:0071316)", 0.04251217773219479, 28.8125, 90.98885818439754, ["TNF"], 0.18260409148373424, 0, 0], [294, "regulation of granulocyte colony-stimulating factor production (GO:0071655)", 0.04251217773219479, 28.8125, 90.98885818439754, ["CD34"], 0.18260409148373424, 0, 0], [295, "regulation of inositol trisphosphate biosynthetic process (GO:0032960)", 0.04251217773219479, 28.8125, 90.98885818439754, ["P2RY6"], 0.18260409148373424, 0, 0], [296, "cerebral cortex neuron differentiation (GO:0021895)", 0.04251217773219479, 28.8125, 90.98885818439754, ["TOX"], 0.18260409148373424, 0, 0], [297, "regulation of mononuclear cell proliferation (GO:0032944)", 0.04251217773219479, 28.8125, 90.98885818439754, ["CSF1"], 0.18260409148373424, 0, 0], [298, "p38MAPK cascade (GO:0038066)", 0.04251217773219479, 28.8125, 90.98885818439754, ["LGALS9"], 0.18260409148373424, 0, 0], [299, "regulation of neutrophil degranulation (GO:0043313)", 0.04251217773219479, 28.8125, 90.98885818439754, ["ITGB2"], 0.18260409148373424, 0, 0], [300, "regulation of NK T cell proliferation (GO:0051140)", 0.04251217773219479, 28.8125, 90.98885818439754, ["IL23A"], 0.18260409148373424, 0, 0], [301, "regulation of receptor catabolic process (GO:2000644)", 0.04251217773219479, 28.8125, 90.98885818439754, ["DTX3L"], 0.18260409148373424, 0, 0], [302, "regulation of ribonuclease activity (GO:0060700)", 0.04251217773219479, 28.8125, 90.98885818439754, ["OAS3"], 0.18260409148373424, 0, 0], [303, "exocyst localization (GO:0051601)", 0.04251217773219479, 28.8125, 90.98885818439754, ["TNFAIP2"], 0.18260409148373424, 0, 0], [304, "extracellular exosome biogenesis (GO:0097734)", 0.04251217773219479, 28.8125, 90.98885818439754, ["CD34"], 0.18260409148373424, 0, 0], [305, "positive regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000563)", 0.04251217773219479, 28.8125, 90.98885818439754, ["LGALS9"], 0.18260409148373424, 0, 0], [306, "positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0032831)", 0.04251217773219479, 28.8125, 90.98885818439754, ["LGALS9"], 0.18260409148373424, 0, 0], [307, "positive regulation of cell fate commitment (GO:0010455)", 0.04251217773219479, 28.8125, 90.98885818439754, ["IL23A"], 0.18260409148373424, 0, 0], [308, "regulation of T-helper 1 cell cytokine production (GO:2000554)", 0.04251217773219479, 28.8125, 90.98885818439754, ["IL1B"], 0.18260409148373424, 0, 0], [309, "positive regulation of dendritic cell differentiation (GO:2001200)", 0.04251217773219479, 28.8125, 90.98885818439754, ["LGALS9"], 0.18260409148373424, 0, 0], [310, "positive regulation of DNA demethylation (GO:1901537)", 0.04251217773219479, 28.8125, 90.98885818439754, ["TOX"], 0.18260409148373424, 0, 0], [311, "regulation of triglyceride metabolic process (GO:0090207)", 0.04251217773219479, 28.8125, 90.98885818439754, ["C3"], 0.18260409148373424, 0, 0], [312, "positive regulation of macrophage proliferation (GO:0120041)", 0.04251217773219479, 28.8125, 90.98885818439754, ["MAPK3"], 0.18260409148373424, 0, 0], [313, "positive regulation of mononuclear cell proliferation (GO:0032946)", 0.04251217773219479, 28.8125, 90.98885818439754, ["CSF1"], 0.18260409148373424, 0, 0], [314, "positive regulation of natural killer cell proliferation (GO:0032819)", 0.04251217773219479, 28.8125, 90.98885818439754, ["IL23A"], 0.18260409148373424, 0, 0], [315, "positive regulation of prostaglandin biosynthetic process (GO:0031394)", 0.04251217773219479, 28.8125, 90.98885818439754, ["IL1B"], 0.18260409148373424, 0, 0], [316, "positive regulation of prostaglandin secretion (GO:0032308)", 0.04251217773219479, 28.8125, 90.98885818439754, ["IL1B"], 0.18260409148373424, 0, 0], [317, "lymph node development (GO:0048535)", 0.04251217773219479, 28.8125, 90.98885818439754, ["PDPN"], 0.18260409148373424, 0, 0], [318, "mature conventional dendritic cell differentiation (GO:0097029)", 0.04251217773219479, 28.8125, 90.98885818439754, ["LGALS9"], 0.18260409148373424, 0, 0], [319, "toll-like receptor 2 signaling pathway (GO:0034134)", 0.04251217773219479, 28.8125, 90.98885818439754, ["LGALS9"], 0.18260409148373424, 0, 0], [320, "positive regulation of T-helper 1 cell cytokine production (GO:2000556)", 0.04251217773219479, 28.8125, 90.98885818439754, ["IL1B"], 0.18260409148373424, 0, 0], [321, "tricuspid valve development (GO:0003175)", 0.04251217773219479, 28.8125, 90.98885818439754, ["HEY2"], 0.18260409148373424, 0, 0], [322, "tricuspid valve morphogenesis (GO:0003186)", 0.04251217773219479, 28.8125, 90.98885818439754, ["HEY2"], 0.18260409148373424, 0, 0], [323, "ventricular cardiac muscle cell differentiation (GO:0055012)", 0.04251217773219479, 28.8125, 90.98885818439754, ["HEY2"], 0.18260409148373424, 0, 0], [324, "postsynaptic endocytosis (GO:0140239)", 0.04251217773219479, 28.8125, 90.98885818439754, ["MX2"], 0.18260409148373424, 0, 0], [325, "postsynaptic neurotransmitter receptor internalization (GO:0098884)", 0.04251217773219479, 28.8125, 90.98885818439754, ["MX2"], 0.18260409148373424, 0, 0], [326, "vitamin D3 metabolic process (GO:0070640)", 0.04251217773219479, 28.8125, 90.98885818439754, ["CYP27A1"], 0.18260409148373424, 0, 0], [327, "negative regulation of endothelial cell migration (GO:0010596)", 0.04267659361871976, 6.4298245614035086, 20.280339662603236, ["TNF", "ADAMTS9"], 0.18260409148373424, 0, 0], [328, "negative regulation of innate immune response (GO:0045824)", 0.04267659361871976, 6.4298245614035086, 20.280339662603236, ["OAS3", "IRAK3"], 0.18260409148373424, 0, 0], [329, "lymphocyte proliferation (GO:0046651)", 0.04267659361871976, 6.4298245614035086, 20.280339662603236, ["TNFSF14", "RASGRP1"], 0.18260409148373424, 0, 0], [330, "ventricular septum development (GO:0003281)", 0.04267659361871976, 6.4298245614035086, 20.280339662603236, ["HEY2", "APLNR"], 0.18260409148373424, 0, 0], [331, "positive regulation of autophagy (GO:0010508)", 0.043259088783534454, 4.004056795131846, 12.574932249113482, ["TRIML2", "TRIM14", "TICAM1"], 0.1839814257902128, 0, 0], [332, "positive regulation of binding (GO:0051099)", 0.043259088783534454, 4.004056795131846, 12.574932249113482, ["CSF3", "DTX3L", "MMP9"], 0.1839814257902128, 0, 0], [333, "positive regulation of transport (GO:0051050)", 0.04445897979591742, 3.958355614973262, 12.323106456134568, ["IL1B", "IL2RG", "TNF"], 0.18798691733693854, 0, 0], [334, "regulation of intracellular transport (GO:0032386)", 0.04473343075439897, 6.255729413624151, 19.43676501698284, ["MX2", "NEFH"], 0.18798691733693854, 0, 0], [335, "regulation of nitric-oxide synthase activity (GO:0050999)", 0.04473343075439897, 6.255729413624151, 19.43676501698284, ["IL1B", "TNF"], 0.18798691733693854, 0, 0], [336, "response to peptide (GO:1901652)", 0.04473343075439897, 6.255729413624151, 19.43676501698284, ["STAT5A", "MMP9"], 0.18798691733693854, 0, 0], [337, "regulation of peptidyl-tyrosine phosphorylation (GO:0050730)", 0.045675358781011255, 3.9136814276272305, 12.078389226107216, ["CSF3", "IL23A", "ITGB2"], 0.19137568723675935, 0, 0], [338, "negative regulation of blood coagulation (GO:0030195)", 0.04682631134694598, 6.0907971683594955, 18.645818436432393, ["C1QTNF1", "CD34"], 0.1924730551047561, 0, 0], [339, "lymphocyte migration (GO:0072676)", 0.04682631134694598, 6.0907971683594955, 18.645818436432393, ["CCL22", "CCL20"], 0.1924730551047561, 0, 0], [340, "interleukin-1-mediated signaling pathway (GO:0070498)", 0.04815727786032467, 3.827278603749192, 11.60921913425076, ["IL1B", "IRAK3", "MAPK3"], 0.1924730551047561, 0, 0], [341, "regulation of cell development (GO:0060284)", 0.048954465987286, 5.934322986954566, 17.903049409987798, ["IL1B", "HEY2"], 0.1924730551047561, 0, 0], [342, "cortical cytoskeleton organization (GO:0030865)", 0.048954465987286, 5.934322986954566, 17.903049409987798, ["RHOF", "TNF"], 0.1924730551047561, 0, 0], [343, "regulation of viral transcription (GO:0046782)", 0.048954465987286, 5.934322986954566, 17.903049409987798, ["IFITM3", "TRIM14"], 0.1924730551047561, 0, 0], [344, "apoptotic process (GO:0006915)", 0.05066057717429533, 2.5812526337968817, 7.698862797384698, ["TNFSF14", "IL1B", "ITGB2", "IFI6", "TNFRSF10A"], 0.1924730551047561, 0, 0], [345, "negative regulation of cellular response to hypoxia (GO:1900038)", 0.0507964976461815, 23.048837209302327, 68.68387238831629, ["CD34"], 0.1924730551047561, 0, 0], [346, "regulation of adiponectin secretion (GO:0070163)", 0.0507964976461815, 23.048837209302327, 68.68387238831629, ["IL1B"], 0.1924730551047561, 0, 0], [347, "negative regulation of mast cell activation (GO:0033004)", 0.0507964976461815, 23.048837209302327, 68.68387238831629, ["MILR1"], 0.1924730551047561, 0, 0], [348, "regulation of cellular response to hypoxia (GO:1900037)", 0.0507964976461815, 23.048837209302327, 68.68387238831629, ["CD34"], 0.1924730551047561, 0, 0], [349, "negative regulation of morphogenesis of an epithelium (GO:1905331)", 0.0507964976461815, 23.048837209302327, 68.68387238831629, ["TNF"], 0.1924730551047561, 0, 0], [350, "negative regulation of myeloid leukocyte mediated immunity (GO:0002887)", 0.0507964976461815, 23.048837209302327, 68.68387238831629, ["LGALS9"], 0.1924730551047561, 0, 0], [351, "regulation of DNA demethylation (GO:1901535)", 0.0507964976461815, 23.048837209302327, 68.68387238831629, ["TOX"], 0.1924730551047561, 0, 0], [352, "regulation of immature T cell proliferation in thymus (GO:0033084)", 0.0507964976461815, 23.048837209302327, 68.68387238831629, ["IL1B"], 0.1924730551047561, 0, 0], [353, "choline transport (GO:0015871)", 0.0507964976461815, 23.048837209302327, 68.68387238831629, ["SLC44A4"], 0.1924730551047561, 0, 0], [354, "neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)", 0.0507964976461815, 23.048837209302327, 68.68387238831629, ["GRIP2"], 0.1924730551047561, 0, 0], [355, "regulation of long-chain fatty acid import across plasma membrane (GO:0010746)", 0.0507964976461815, 23.048837209302327, 68.68387238831629, ["ACSL5"], 0.1924730551047561, 0, 0], [356, "regulation of macrophage proliferation (GO:0120040)", 0.0507964976461815, 23.048837209302327, 68.68387238831629, ["MAPK3"], 0.1924730551047561, 0, 0], [357, "regulation of NK T cell activation (GO:0051133)", 0.0507964976461815, 23.048837209302327, 68.68387238831629, ["IL23A"], 0.1924730551047561, 0, 0], [358, "regulation of nuclease activity (GO:0032069)", 0.0507964976461815, 23.048837209302327, 68.68387238831629, ["OAS3"], 0.1924730551047561, 0, 0], [359, "embryonic camera-type eye development (GO:0031076)", 0.0507964976461815, 23.048837209302327, 68.68387238831629, ["NES"], 0.1924730551047561, 0, 0], [360, "positive regulation of animal organ morphogenesis (GO:0110110)", 0.0507964976461815, 23.048837209302327, 68.68387238831629, ["CD34"], 0.1924730551047561, 0, 0], [361, "regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001188)", 0.0507964976461815, 23.048837209302327, 68.68387238831629, ["LGALS9"], 0.1924730551047561, 0, 0], [362, "regulation of T-helper 17 cell lineage commitment (GO:2000328)", 0.0507964976461815, 23.048837209302327, 68.68387238831629, ["IL23A"], 0.1924730551047561, 0, 0], [363, "glomerulus vasculature development (GO:0072012)", 0.0507964976461815, 23.048837209302327, 68.68387238831629, ["CD34"], 0.1924730551047561, 0, 0], [364, "regulation of vitamin D biosynthetic process (GO:0060556)", 0.0507964976461815, 23.048837209302327, 68.68387238831629, ["TNF"], 0.1924730551047561, 0, 0], [365, "positive regulation of I-kappaB phosphorylation (GO:1903721)", 0.0507964976461815, 23.048837209302327, 68.68387238831629, ["TNF"], 0.1924730551047561, 0, 0], [366, "response to peptidoglycan (GO:0032494)", 0.0507964976461815, 23.048837209302327, 68.68387238831629, ["IRAK3"], 0.1924730551047561, 0, 0], [367, "positive regulation of microglial cell migration (GO:1904141)", 0.0507964976461815, 23.048837209302327, 68.68387238831629, ["CSF1"], 0.1924730551047561, 0, 0], [368, "positive regulation of receptor binding (GO:1900122)", 0.0507964976461815, 23.048837209302327, 68.68387238831629, ["MMP9"], 0.1924730551047561, 0, 0], [369, "taurine metabolic process (GO:0019530)", 0.0507964976461815, 23.048837209302327, 68.68387238831629, ["STAT5A"], 0.1924730551047561, 0, 0], [370, "positive regulation of T cell differentiation in thymus (GO:0033089)", 0.0507964976461815, 23.048837209302327, 68.68387238831629, ["VNN1"], 0.1924730551047561, 0, 0], [371, "ventricular cardiac muscle cell development (GO:0055015)", 0.0507964976461815, 23.048837209302327, 68.68387238831629, ["HEY2"], 0.1924730551047561, 0, 0], [372, "regulation of chemokine production (GO:0032642)", 0.051117135739577574, 5.785672514619883, 17.20448118441229, ["LGALS9", "TNF"], 0.1924730551047561, 0, 0], [373, "regulation of nervous system development (GO:0051960)", 0.051117135739577574, 5.785672514619883, 17.20448118441229, ["IL1B", "HEY2"], 0.1924730551047561, 0, 0], [374, "positive regulation of protein tyrosine kinase activity (GO:0061098)", 0.051117135739577574, 5.785672514619883, 17.20448118441229, ["NCF1", "HBEGF"], 0.1924730551047561, 0, 0], [375, "monocyte chemotaxis (GO:0002548)", 0.051117135739577574, 5.785672514619883, 17.20448118441229, ["CCL22", "CCL20"], 0.1924730551047561, 0, 0], [376, "regulation of cytokine production involved in inflammatory response (GO:1900015)", 0.05331357200357206, 5.644273284838111, 16.546550320972486, ["TICAM1", "TNF"], 0.1946763760598752, 0, 0], [377, "negative regulation of type I interferon production (GO:0032480)", 0.05331357200357206, 5.644273284838111, 16.546550320972486, ["HERC5", "UBE2L6"], 0.1946763760598752, 0, 0], [378, "positive regulation of leukocyte mediated cytotoxicity (GO:0001912)", 0.05331357200357206, 5.644273284838111, 16.546550320972486, ["IL23A", "RASGRP1"], 0.1946763760598752, 0, 0], [379, "positive regulation of T cell differentiation (GO:0045582)", 0.05331357200357206, 5.644273284838111, 16.546550320972486, ["VNN1", "IL23A"], 0.1946763760598752, 0, 0], [380, "organic anion transport (GO:0015711)", 0.054645065389659644, 3.6270220588235293, 10.54337723214052, ["SLC44A4", "SLC26A9", "CA14"], 0.1946763760598752, 0, 0], [381, "positive regulation of stress-activated MAPK cascade (GO:0032874)", 0.054645065389659644, 3.6270220588235293, 10.54337723214052, ["NCF1", "IL1B", "RASGRP1"], 0.1946763760598752, 0, 0], [382, "regulation of endothelial cell apoptotic process (GO:2000351)", 0.05554303645035014, 5.5096073517126145, 15.926055182770193, ["ECSCR", "TNF"], 0.1946763760598752, 0, 0], [383, "detection of chemical stimulus involved in sensory perception of taste (GO:0050912)", 0.05554303645035014, 5.5096073517126145, 15.926055182770193, ["TAS1R3", "TAS2R4"], 0.1946763760598752, 0, 0], [384, "response to amyloid-beta (GO:1904645)", 0.05554303645035014, 5.5096073517126145, 15.926055182770193, ["MMP9", "GRIN1"], 0.1946763760598752, 0, 0], [385, "lymphocyte chemotaxis (GO:0048247)", 0.05554303645035014, 5.5096073517126145, 15.926055182770193, ["CCL22", "CCL20"], 0.1946763760598752, 0, 0], [386, "cell-matrix adhesion (GO:0007160)", 0.05599044637853729, 3.5894481503941784, 10.346850641993324, ["ITGB2", "ADAMTS9", "CD34"], 0.1946763760598752, 0, 0], [387, "positive regulation of response to biotic stimulus (GO:0002833)", 0.05780480081975424, 5.381204950360397, 15.340111880069527, ["LY96", "IFI35"], 0.1946763760598752, 0, 0], [388, "positive regulation of vasculature development (GO:1904018)", 0.05872830063968307, 3.516577540106952, 9.968911974283797, ["IL1B", "APLNR", "CD34"], 0.1946763760598752, 0, 0], [389, "negative regulation of cardiocyte differentiation (GO:1905208)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["HEY2"], 0.1946763760598752, 0, 0], [390, "atrioventricular valve formation (GO:0003190)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["OLFM1"], 0.1946763760598752, 0, 0], [391, "negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["PARP14"], 0.1946763760598752, 0, 0], [392, "regulation of dopamine metabolic process (GO:0042053)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["ITGB2"], 0.1946763760598752, 0, 0], [393, "negative regulation of response to interferon-gamma (GO:0060331)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["PARP14"], 0.1946763760598752, 0, 0], [394, "cellular response to laminar fluid shear stress (GO:0071499)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["KLF2"], 0.1946763760598752, 0, 0], [395, "regulation of I-kappaB phosphorylation (GO:1903719)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["TNF"], 0.1946763760598752, 0, 0], [396, "neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["GRIP2"], 0.1946763760598752, 0, 0], [397, "complement activation, alternative pathway (GO:0006957)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["C3"], 0.1946763760598752, 0, 0], [398, "coronary vasculature development (GO:0060976)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["APLNR"], 0.1946763760598752, 0, 0], [399, "regulation of microglial cell migration (GO:1904139)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["CSF1"], 0.1946763760598752, 0, 0], [400, "death-inducing signaling complex assembly (GO:0071550)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["TNF"], 0.1946763760598752, 0, 0], [401, "detection of molecule of bacterial origin (GO:0032490)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["LY96"], 0.1946763760598752, 0, 0], [402, "regulation of myosin-light-chain-phosphatase activity (GO:0035507)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["TNF"], 0.1946763760598752, 0, 0], [403, "regulation of natural killer cell proliferation (GO:0032817)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["IL23A"], 0.1946763760598752, 0, 0], [404, "pantothenate metabolic process (GO:0015939)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["VNN1"], 0.1946763760598752, 0, 0], [405, "dorsal aorta development (GO:0035907)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["HEY2"], 0.1946763760598752, 0, 0], [406, "dorsal aorta morphogenesis (GO:0035912)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["HEY2"], 0.1946763760598752, 0, 0], [407, "regulation of prostaglandin biosynthetic process (GO:0031392)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["IL1B"], 0.1946763760598752, 0, 0], [408, "positive regulation of activation of Janus kinase activity (GO:0010536)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["IL23A"], 0.1946763760598752, 0, 0], [409, "excitatory chemical synaptic transmission (GO:0098976)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["GRIN1"], 0.1946763760598752, 0, 0], [410, "positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["TNF"], 0.1946763760598752, 0, 0], [411, "positive regulation of humoral immune response (GO:0002922)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["IL1B"], 0.1946763760598752, 0, 0], [412, "positive regulation of icosanoid secretion (GO:0032305)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["IL1B"], 0.1946763760598752, 0, 0], [413, "retinal rod cell development (GO:0046548)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["RPGRIP1"], 0.1946763760598752, 0, 0], [414, "hyaluronan biosynthetic process (GO:0030213)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["IL1B"], 0.1946763760598752, 0, 0], [415, "positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["LY96"], 0.1946763760598752, 0, 0], [416, "RIG-I signaling pathway (GO:0039529)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["OAS3"], 0.1946763760598752, 0, 0], [417, "iron import into cell (GO:0033212)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["SLC11A2"], 0.1946763760598752, 0, 0], [418, "positive regulation of NK T cell activation (GO:0051135)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["IL23A"], 0.1946763760598752, 0, 0], [419, "positive regulation of podosome assembly (GO:0071803)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["TNF"], 0.1946763760598752, 0, 0], [420, "synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["MX2"], 0.1946763760598752, 0, 0], [421, "positive regulation of receptor catabolic process (GO:2000646)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["DTX3L"], 0.1946763760598752, 0, 0], [422, "membrane biogenesis (GO:0044091)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["TLCD1"], 0.1946763760598752, 0, 0], [423, "TRAIL-activated apoptotic signaling pathway (GO:0036462)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["TNFRSF10A"], 0.1946763760598752, 0, 0], [424, "positive regulation of T-helper 17 cell differentiation (GO:2000321)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["IL23A"], 0.1946763760598752, 0, 0], [425, "positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["IL1B"], 0.1946763760598752, 0, 0], [426, "vascular associated smooth muscle cell development (GO:0097084)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["HEY2"], 0.1946763760598752, 0, 0], [427, "vascular wound healing (GO:0061042)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["CD34"], 0.1946763760598752, 0, 0], [428, "modulation by symbiont of host apoptotic process (GO:0052150)", 0.059009553083304946, 19.20639534883721, 54.35517308004342, ["MAPK3"], 0.1946763760598752, 0, 0], [429, "epidermal growth factor receptor signaling pathway (GO:0007173)", 0.06242236629695057, 5.141520467836258, 14.261712118398474, ["FAM83A", "HBEGF"], 0.19552747268066467, 0, 0], [430, "epithelial to mesenchymal transition (GO:0001837)", 0.06242236629695057, 5.141520467836258, 14.261712118398474, ["OLFM1", "HEY2"], 0.19552747268066467, 0, 0], [431, "positive regulation of cell-cell adhesion (GO:0022409)", 0.06242236629695057, 5.141520467836258, 14.261712118398474, ["IL1B", "TNF"], 0.19552747268066467, 0, 0], [432, "positive regulation of neuron death (GO:1901216)", 0.06242236629695057, 5.141520467836258, 14.261712118398474, ["ITGB2", "TNF"], 0.19552747268066467, 0, 0], [433, "regulation of JNK cascade (GO:0046328)", 0.06295136136919655, 3.412629757785467, 9.437262077006439, ["NCF1", "IL1B", "RASGRP1"], 0.19552747268066467, 0, 0], [434, "positive regulation of protein serine/threonine kinase activity (GO:0071902)", 0.06438965645909725, 3.3793260993717875, 9.268823305756863, ["IL1B", "TNF", "RASGRP1"], 0.19552747268066467, 0, 0], [435, "negative regulation of MAP kinase activity (GO:0043407)", 0.06477676044194086, 5.029494024917366, 13.764761369929921, ["IL1B", "IRAK3"], 0.19552747268066467, 0, 0], [436, "regulation of interleukin-2 production (GO:0032663)", 0.06477676044194086, 5.029494024917366, 13.764761369929921, ["IL1B", "CD34"], 0.19552747268066467, 0, 0], [437, "cognition (GO:0050890)", 0.06477676044194086, 5.029494024917366, 13.764761369929921, ["CTNS", "TNF"], 0.19552747268066467, 0, 0], [438, "defense response to bacterium (GO:0042742)", 0.06682102959645289, 2.704692445300674, 7.318187595800986, ["PGLYRP4", "IL23A", "OAS3", "WFDC5"], 0.19552747268066467, 0, 0], [439, "negative regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000562)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["LGALS9"], 0.19552747268066467, 0, 0], [440, "regulation of activation of Janus kinase activity (GO:0010533)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["IL23A"], 0.19552747268066467, 0, 0], [441, "regulation of alpha-beta T cell proliferation (GO:0046640)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["EBI3"], 0.19552747268066467, 0, 0], [442, "aromatic compound catabolic process (GO:0019439)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["PON3"], 0.19552747268066467, 0, 0], [443, "regulation of apoptotic cell clearance (GO:2000425)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["C3"], 0.19552747268066467, 0, 0], [444, "benzene-containing compound metabolic process (GO:0042537)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["KMO"], 0.19552747268066467, 0, 0], [445, "negative regulation of mitochondrial membrane potential (GO:0010917)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["RNF122"], 0.19552747268066467, 0, 0], [446, "regulation of chemokine (C-C motif) ligand 5 production (GO:0071649)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["OAS3"], 0.19552747268066467, 0, 0], [447, "regulation of dendritic cell chemotaxis (GO:2000508)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["LGALS9"], 0.19552747268066467, 0, 0], [448, "regulation of extent of cell growth (GO:0061387)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["OLFM1"], 0.19552747268066467, 0, 0], [449, "negative regulation of response to reactive oxygen species (GO:1901032)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["GPR37L1"], 0.19552747268066467, 0, 0], [450, "negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["HEY2"], 0.19552747268066467, 0, 0], [451, "DNA damage induced protein phosphorylation (GO:0006975)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["MAPK3"], 0.19552747268066467, 0, 0], [452, "regulation of nitrogen compound metabolic process (GO:0051171)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["TNF"], 0.19552747268066467, 0, 0], [453, "dynamin family protein polymerization involved in membrane fission (GO:0003373)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["MX2"], 0.19552747268066467, 0, 0], [454, "dynamin family protein polymerization involved in mitochondrial fission (GO:0003374)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["MX2"], 0.19552747268066467, 0, 0], [455, "platelet activating factor metabolic process (GO:0046469)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["PLA2G4C"], 0.19552747268066467, 0, 0], [456, "regulation of protein localization to early endosome (GO:1902965)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["DTX3L"], 0.19552747268066467, 0, 0], [457, "positive regulation of apoptotic cell clearance (GO:2000427)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["C3"], 0.19552747268066467, 0, 0], [458, "regulation of RNA biosynthetic process (GO:2001141)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["IL1B"], 0.19552747268066467, 0, 0], [459, "folic acid transport (GO:0015884)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["PDPN"], 0.19552747268066467, 0, 0], [460, "positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["LGALS9"], 0.19552747268066467, 0, 0], [461, "positive regulation of dendritic cell chemotaxis (GO:2000510)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["LGALS9"], 0.19552747268066467, 0, 0], [462, "positive regulation of dendritic cell cytokine production (GO:0002732)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["TICAM1"], 0.19552747268066467, 0, 0], [463, "regulation of vascular wound healing (GO:0061043)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["TNF"], 0.19552747268066467, 0, 0], [464, "positive regulation of extracellular matrix disassembly (GO:0090091)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["PDPN"], 0.19552747268066467, 0, 0], [465, "positive regulation of glial cell migration (GO:1903977)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["CSF1"], 0.19552747268066467, 0, 0], [466, "positive regulation of homotypic cell-cell adhesion (GO:0034112)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["PDPN"], 0.19552747268066467, 0, 0], [467, "positive regulation of isomerase activity (GO:0010912)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["ITGB2"], 0.19552747268066467, 0, 0], [468, "positive regulation of leukocyte differentiation (GO:1902107)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["LGALS9"], 0.19552747268066467, 0, 0], [469, "positive regulation of membrane invagination (GO:1905155)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["C3"], 0.19552747268066467, 0, 0], [470, "leukocyte aggregation (GO:0070486)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["IL1B"], 0.19552747268066467, 0, 0], [471, "lymphatic endothelial cell differentiation (GO:0060836)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["PDPN"], 0.19552747268066467, 0, 0], [472, "positive regulation of protein localization to early endosome (GO:1902966)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["DTX3L"], 0.19552747268066467, 0, 0], [473, "positive regulation of protein localization to endosome (GO:1905668)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["DTX3L"], 0.19552747268066467, 0, 0], [474, "synaptic vesicle budding (GO:0070142)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["MX2"], 0.19552747268066467, 0, 0], [475, "mast cell activation involved in immune response (GO:0002279)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["MILR1"], 0.19552747268066467, 0, 0], [476, "mast cell degranulation (GO:0043303)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["MILR1"], 0.19552747268066467, 0, 0], [477, "positive regulation of steroid biosynthetic process (GO:0010893)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["TNF"], 0.19552747268066467, 0, 0], [478, "venous blood vessel development (GO:0060841)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["APLNR"], 0.19552747268066467, 0, 0], [479, "natural killer cell differentiation (GO:0001779)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["TOX"], 0.19552747268066467, 0, 0], [480, "negative regulation by symbiont of host apoptotic process (GO:0033668)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["MAPK3"], 0.19552747268066467, 0, 0], [481, "negative regulation by symbiont of host programmed cell death (GO:0052041)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["MAPK3"], 0.19552747268066467, 0, 0], [482, "negative regulation of amyloid-beta clearance (GO:1900222)", 0.06715195309796386, 16.461794019933556, 44.459968362117436, ["TNF"], 0.19552747268066467, 0, 0], [483, "receptor internalization (GO:0031623)", 0.06716064040376939, 4.922234664675874, 13.29332121089862, ["MX2", "ITGB2"], 0.19552747268066467, 0, 0], [484, "cellular defense response (GO:0006968)", 0.06716064040376939, 4.922234664675874, 13.29332121089862, ["NCF1", "LY96"], 0.19552747268066467, 0, 0], [485, "positive regulation of reactive oxygen species metabolic process (GO:2000379)", 0.06716064040376939, 4.922234664675874, 13.29332121089862, ["ITGB2", "GRIN1"], 0.19552747268066467, 0, 0], [486, "regulation of complement activation (GO:0030449)", 0.06957332673799577, 4.819444444444445, 12.845622020856771, ["C3", "IL1B"], 0.2017197892280288, 0, 0], [487, "chloride transmembrane transport (GO:1902476)", 0.06957332673799577, 4.819444444444445, 12.845622020856771, ["GABRR2", "CLCN1"], 0.2017197892280288, 0, 0], [488, "regulation of immune response (GO:0050776)", 0.07016552750113744, 2.657920540997464, 7.061824167685692, ["HERC5", "C3", "ITGB2", "CD34"], 0.203019927933619, 0, 0], [489, "negative regulation of biomineralization (GO:0110150)", 0.07522430168027945, 14.403343023255815, 37.26549487043892, ["HEY2"], 0.20465648164268704, 0, 0], [490, "actin-mediated cell contraction (GO:0070252)", 0.07522430168027945, 14.403343023255815, 37.26549487043892, ["PDPN"], 0.20465648164268704, 0, 0], [491, "regulation of cell adhesion molecule production (GO:0060353)", 0.07522430168027945, 14.403343023255815, 37.26549487043892, ["IL1B"], 0.20465648164268704, 0, 0], [492, "negative regulation of leukocyte degranulation (GO:0043301)", 0.07522430168027945, 14.403343023255815, 37.26549487043892, ["LGALS9"], 0.20465648164268704, 0, 0], [493, "negative regulation of lipid localization (GO:1905953)", 0.07522430168027945, 14.403343023255815, 37.26549487043892, ["TNF"], 0.20465648164268704, 0, 0], [494, "negative regulation of membrane potential (GO:0045837)", 0.07522430168027945, 14.403343023255815, 37.26549487043892, ["RNF122"], 0.20465648164268704, 0, 0], [495, "negative regulation of nitric oxide biosynthetic process (GO:0045019)", 0.07522430168027945, 14.403343023255815, 37.26549487043892, ["CD34"], 0.20465648164268704, 0, 0], [496, "negative regulation of nitric oxide metabolic process (GO:1904406)", 0.07522430168027945, 14.403343023255815, 37.26549487043892, ["CD34"], 0.20465648164268704, 0, 0], [497, "negative regulation of platelet aggregation (GO:0090331)", 0.07522430168027945, 14.403343023255815, 37.26549487043892, ["C1QTNF1"], 0.20465648164268704, 0, 0], [498, "negative regulation of production of molecular mediator of immune response (GO:0002701)", 0.07522430168027945, 14.403343023255815, 37.26549487043892, ["TNF"], 0.20465648164268704, 0, 0], [499, "cellular response to leptin stimulus (GO:0044320)", 0.07522430168027945, 14.403343023255815, 37.26549487043892, ["EBI3"], 0.20465648164268704, 0, 0], [500, "negative regulation of systemic arterial blood pressure (GO:0003085)", 0.07522430168027945, 14.403343023255815, 37.26549487043892, ["GPR37L1"], 0.20465648164268704, 0, 0], [501, "cholesterol catabolic process (GO:0006707)", 0.07522430168027945, 14.403343023255815, 37.26549487043892, ["CYP27A1"], 0.20465648164268704, 0, 0], [502, "neurotransmitter receptor transport to postsynaptic membrane (GO:0098969)", 0.07522430168027945, 14.403343023255815, 37.26549487043892, ["GRIP2"], 0.20465648164268704, 0, 0], [503, "nucleoside diphosphate catabolic process (GO:0009134)", 0.07522430168027945, 14.403343023255815, 37.26549487043892, ["ENTPD3"], 0.20465648164268704, 0, 0], [504, "organic acid catabolic process (GO:0016054)", 0.07522430168027945, 14.403343023255815, 37.26549487043892, ["PON3"], 0.20465648164268704, 0, 0], [505, "epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198)", 0.07522430168027945, 14.403343023255815, 37.26549487043892, ["HEY2"], 0.20465648164268704, 0, 0], [506, "positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589)", 0.07522430168027945, 14.403343023255815, 37.26549487043892, ["APLNR"], 0.20465648164268704, 0, 0], [507, "regulation of T-helper 1 type immune response (GO:0002825)", 0.07522430168027945, 14.403343023255815, 37.26549487043892, ["IL23A"], 0.20465648164268704, 0, 0], [508, "positive regulation of chromatin binding (GO:0035563)", 0.07522430168027945, 14.403343023255815, 37.26549487043892, ["DTX3L"], 0.20465648164268704, 0, 0], [509, "glomerular filtration (GO:0003094)", 0.07522430168027945, 14.403343023255815, 37.26549487043892, ["CD34"], 0.20465648164268704, 0, 0], [510, "positive regulation of inositol phosphate biosynthetic process (GO:0060732)", 0.07522430168027945, 14.403343023255815, 37.26549487043892, ["P2RY6"], 0.20465648164268704, 0, 0], [511, "retinal rod cell differentiation (GO:0060221)", 0.07522430168027945, 14.403343023255815, 37.26549487043892, ["RPGRIP1"], 0.20465648164268704, 0, 0], [512, "positive regulation of memory T cell differentiation (GO:0043382)", 0.07522430168027945, 14.403343023255815, 37.26549487043892, ["IL23A"], 0.20465648164268704, 0, 0], [513, "interleukin-23-mediated signaling pathway (GO:0038155)", 0.07522430168027945, 14.403343023255815, 37.26549487043892, ["IL23A"], 0.20465648164268704, 0, 0], [514, "kynurenine metabolic process (GO:0070189)", 0.07522430168027945, 14.403343023255815, 37.26549487043892, ["KMO"], 0.20465648164268704, 0, 0], [515, "positive regulation of phagocytosis, engulfment (GO:0060100)", 0.07522430168027945, 14.403343023255815, 37.26549487043892, ["C3"], 0.20465648164268704, 0, 0], [516, "sterol catabolic process (GO:0016127)", 0.07522430168027945, 14.403343023255815, 37.26549487043892, ["CYP27A1"], 0.20465648164268704, 0, 0], [517, "synapse pruning (GO:0098883)", 0.07522430168027945, 14.403343023255815, 37.26549487043892, ["C3"], 0.20465648164268704, 0, 0], [518, "T-helper 1 type immune response (GO:0042088)", 0.07522430168027945, 14.403343023255815, 37.26549487043892, ["EBI3"], 0.20465648164268704, 0, 0], [519, "mast cell mediated immunity (GO:0002448)", 0.07522430168027945, 14.403343023255815, 37.26549487043892, ["MILR1"], 0.20465648164268704, 0, 0], [520, "positive regulation of kinase activity (GO:0033674)", 0.07643175220880455, 3.1344992050874403, 8.05991667411373, ["CSF1", "ROR2", "TNF"], 0.20544895683291528, 0, 0], [521, "negative regulation of cysteine-type endopeptidase activity (GO:2000117)", 0.0769775707667153, 4.535259717922257, 11.62949976835775, ["IFI6", "TNF"], 0.20544895683291528, 0, 0], [522, "cardiac muscle tissue development (GO:0048738)", 0.0769775707667153, 4.535259717922257, 11.62949976835775, ["HEY2", "ADAMTS9"], 0.20544895683291528, 0, 0], [523, "heart morphogenesis (GO:0003007)", 0.0769775707667153, 4.535259717922257, 11.62949976835775, ["OLFM1", "HEY2"], 0.20544895683291528, 0, 0], [524, "inorganic anion transport (GO:0015698)", 0.07949887546099389, 4.447818263607737, 11.261931007817143, ["SLC26A9", "CLCN1"], 0.20544895683291528, 0, 0], [525, "positive regulation of angiogenesis (GO:0045766)", 0.07958702991756415, 3.0787090057261843, 7.791917368885482, ["IL1B", "APLNR", "CD34"], 0.20544895683291528, 0, 0], [526, "positive regulation of multicellular organismal process (GO:0051240)", 0.07971180018488294, 2.0653913412113827, 5.224072074326114, ["OLFM1", "UCN", "IL23A", "IL1B", "PDPN", "TNF"], 0.20544895683291528, 0, 0], [527, "regulation of blood vessel endothelial cell migration (GO:0043535)", 0.08204572869137172, 4.36367648681452, 10.911279324330774, ["STAT5A", "TNF"], 0.20544895683291528, 0, 0], [528, "regulation of protein binding (GO:0043393)", 0.08279836902764963, 3.024859335038363, 7.535973974225548, ["CSF3", "DTX3L", "NES"], 0.20544895683291528, 0, 0], [529, "protein poly-ADP-ribosylation (GO:0070212)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["PARP14"], 0.20544895683291528, 0, 0], [530, "negative regulation of cAMP-mediated signaling (GO:0043951)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["APLNR"], 0.20544895683291528, 0, 0], [531, "regulation of actin filament-based movement (GO:1903115)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["PDPN"], 0.20544895683291528, 0, 0], [532, "regulation of axon guidance (GO:1902667)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["ZSWIM4"], 0.20544895683291528, 0, 0], [533, "negative regulation of hormone secretion (GO:0046888)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["IL1B"], 0.20544895683291528, 0, 0], [534, "regulation of epithelial cell apoptotic process (GO:1904035)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["TNF"], 0.20544895683291528, 0, 0], [535, "cellular response to dopamine (GO:1903351)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["MAPK3"], 0.20544895683291528, 0, 0], [536, "cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["TICAM1"], 0.20544895683291528, 0, 0], [537, "cellular response to purine-containing compound (GO:0071415)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["P2RY6"], 0.20544895683291528, 0, 0], [538, "negative regulation of transmembrane transport (GO:0034763)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["IL1B"], 0.20544895683291528, 0, 0], [539, "negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["PARP14"], 0.20544895683291528, 0, 0], [540, "regulation of hydrogen peroxide-induced cell death (GO:1903205)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["GPR37L1"], 0.20544895683291528, 0, 0], [541, "neuron remodeling (GO:0016322)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["C3"], 0.20544895683291528, 0, 0], [542, "regulation of macrophage migration (GO:1905521)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["CSF1"], 0.20544895683291528, 0, 0], [543, "regulation of mast cell activation (GO:0033003)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["MILR1"], 0.20544895683291528, 0, 0], [544, "regulation of memory T cell differentiation (GO:0043380)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["IL23A"], 0.20544895683291528, 0, 0], [545, "cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["OAS3"], 0.20544895683291528, 0, 0], [546, "regulation of phagocytosis, engulfment (GO:0060099)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["C3"], 0.20544895683291528, 0, 0], [547, "regulation of podosome assembly (GO:0071801)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["TNF"], 0.20544895683291528, 0, 0], [548, "endothelium development (GO:0003158)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["CD34"], 0.20544895683291528, 0, 0], [549, "positive regulation by symbiont of entry into host (GO:0075294)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["LGALS9"], 0.20544895683291528, 0, 0], [550, "regulation of receptor binding (GO:1900120)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["MMP9"], 0.20544895683291528, 0, 0], [551, "ether lipid biosynthetic process (GO:0008611)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["PLA2G4C"], 0.20544895683291528, 0, 0], [552, "regulation of T-helper 17 type immune response (GO:2000316)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["IL23A"], 0.20544895683291528, 0, 0], [553, "renal filtration (GO:0097205)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["CD34"], 0.20544895683291528, 0, 0], [554, "granulocyte migration (GO:0097530)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["ITGB2"], 0.20544895683291528, 0, 0], [555, "response to dopamine (GO:1903350)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["MAPK3"], 0.20544895683291528, 0, 0], [556, "response to laminar fluid shear stress (GO:0034616)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["KLF2"], 0.20544895683291528, 0, 0], [557, "histone H2B ubiquitination (GO:0033523)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["DTX3L"], 0.20544895683291528, 0, 0], [558, "positive regulation of keratinocyte migration (GO:0051549)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["MMP9"], 0.20544895683291528, 0, 0], [559, "indolalkylamine catabolic process (GO:0046218)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["KMO"], 0.20544895683291528, 0, 0], [560, "positive regulation of monocyte differentiation (GO:0045657)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["CSF1"], 0.20544895683291528, 0, 0], [561, "ionotropic glutamate receptor signaling pathway (GO:0035235)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["GRIN1"], 0.20544895683291528, 0, 0], [562, "iron ion transmembrane transport (GO:0034755)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["SLC11A2"], 0.20544895683291528, 0, 0], [563, "leptin-mediated signaling pathway (GO:0033210)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["EBI3"], 0.20544895683291528, 0, 0], [564, "lipid droplet formation (GO:0140042)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["PLA2G4C"], 0.20544895683291528, 0, 0], [565, "positive regulation of T cell apoptotic process (GO:0070234)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["LGALS9"], 0.20544895683291528, 0, 0], [566, "positive regulation of tissue remodeling (GO:0034105)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["IL23A"], 0.20544895683291528, 0, 0], [567, "positive regulation of toll-like receptor 4 signaling pathway (GO:0034145)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["IFI35"], 0.20544895683291528, 0, 0], [568, "positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["IL1B"], 0.20544895683291528, 0, 0], [569, "positive regulation of vasculogenesis (GO:2001214)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["CD34"], 0.20544895683291528, 0, 0], [570, "positive regulation of viral entry into host cell (GO:0046598)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["LGALS9"], 0.20544895683291528, 0, 0], [571, "monocyte activation (GO:0042117)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["CSF1"], 0.20544895683291528, 0, 0], [572, "negative regulation of alpha-beta T cell proliferation (GO:0046642)", 0.0832271978105011, 12.80232558139535, 31.82889974049287, ["LGALS9"], 0.20544895683291528, 0, 0], [573, "positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280)", 0.08442476458999366, 2.998630831643002, 7.412299063586843, ["TNFRSF10A", "LGALS9", "TNF"], 0.20707091582317044, 0, 0], [574, "blood vessel morphogenesis (GO:0048514)", 0.08461750597023325, 4.282651072124756, 10.576495504851723, ["HEY2", "APLNR"], 0.20707091582317044, 0, 0], [575, "negative regulation of metabolic process (GO:0009892)", 0.08461750597023325, 4.282651072124756, 10.576495504851723, ["IL1B", "PLCL1"], 0.20707091582317044, 0, 0], [576, "positive regulation of interleukin-1 beta production (GO:0032731)", 0.08461750597023325, 4.282651072124756, 10.576495504851723, ["LGALS9", "TNF"], 0.20707091582317044, 0, 0], [577, "Rho protein signal transduction (GO:0007266)", 0.08461750597023325, 4.282651072124756, 10.576495504851723, ["PLEKHG7", "PDPN"], 0.20707091582317044, 0, 0], [578, "icosanoid metabolic process (GO:0006690)", 0.08721359160289648, 4.204572036150983, 10.256612394024215, ["PON3", "PLA2G4C"], 0.2082842466002369, 0, 0], [579, "positive regulation of proteolysis (GO:0045862)", 0.08721359160289648, 4.204572036150983, 10.256612394024215, ["IL1B", "TNF"], 0.2082842466002369, 0, 0], [580, "cellular response to tumor necrosis factor (GO:0071356)", 0.08814136448648476, 2.4462161320460916, 5.941402371073382, ["CCL22", "TNFSF14", "CCL20", "TNF"], 0.2082842466002369, 0, 0], [581, "receptor metabolic process (GO:0043112)", 0.08983337851820446, 4.129281537176274, 9.950737174163859, ["MX2", "ITGB2"], 0.2082842466002369, 0, 0], [582, "cellular response to organic substance (GO:0071310)", 0.09106569469596189, 2.8980882352941175, 6.944324007146888, ["CSF3", "IL1B", "TNF"], 0.2082842466002369, 0, 0], [583, "protein polyglutamylation (GO:0018095)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["TPGS1"], 0.2082842466002369, 0, 0], [584, "alcohol catabolic process (GO:0046164)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["CYP27A1"], 0.2082842466002369, 0, 0], [585, "angiogenesis involved in wound healing (GO:0060055)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["CD34"], 0.2082842466002369, 0, 0], [586, "atrial septum morphogenesis (GO:0060413)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["HEY2"], 0.2082842466002369, 0, 0], [587, "negative regulation of homotypic cell-cell adhesion (GO:0034111)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["C1QTNF1"], 0.2082842466002369, 0, 0], [588, "regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["LGALS9"], 0.2082842466002369, 0, 0], [589, "negative regulation of natural killer cell mediated immunity (GO:0002716)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["LGALS9"], 0.2082842466002369, 0, 0], [590, "regulation of cytoplasmic transport (GO:1903649)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["MAPK3"], 0.2082842466002369, 0, 0], [591, "regulation of dendritic cell apoptotic process (GO:2000668)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["LGALS9"], 0.2082842466002369, 0, 0], [592, "negative regulation of response to cytokine stimulus (GO:0060761)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["IRAK3"], 0.2082842466002369, 0, 0], [593, "cellular response to UV-A (GO:0071492)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["MMP9"], 0.2082842466002369, 0, 0], [594, "regulation of lamellipodium morphogenesis (GO:2000392)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["PDPN"], 0.2082842466002369, 0, 0], [595, "Notch signaling involved in heart development (GO:0061314)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["HEY2"], 0.2082842466002369, 0, 0], [596, "copper ion transport (GO:0006825)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["SLC11A2"], 0.2082842466002369, 0, 0], [597, "regulation of melanin biosynthetic process (GO:0048021)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["CTNS"], 0.2082842466002369, 0, 0], [598, "regulation of microtubule-based movement (GO:0060632)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["NEFH"], 0.2082842466002369, 0, 0], [599, "regulation of mitochondrial depolarization (GO:0051900)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["IFI6"], 0.2082842466002369, 0, 0], [600, "detection of light stimulus involved in sensory perception (GO:0050962)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["CNGB1"], 0.2082842466002369, 0, 0], [601, "detection of light stimulus involved in visual perception (GO:0050908)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["CNGB1"], 0.2082842466002369, 0, 0], [602, "regulation of phospholipase activity (GO:0010517)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["RASGRP1"], 0.2082842466002369, 0, 0], [603, "regulation of stress-activated protein kinase signaling cascade (GO:0070302)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["MAPK3"], 0.2082842466002369, 0, 0], [604, "regulation of T cell mediated immunity (GO:0002709)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["IL1B"], 0.2082842466002369, 0, 0], [605, "positive regulation of ceramide biosynthetic process (GO:2000304)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["TNF"], 0.2082842466002369, 0, 0], [606, "response to corticosteroid (GO:0031960)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["TNF"], 0.2082842466002369, 0, 0], [607, "hematopoietic stem cell proliferation (GO:0071425)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["CD34"], 0.2082842466002369, 0, 0], [608, "positive regulation of interleukin-13 production (GO:0032736)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["LGALS9"], 0.2082842466002369, 0, 0], [609, "positive regulation of leukocyte apoptotic process (GO:2000108)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["LGALS9"], 0.2082842466002369, 0, 0], [610, "positive regulation of lipid localization (GO:1905954)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["C3"], 0.2082842466002369, 0, 0], [611, "rhodopsin mediated signaling pathway (GO:0016056)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["CNGB1"], 0.2082842466002369, 0, 0], [612, "positive regulation of macrophage differentiation (GO:0045651)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["CSF1"], 0.2082842466002369, 0, 0], [613, "interleukin-35-mediated signaling pathway (GO:0070757)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["EBI3"], 0.2082842466002369, 0, 0], [614, "T cell homeostasis (GO:0043029)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["TNFSF14"], 0.2082842466002369, 0, 0], [615, "positive regulation of sphingolipid biosynthetic process (GO:0090154)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["TNF"], 0.2082842466002369, 0, 0], [616, "tryptophan catabolic process (GO:0006569)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["KMO"], 0.2082842466002369, 0, 0], [617, "tryptophan metabolic process (GO:0006568)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["KMO"], 0.2082842466002369, 0, 0], [618, "negative regulation of activated T cell proliferation (GO:0046007)", 0.09116123541001869, 11.521511627906976, 27.5954665588185, ["LGALS9"], 0.2082842466002369, 0, 0], [619, "negative regulation of intracellular signal transduction (GO:1902532)", 0.09327781435073232, 2.395290672848167, 5.682043831854596, ["TNIP3", "APLNR", "IFI35", "MMP9"], 0.2127758866934314, 0, 0], [620, "positive regulation of cellular process (GO:0048522)", 0.09358851840071268, 1.7114646024707, 4.054198764159168, ["CSF3", "SLC44A4", "CSF1", "IL1B", "PDPN", "IL2RG", "TNF", "GRIN1", "HBEGF"], 0.21314030319646177, 0, 0], [621, "cellular response to oxidative stress (GO:0034599)", 0.09446564415204552, 2.8502892960462876, 6.725311933449305, ["NCF1", "MMP9", "MAPK3"], 0.2147914485389505, 0, 0], [622, "adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193)", 0.0951416708887734, 3.986489211534584, 9.377770283137103, ["MARCO", "GPR37L1"], 0.21563409196620872, 0, 0], [623, "response to organic cyclic compound (GO:0014070)", 0.0951416708887734, 3.986489211534584, 9.377770283137103, ["IL1B", "TNF"], 0.21563409196620872, 0, 0], [624, "protein mono-ADP-ribosylation (GO:0140289)", 0.09902700340508695, 10.473572938689218, 24.218699444952154, ["PARP14"], 0.21882023287634236, 0, 0], [625, "negative regulation of gene silencing by miRNA (GO:0060965)", 0.09902700340508695, 10.473572938689218, 24.218699444952154, ["TNF"], 0.21882023287634236, 0, 0], [626, "negative regulation of glucose transmembrane transport (GO:0010829)", 0.09902700340508695, 10.473572938689218, 24.218699444952154, ["IL1B"], 0.21882023287634236, 0, 0], [627, "negative regulation of hemostasis (GO:1900047)", 0.09902700340508695, 10.473572938689218, 24.218699444952154, ["CD34"], 0.21882023287634236, 0, 0], [628, "carboxylic acid catabolic process (GO:0046395)", 0.09902700340508695, 10.473572938689218, 24.218699444952154, ["PON3"], 0.21882023287634236, 0, 0], [629, "regulation of chromatin binding (GO:0035561)", 0.09902700340508695, 10.473572938689218, 24.218699444952154, ["DTX3L"], 0.21882023287634236, 0, 0], [630, "regulation of dendritic cell differentiation (GO:2001198)", 0.09902700340508695, 10.473572938689218, 24.218699444952154, ["LGALS9"], 0.21882023287634236, 0, 0], [631, "negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799)", 0.09902700340508695, 10.473572938689218, 24.218699444952154, ["TNF"], 0.21882023287634236, 0, 0], [632, "cellular response to fluid shear stress (GO:0071498)", 0.09902700340508695, 10.473572938689218, 24.218699444952154, ["KLF2"], 0.21882023287634236, 0, 0], [633, "regulation of feeding behavior (GO:0060259)", 0.09902700340508695, 10.473572938689218, 24.218699444952154, ["UCN"], 0.21882023287634236, 0, 0], [634, "regulation of keratinocyte migration (GO:0051547)", 0.09902700340508695, 10.473572938689218, 24.218699444952154, ["MMP9"], 0.21882023287634236, 0, 0], [635, "phospholipid homeostasis (GO:0055091)", 0.09902700340508695, 10.473572938689218, 24.218699444952154, ["TLCD1"], 0.21882023287634236, 0, 0], [636, "sensory perception of taste (GO:0050909)", 0.09902700340508695, 10.473572938689218, 24.218699444952154, ["TAS1R3"], 0.21882023287634236, 0, 0], [637, "positive regulation of protein depolymerization (GO:1901881)", 0.09902700340508695, 10.473572938689218, 24.218699444952154, ["NES"], 0.21882023287634236, 0, 0], [638, "toll-like receptor 3 signaling pathway (GO:0034138)", 0.09902700340508695, 10.473572938689218, 24.218699444952154, ["TICAM1"], 0.21882023287634236, 0, 0], [639, "positive regulation of T-helper 17 type immune response (GO:2000318)", 0.09902700340508695, 10.473572938689218, 24.218699444952154, ["IL23A"], 0.21882023287634236, 0, 0], [640, "regulation of angiogenesis (GO:0045765)", 0.09989414557990292, 2.33451280068984, 5.37788686811247, ["IL1B", "APLNR", "ECSCR", "CD34"], 0.2203914586856608, 0, 0], [641, "positive regulation of cysteine-type endopeptidase activity (GO:2001056)", 0.10053769641349458, 3.8532163742690058, 8.851695479956536, ["TNF", "GRIN1"], 0.22077640332170195, 0, 0], [642, "positive regulation of interleukin-1 production (GO:0032732)", 0.10053769641349458, 3.8532163742690058, 8.851695479956536, ["LGALS9", "TNF"], 0.22077640332170195, 0, 0], [643, "stress-activated MAPK cascade (GO:0051403)", 0.10053769641349458, 3.8532163742690058, 8.851695479956536, ["LGALS9", "MAPK3"], 0.22077640332170195, 0, 0], [644, "cellular response to metal ion (GO:0071248)", 0.10497135663348564, 2.7158547794117647, 6.121720699131513, ["NCF1", "MMP9", "MAPK3"], 0.22819519073272126, 0, 0], [645, "negative regulation of intrinsic apoptotic signaling pathway (GO:2001243)", 0.10601690081577753, 3.7285417845689492, 8.367432235575125, ["VNN1", "MMP9"], 0.22819519073272126, 0, 0], [646, "regulation of extrinsic apoptotic signaling pathway (GO:2001236)", 0.10601690081577753, 3.7285417845689492, 8.367432235575125, ["TNFRSF10A", "TNF"], 0.22819519073272126, 0, 0], [647, "regulation of innate immune response (GO:0045088)", 0.10601690081577753, 3.7285417845689492, 8.367432235575125, ["IRAK3", "IFI35"], 0.22819519073272126, 0, 0], [648, "negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)", 0.10682508574669175, 9.600290697674419, 21.471650113294665, ["LGALS9"], 0.22819519073272126, 0, 0], [649, "negative regulation of hydrogen peroxide-induced cell death (GO:1903206)", 0.10682508574669175, 9.600290697674419, 21.471650113294665, ["GPR37L1"], 0.22819519073272126, 0, 0], [650, "cardiac right ventricle morphogenesis (GO:0003215)", 0.10682508574669175, 9.600290697674419, 21.471650113294665, ["HEY2"], 0.22819519073272126, 0, 0], [651, "regulation of interleukin-5 production (GO:0032674)", 0.10682508574669175, 9.600290697674419, 21.471650113294665, ["LGALS9"], 0.22819519073272126, 0, 0], [652, "regulation of nucleocytoplasmic transport (GO:0046822)", 0.10682508574669175, 9.600290697674419, 21.471650113294665, ["MX2"], 0.22819519073272126, 0, 0], [653, "positive regulation of calcineurin-mediated signaling (GO:0106058)", 0.10682508574669175, 9.600290697674419, 21.471650113294665, ["TNF"], 0.22819519073272126, 0, 0], [654, "positive regulation of calcineurin-NFAT signaling cascade (GO:0070886)", 0.10682508574669175, 9.600290697674419, 21.471650113294665, ["TNF"], 0.22819519073272126, 0, 0], [655, "positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)", 0.10682508574669175, 9.600290697674419, 21.471650113294665, ["LGALS9"], 0.22819519073272126, 0, 0], [656, "positive regulation of histone deacetylation (GO:0031065)", 0.10682508574669175, 9.600290697674419, 21.471650113294665, ["APLNR"], 0.22819519073272126, 0, 0], [657, "response to iron ion (GO:0010039)", 0.10682508574669175, 9.600290697674419, 21.471650113294665, ["SLC11A2"], 0.22819519073272126, 0, 0], [658, "positive regulation of protein localization to cell surface (GO:2000010)", 0.10682508574669175, 9.600290697674419, 21.471650113294665, ["TNF"], 0.22819519073272126, 0, 0], [659, "macrophage activation involved in immune response (GO:0002281)", 0.10682508574669175, 9.600290697674419, 21.471650113294665, ["IFI35"], 0.22819519073272126, 0, 0], [660, "positive regulation of reactive oxygen species biosynthetic process (GO:1903428)", 0.10682508574669175, 9.600290697674419, 21.471650113294665, ["GRIN1"], 0.22819519073272126, 0, 0], [661, "protein heterotetramerization (GO:0051290)", 0.10682508574669175, 9.600290697674419, 21.471650113294665, ["GRIN1"], 0.22819519073272126, 0, 0], [662, "inorganic anion transmembrane transport (GO:0098661)", 0.10878630728388616, 3.669172932330827, 8.139582441123666, ["GABRR2", "CLCN1"], 0.23168365895150417, 0, 0], [663, "protein autoubiquitination (GO:0051865)", 0.10878630728388616, 3.669172932330827, 8.139582441123666, ["DTX3L", "RNF122"], 0.23168365895150417, 0, 0], [664, "regulation of protein localization (GO:0032880)", 0.11157485899949017, 3.6116593567251463, 7.920583979311403, ["TRIML2", "TRIM14"], 0.23374733921751606, 0, 0], [665, "ERBB signaling pathway (GO:0038127)", 0.11157485899949017, 3.6116593567251463, 7.920583979311403, ["HBEGF", "FAM83A"], 0.23374733921751606, 0, 0], [666, "positive regulation of cell death (GO:0010942)", 0.11157485899949017, 3.6116593567251463, 7.920583979311403, ["ITGB2", "TNF"], 0.23374733921751606, 0, 0], [667, "positive regulation of catabolic process (GO:0009896)", 0.1143820225174098, 3.55591542959964, 7.709976223299157, ["IL1B", "TNF"], 0.23374733921751606, 0, 0], [668, "negative regulation of cell activation (GO:0050866)", 0.11455606142954752, 8.861359570661897, 19.199827642632826, ["C1QTNF1"], 0.23374733921751606, 0, 0], [669, "negative regulation of coagulation (GO:0050819)", 0.11455606142954752, 8.861359570661897, 19.199827642632826, ["CD34"], 0.23374733921751606, 0, 0], [670, "atrial septum development (GO:0003283)", 0.11455606142954752, 8.861359570661897, 19.199827642632826, ["HEY2"], 0.23374733921751606, 0, 0], [671, "atrioventricular valve development (GO:0003171)", 0.11455606142954752, 8.861359570661897, 19.199827642632826, ["APLNR"], 0.23374733921751606, 0, 0], [672, "negative regulation of interleukin-12 production (GO:0032695)", 0.11455606142954752, 8.861359570661897, 19.199827642632826, ["IRAK3"], 0.23374733921751606, 0, 0], [673, "cardiac left ventricle morphogenesis (GO:0003214)", 0.11455606142954752, 8.861359570661897, 19.199827642632826, ["HEY2"], 0.23374733921751606, 0, 0], [674, "cellular response to low-density lipoprotein particle stimulus (GO:0071404)", 0.11455606142954752, 8.861359570661897, 19.199827642632826, ["ITGB2"], 0.23374733921751606, 0, 0], [675, "regulation of histone deacetylation (GO:0031063)", 0.11455606142954752, 8.861359570661897, 19.199827642632826, ["APLNR"], 0.23374733921751606, 0, 0], [676, "neurotransmitter biosynthetic process (GO:0042136)", 0.11455606142954752, 8.861359570661897, 19.199827642632826, ["SLC44A4"], 0.23374733921751606, 0, 0], [677, "regulation of lamellipodium organization (GO:1902743)", 0.11455606142954752, 8.861359570661897, 19.199827642632826, ["PDPN"], 0.23374733921751606, 0, 0], [678, "regulation of macrophage cytokine production (GO:0010935)", 0.11455606142954752, 8.861359570661897, 19.199827642632826, ["IRAK3"], 0.23374733921751606, 0, 0], [679, "nucleoside phosphate catabolic process (GO:1901292)", 0.11455606142954752, 8.861359570661897, 19.199827642632826, ["ENTPD3"], 0.23374733921751606, 0, 0], [680, "detection of bacterium (GO:0016045)", 0.11455606142954752, 8.861359570661897, 19.199827642632826, ["PGLYRP4"], 0.23374733921751606, 0, 0], [681, "regulation of retinoic acid receptor signaling pathway (GO:0048385)", 0.11455606142954752, 8.861359570661897, 19.199827642632826, ["KLF2"], 0.23374733921751606, 0, 0], [682, "positive regulation of cyclase activity (GO:0031281)", 0.11455606142954752, 8.861359570661897, 19.199827642632826, ["MAPK3"], 0.23374733921751606, 0, 0], [683, "growth hormone receptor signaling pathway via JAK-STAT (GO:0060397)", 0.11455606142954752, 8.861359570661897, 19.199827642632826, ["STAT5A"], 0.23374733921751606, 0, 0], [684, "response to UV-A (GO:0070141)", 0.11455606142954752, 8.861359570661897, 19.199827642632826, ["MMP9"], 0.23374733921751606, 0, 0], [685, "positive regulation of leukocyte degranulation (GO:0043302)", 0.11455606142954752, 8.861359570661897, 19.199827642632826, ["ITGB2"], 0.23374733921751606, 0, 0], [686, "positive regulation of lymphocyte migration (GO:2000403)", 0.11455606142954752, 8.861359570661897, 19.199827642632826, ["CCL20"], 0.23374733921751606, 0, 0], [687, "positive regulation of protein deacetylation (GO:0090312)", 0.11455606142954752, 8.861359570661897, 19.199827642632826, ["APLNR"], 0.23374733921751606, 0, 0], [688, "positive regulation of protein-containing complex disassembly (GO:0043243)", 0.11455606142954752, 8.861359570661897, 19.199827642632826, ["TNF"], 0.23374733921751606, 0, 0], [689, "manganese ion transport (GO:0006828)", 0.11455606142954752, 8.861359570661897, 19.199827642632826, ["SLC11A2"], 0.23374733921751606, 0, 0], [690, "positive regulation of superoxide anion generation (GO:0032930)", 0.11455606142954752, 8.861359570661897, 19.199827642632826, ["ITGB2"], 0.23374733921751606, 0, 0], [691, "microvillus organization (GO:0032528)", 0.11455606142954752, 8.861359570661897, 19.199827642632826, ["FXYD5"], 0.23374733921751606, 0, 0], [692, "vasodilation (GO:0042311)", 0.11455606142954752, 8.861359570661897, 19.199827642632826, ["KLF2"], 0.23374733921751606, 0, 0], [693, "negative regulation of multicellular organismal process (GO:0051241)", 0.11518886367470851, 2.210989010989011, 4.778350105742464, ["PLCL1", "IL1B", "HEY2", "TNF"], 0.23469938745842486, 0, 0], [694, "interferon-gamma-mediated signaling pathway (GO:0060333)", 0.11720727208394388, 3.5018607123870282, 7.507328759776381, ["OAS3", "IRF9"], 0.23846782158865817, 0, 0], [695, "positive regulation of cell population proliferation (GO:0008284)", 0.11794806329261563, 1.7481489125667553, 3.7366873431891805, ["CSF3", "CSF1", "IL1B", "TOX", "TNF", "NES", "HBEGF"], 0.23954306427772531, 0, 0], [696, "extracellular structure organization (GO:0043062)", 0.1180750515136663, 2.189907335045216, 4.678594298320033, ["COL24A1", "ITGB2", "MMP9", "ADAMTS9"], 0.23954306427772531, 0, 0], [697, "external encapsulating structure organization (GO:0045229)", 0.1195299404288275, 2.179514959579965, 4.629700376176692, ["COL24A1", "ITGB2", "MMP9", "ADAMTS9"], 0.24035564405970272, 0, 0], [698, "cell chemotaxis (GO:0060326)", 0.12005008958722514, 3.4494195688225537, 7.312238999895576, ["CCL20", "HBEGF"], 0.24035564405970272, 0, 0], [699, "positive regulation of MAP kinase activity (GO:0043406)", 0.12005008958722514, 3.4494195688225537, 7.312238999895576, ["TNF", "RASGRP1"], 0.24035564405970272, 0, 0], [700, "negative regulation of blood pressure (GO:0045776)", 0.12222050455727093, 8.227990033222591, 17.294646347456485, ["GPR37L1"], 0.24035564405970272, 0, 0], [701, "negative regulation of leukocyte activation (GO:0002695)", 0.12222050455727093, 8.227990033222591, 17.294646347456485, ["MILR1"], 0.24035564405970272, 0, 0], [702, "negative regulation of leukocyte mediated cytotoxicity (GO:0001911)", 0.12222050455727093, 8.227990033222591, 17.294646347456485, ["LGALS9"], 0.24035564405970272, 0, 0], [703, "regulation of extracellular matrix disassembly (GO:0010715)", 0.12222050455727093, 8.227990033222591, 17.294646347456485, ["PDPN"], 0.24035564405970272, 0, 0], [704, "negative regulation of ubiquitin-protein transferase activity (GO:0051444)", 0.12222050455727093, 8.227990033222591, 17.294646347456485, ["DTX3L"], 0.24035564405970272, 0, 0], [705, "regulation of macrophage differentiation (GO:0045649)", 0.12222050455727093, 8.227990033222591, 17.294646347456485, ["CSF1"], 0.24035564405970272, 0, 0], [706, "nucleobase-containing small molecule catabolic process (GO:0034656)", 0.12222050455727093, 8.227990033222591, 17.294646347456485, ["ENTPD3"], 0.24035564405970272, 0, 0], [707, "peptidyl-tyrosine autophosphorylation (GO:0038083)", 0.12222050455727093, 8.227990033222591, 17.294646347456485, ["MAPK3"], 0.24035564405970272, 0, 0], [708, "regulation of phospholipase C activity (GO:1900274)", 0.12222050455727093, 8.227990033222591, 17.294646347456485, ["RASGRP1"], 0.24035564405970272, 0, 0], [709, "phototransduction, visible light (GO:0007603)", 0.12222050455727093, 8.227990033222591, 17.294646347456485, ["CNGB1"], 0.24035564405970272, 0, 0], [710, "eye photoreceptor cell development (GO:0042462)", 0.12222050455727093, 8.227990033222591, 17.294646347456485, ["RPGRIP1"], 0.24035564405970272, 0, 0], [711, "regulation of superoxide anion generation (GO:0032928)", 0.12222050455727093, 8.227990033222591, 17.294646347456485, ["ITGB2"], 0.24035564405970272, 0, 0], [712, "regulation of triglyceride biosynthetic process (GO:0010866)", 0.12222050455727093, 8.227990033222591, 17.294646347456485, ["C3"], 0.24035564405970272, 0, 0], [713, "response to ethanol (GO:0045471)", 0.12222050455727093, 8.227990033222591, 17.294646347456485, ["GRIN1"], 0.24035564405970272, 0, 0], [714, "interleukin-27-mediated signaling pathway (GO:0070106)", 0.12222050455727093, 8.227990033222591, 17.294646347456485, ["EBI3"], 0.24035564405970272, 0, 0], [715, "lipoxygenase pathway (GO:0019372)", 0.12222050455727093, 8.227990033222591, 17.294646347456485, ["PON3"], 0.24035564405970272, 0, 0], [716, "positive regulation of protein export from nucleus (GO:0046827)", 0.12222050455727093, 8.227990033222591, 17.294646347456485, ["IL1B"], 0.24035564405970272, 0, 0], [717, "superoxide anion generation (GO:0042554)", 0.12222050455727093, 8.227990033222591, 17.294646347456485, ["NCF1"], 0.24035564405970272, 0, 0], [718, "microvillus assembly (GO:0030033)", 0.12222050455727093, 8.227990033222591, 17.294646347456485, ["FXYD5"], 0.24035564405970272, 0, 0], [719, "establishment of protein localization to membrane (GO:0090150)", 0.12290996435911004, 3.3985208118335053, 7.124330014814563, ["NCF1", "ZDHHC23"], 0.2413753402991146, 0, 0], [720, "Ras protein signal transduction (GO:0007265)", 0.12534683786897033, 2.499534490055015, 5.190709991921242, ["PLEKHG7", "PDPN", "RASGRP1"], 0.24473218409680786, 0, 0], [721, "positive regulation of cellular protein localization (GO:1903829)", 0.12578639324063928, 3.3490973811339946, 6.943248560609297, ["DTX3L", "TNF"], 0.24473218409680786, 0, 0], [722, "receptor-mediated endocytosis (GO:0006898)", 0.12726596768089446, 2.4815546218487397, 5.115665664553765, ["MARCO", "MX2", "ITGB2"], 0.24473218409680786, 0, 0], [723, "nitrogen compound transport (GO:0071705)", 0.12726596768089446, 2.4815546218487397, 5.115665664553765, ["SLC44A4", "ARRDC2", "PDPN"], 0.24473218409680786, 0, 0], [724, "extrinsic apoptotic signaling pathway (GO:0097191)", 0.12867888036489056, 3.3010860484544695, 6.768663288061007, ["TNFRSF10A", "TNF"], 0.24473218409680786, 0, 0], [725, "activation of NF-kappaB-inducing kinase activity (GO:0007250)", 0.1298189843403039, 7.67906976744186, 15.677698087388547, ["TNFRSF10A"], 0.24473218409680786, 0, 0], [726, "aromatic amino acid family catabolic process (GO:0009074)", 0.1298189843403039, 7.67906976744186, 15.677698087388547, ["KMO"], 0.24473218409680786, 0, 0], [727, "negative regulation of epithelial cell differentiation (GO:0030857)", 0.1298189843403039, 7.67906976744186, 15.677698087388547, ["MMP9"], 0.24473218409680786, 0, 0], [728, "regulation of amyloid-beta clearance (GO:1900221)", 0.1298189843403039, 7.67906976744186, 15.677698087388547, ["TNF"], 0.24473218409680786, 0, 0], [729, "regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587)", 0.1298189843403039, 7.67906976744186, 15.677698087388547, ["APLNR"], 0.24473218409680786, 0, 0], [730, "regulation of ceramide biosynthetic process (GO:2000303)", 0.1298189843403039, 7.67906976744186, 15.677698087388547, ["TNF"], 0.24473218409680786, 0, 0], [731, "negative regulation of natural killer cell mediated cytotoxicity (GO:0045953)", 0.1298189843403039, 7.67906976744186, 15.677698087388547, ["LGALS9"], 0.24473218409680786, 0, 0], [732, "regulation of defense response to virus (GO:0050688)", 0.1298189843403039, 7.67906976744186, 15.677698087388547, ["HERC5"], 0.24473218409680786, 0, 0], [733, "negative regulation of platelet activation (GO:0010544)", 0.1298189843403039, 7.67906976744186, 15.677698087388547, ["C1QTNF1"], 0.24473218409680786, 0, 0], [734, "regulation of ERBB signaling pathway (GO:1901184)", 0.1298189843403039, 7.67906976744186, 15.677698087388547, ["IFI6"], 0.24473218409680786, 0, 0], [735, "negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426)", 0.1298189843403039, 7.67906976744186, 15.677698087388547, ["PARP14"], 0.24473218409680786, 0, 0], [736, "negative regulation of transcription regulatory region DNA binding (GO:2000678)", 0.1298189843403039, 7.67906976744186, 15.677698087388547, ["HEY2"], 0.24473218409680786, 0, 0], [737, "negative regulation of type I interferon-mediated signaling pathway (GO:0060339)", 0.1298189843403039, 7.67906976744186, 15.677698087388547, ["OAS3"], 0.24473218409680786, 0, 0], [738, "regulation of interleukin-13 production (GO:0032656)", 0.1298189843403039, 7.67906976744186, 15.677698087388547, ["LGALS9"], 0.24473218409680786, 0, 0], [739, "neuron cell-cell adhesion (GO:0007158)", 0.1298189843403039, 7.67906976744186, 15.677698087388547, ["ASTN1"], 0.24473218409680786, 0, 0], [740, "regulation of mast cell degranulation (GO:0043304)", 0.1298189843403039, 7.67906976744186, 15.677698087388547, ["LGALS9"], 0.24473218409680786, 0, 0], [741, "nucleoside diphosphate metabolic process (GO:0009132)", 0.1298189843403039, 7.67906976744186, 15.677698087388547, ["ENTPD3"], 0.24473218409680786, 0, 0], [742, "dendrite self-avoidance (GO:0070593)", 0.1298189843403039, 7.67906976744186, 15.677698087388547, ["MYPN"], 0.24473218409680786, 0, 0], [743, "regulation of monocyte differentiation (GO:0045655)", 0.1298189843403039, 7.67906976744186, 15.677698087388547, ["CSF1"], 0.24473218409680786, 0, 0], [744, "polyol biosynthetic process (GO:0046173)", 0.1298189843403039, 7.67906976744186, 15.677698087388547, ["CYP27A1"], 0.24473218409680786, 0, 0], [745, "epiboly involved in wound healing (GO:0090505)", 0.1298189843403039, 7.67906976744186, 15.677698087388547, ["PDPN"], 0.24473218409680786, 0, 0], [746, "regulation of systemic arterial blood pressure (GO:0003073)", 0.1298189843403039, 7.67906976744186, 15.677698087388547, ["GPR37L1"], 0.24473218409680786, 0, 0], [747, "positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034)", 0.1298189843403039, 7.67906976744186, 15.677698087388547, ["DTX3L"], 0.24473218409680786, 0, 0], [748, "positive regulation of endothelial cell apoptotic process (GO:2000353)", 0.1298189843403039, 7.67906976744186, 15.677698087388547, ["ECSCR"], 0.24473218409680786, 0, 0], [749, "positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081)", 0.1298189843403039, 7.67906976744186, 15.677698087388547, ["TICAM1"], 0.24473218409680786, 0, 0], [750, "regulation of cytokine-mediated signaling pathway (GO:0001959)", 0.13451008201702722, 3.2090643274853803, 6.437755688765701, ["IRAK3", "TNF"], 0.25256414336175853, 0, 0], [751, "NIK/NF-kappaB signaling (GO:0038061)", 0.13451008201702722, 3.2090643274853803, 6.437755688765701, ["TNFRSF10A", "NFKB2"], 0.25256414336175853, 0, 0], [752, "regulation of peptide hormone secretion (GO:0090276)", 0.13451008201702722, 3.2090643274853803, 6.437755688765701, ["IL1B", "TNF"], 0.25256414336175853, 0, 0], [753, "positive regulation of transferase activity (GO:0051347)", 0.13701731691968547, 2.395375253549696, 4.761162736795246, ["DTX3L", "ROR2", "MAPK3"], 0.25303305229691303, 0, 0], [754, "protein polyubiquitination (GO:0000209)", 0.13711709814463405, 1.8799121590383727, 3.7352350430597405, ["HERC5", "DTX3L", "TRIML2", "TRIM14", "UBE2L6"], 0.25303305229691303, 0, 0], [755, "pulmonary valve morphogenesis (GO:0003184)", 0.13735206519347104, 7.198764534883721, 14.291043725023991, ["HEY2"], 0.25303305229691303, 0, 0], [756, "negative regulation of interleukin-10 production (GO:0032693)", 0.13735206519347104, 7.198764534883721, 14.291043725023991, ["IL23A"], 0.25303305229691303, 0, 0], [757, "cell surface receptor signaling pathway involved in heart development (GO:0061311)", 0.13735206519347104, 7.198764534883721, 14.291043725023991, ["HEY2"], 0.25303305229691303, 0, 0], [758, "regulation of Golgi organization (GO:1903358)", 0.13735206519347104, 7.198764534883721, 14.291043725023991, ["MAPK3"], 0.25303305229691303, 0, 0], [759, "negative regulation of viral entry into host cell (GO:0046597)", 0.13735206519347104, 7.198764534883721, 14.291043725023991, ["IFITM3"], 0.25303305229691303, 0, 0], [760, "detection of visible light (GO:0009584)", 0.13735206519347104, 7.198764534883721, 14.291043725023991, ["CNGB1"], 0.25303305229691303, 0, 0], [761, "histone H2A ubiquitination (GO:0033522)", 0.13735206519347104, 7.198764534883721, 14.291043725023991, ["DTX3L"], 0.25303305229691303, 0, 0], [762, "response to purine-containing compound (GO:0014074)", 0.13735206519347104, 7.198764534883721, 14.291043725023991, ["P2RY6"], 0.25303305229691303, 0, 0], [763, "positive regulation of telomere capping (GO:1904355)", 0.13735206519347104, 7.198764534883721, 14.291043725023991, ["MAPK3"], 0.25303305229691303, 0, 0], [764, "vasculature development (GO:0001944)", 0.13735206519347104, 7.198764534883721, 14.291043725023991, ["APLNR"], 0.25303305229691303, 0, 0], [765, "muscle tissue morphogenesis (GO:0060415)", 0.13735206519347104, 7.198764534883721, 14.291043725023991, ["HEY2"], 0.25303305229691303, 0, 0], [766, "protein heterooligomerization (GO:0051291)", 0.13735206519347104, 7.198764534883721, 14.291043725023991, ["GRIN1"], 0.25303305229691303, 0, 0], [767, "positive regulation of lymphocyte proliferation (GO:0050671)", 0.13744784073068858, 3.1649443242810222, 6.280866110594027, ["IL23A", "IL1B"], 0.25303305229691303, 0, 0], [768, "transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)", 0.13876082571920242, 1.7538892065115999, 3.4639373323428626, ["NCF1", "CSF1", "ROR2", "MMP9", "GRIN1", "MAPK3"], 0.2551175597858253, 0, 0], [769, "positive regulation of hydrolase activity (GO:0051345)", 0.13899778838117882, 2.3788477034649476, 4.694173647841655, ["CCL22", "CCL20", "RASGRP1"], 0.25522090662447916, 0, 0], [770, "cell morphogenesis involved in neuron differentiation (GO:0048667)", 0.14039974585418583, 3.122016753595701, 6.129335599234157, ["ACTBL2", "NEFH"], 0.2552887303598952, 0, 0], [771, "regulation of T cell proliferation (GO:0042129)", 0.14039974585418583, 3.122016753595701, 6.129335599234157, ["IL23A", "IL1B"], 0.2552887303598952, 0, 0], [772, "regulation of autophagy (GO:0010506)", 0.14069176751925558, 2.0436357949065505, 4.007945470175014, ["TRIML2", "TRIM14", "SNX32", "TICAM1"], 0.2552887303598952, 0, 0], [773, "brain development (GO:0007420)", 0.14098801395111274, 2.3625450180072027, 4.628415638083369, ["CTNS", "NES", "GRIN1"], 0.2552887303598952, 0, 0], [774, "cellular response to organic cyclic compound (GO:0071407)", 0.14098801395111274, 2.3625450180072027, 4.628415638083369, ["P2RY6", "IL1B", "TNF"], 0.2552887303598952, 0, 0], [775, "regulation of cell migration (GO:0030334)", 0.14336031429737595, 1.7360800786486728, 3.372151766812675, ["CSF1", "IL1B", "PDPN", "ROR2", "MMP9", "HBEGF"], 0.2552887303598952, 0, 0], [776, "phosphatidylcholine metabolic process (GO:0046470)", 0.14336533691993736, 3.080233918128655, 5.982920390398475, ["SLC44A4", "PLA2G4C"], 0.2552887303598952, 0, 0], [777, "positive regulation of endothelial cell proliferation (GO:0001938)", 0.14336533691993736, 3.080233918128655, 5.982920390398475, ["STAT5A", "APLNR"], 0.2552887303598952, 0, 0], [778, "positive regulation of type I interferon production (GO:0032481)", 0.14336533691993736, 3.080233918128655, 5.982920390398475, ["OAS3", "NFKB2"], 0.2552887303598952, 0, 0], [779, "negative regulation of cation transmembrane transport (GO:1904063)", 0.14482030667016715, 6.7749658002735975, 13.091006050059688, ["MMP9"], 0.2552887303598952, 0, 0], [780, "pulmonary valve development (GO:0003177)", 0.14482030667016715, 6.7749658002735975, 13.091006050059688, ["HEY2"], 0.2552887303598952, 0, 0], [781, "regulation of early endosome to late endosome transport (GO:2000641)", 0.14482030667016715, 6.7749658002735975, 13.091006050059688, ["MAPK3"], 0.2552887303598952, 0, 0], [782, "neuron maturation (GO:0042551)", 0.14482030667016715, 6.7749658002735975, 13.091006050059688, ["C3"], 0.2552887303598952, 0, 0], [783, "regulation of multicellular organism growth (GO:0040014)", 0.14482030667016715, 6.7749658002735975, 13.091006050059688, ["STAT5A"], 0.2552887303598952, 0, 0], [784, "regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175)", 0.14482030667016715, 6.7749658002735975, 13.091006050059688, ["VNN1"], 0.2552887303598952, 0, 0], [785, "phosphatidylinositol acyl-chain remodeling (GO:0036149)", 0.14482030667016715, 6.7749658002735975, 13.091006050059688, ["PLA2G4C"], 0.2552887303598952, 0, 0], [786, "regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798)", 0.14482030667016715, 6.7749658002735975, 13.091006050059688, ["TNF"], 0.2552887303598952, 0, 0], [787, "endothelial cell proliferation (GO:0001935)", 0.14482030667016715, 6.7749658002735975, 13.091006050059688, ["CD34"], 0.2552887303598952, 0, 0], [788, "positive regulation of amyloid-beta formation (GO:1902004)", 0.14482030667016715, 6.7749658002735975, 13.091006050059688, ["TNF"], 0.2552887303598952, 0, 0], [789, "fluid transport (GO:0042044)", 0.14482030667016715, 6.7749658002735975, 13.091006050059688, ["PDPN"], 0.2552887303598952, 0, 0], [790, "positive regulation of excitatory postsynaptic potential (GO:2000463)", 0.14482030667016715, 6.7749658002735975, 13.091006050059688, ["GRIN1"], 0.2552887303598952, 0, 0], [791, "release of cytochrome c from mitochondria (GO:0001836)", 0.14482030667016715, 6.7749658002735975, 13.091006050059688, ["IFI6"], 0.2552887303598952, 0, 0], [792, "positive regulation of extracellular matrix organization (GO:1903055)", 0.14482030667016715, 6.7749658002735975, 13.091006050059688, ["PDPN"], 0.2552887303598952, 0, 0], [793, "glycoprotein catabolic process (GO:0006516)", 0.14482030667016715, 6.7749658002735975, 13.091006050059688, ["ADAMTS9"], 0.2552887303598952, 0, 0], [794, "positive regulation of interleukin-4 production (GO:0032753)", 0.14482030667016715, 6.7749658002735975, 13.091006050059688, ["LGALS9"], 0.2552887303598952, 0, 0], [795, "positive regulation of macrophage derived foam cell differentiation (GO:0010744)", 0.14482030667016715, 6.7749658002735975, 13.091006050059688, ["CSF1"], 0.2552887303598952, 0, 0], [796, "positive regulation of nitric-oxide synthase activity (GO:0051000)", 0.14482030667016715, 6.7749658002735975, 13.091006050059688, ["TNF"], 0.2552887303598952, 0, 0], [797, "leukocyte tethering or rolling (GO:0050901)", 0.14482030667016715, 6.7749658002735975, 13.091006050059688, ["TNF"], 0.2552887303598952, 0, 0], [798, "long-chain fatty-acyl-CoA biosynthetic process (GO:0035338)", 0.14482030667016715, 6.7749658002735975, 13.091006050059688, ["ACSL5"], 0.2552887303598952, 0, 0], [799, "T cell migration (GO:0072678)", 0.14482030667016715, 6.7749658002735975, 13.091006050059688, ["CCL20"], 0.2552887303598952, 0, 0], [800, "mitochondrial fission (GO:0000266)", 0.14482030667016715, 6.7749658002735975, 13.091006050059688, ["MX2"], 0.2552887303598952, 0, 0], [801, "water transport (GO:0006833)", 0.14482030667016715, 6.7749658002735975, 13.091006050059688, ["PDPN"], 0.2552887303598952, 0, 0], [802, "negative regulation of apoptotic signaling pathway (GO:2001234)", 0.14634416022867328, 3.0395506309633733, 5.841390680232514, ["TNF", "MMP9"], 0.25701238089911277, 0, 0], [803, "protein modification process (GO:0036211)", 0.14634416022867328, 3.0395506309633733, 5.841390680232514, ["UBE2L6", "TGM5"], 0.25701238089911277, 0, 0], [804, "negative regulation of protein serine/threonine kinase activity (GO:0071901)", 0.14634416022867328, 3.0395506309633733, 5.841390680232514, ["IL1B", "IRAK3"], 0.25701238089911277, 0, 0], [805, "positive regulation of protein kinase activity (GO:0045860)", 0.14904377332436677, 2.2994935722633425, 4.377121048694661, ["CSF1", "IL23A", "TNF"], 0.2612913329384744, 0, 0], [806, "axon development (GO:0061564)", 0.14933576889613942, 2.9999240525556314, 5.70452965891532, ["ACTBL2", "NEFH"], 0.2612913329384744, 0, 0], [807, "regulation of cellular response to heat (GO:1900034)", 0.14933576889613942, 2.9999240525556314, 5.70452965891532, ["CD34", "MAPK3"], 0.2612913329384744, 0, 0], [808, "regulation of bicellular tight junction assembly (GO:2000810)", 0.15222426365215072, 6.398255813953488, 12.044079474530164, ["TNF"], 0.26200205656031644, 0, 0], [809, "cardiac atrium morphogenesis (GO:0003209)", 0.15222426365215072, 6.398255813953488, 12.044079474530164, ["HEY2"], 0.26200205656031644, 0, 0], [810, "negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176)", 0.15222426365215072, 6.398255813953488, 12.044079474530164, ["VNN1"], 0.26200205656031644, 0, 0], [811, "negative regulation of RNA metabolic process (GO:0051253)", 0.15222426365215072, 6.398255813953488, 12.044079474530164, ["TNF"], 0.26200205656031644, 0, 0], [812, "positive regulation of actin cytoskeleton reorganization (GO:2000251)", 0.15222426365215072, 6.398255813953488, 12.044079474530164, ["CSF3"], 0.26200205656031644, 0, 0], [813, "excitatory postsynaptic potential (GO:0060079)", 0.15222426365215072, 6.398255813953488, 12.044079474530164, ["GRIN1"], 0.26200205656031644, 0, 0], [814, "glycerolipid catabolic process (GO:0046503)", 0.15222426365215072, 6.398255813953488, 12.044079474530164, ["PLA2G4C"], 0.26200205656031644, 0, 0], [815, "positive regulation of establishment of protein localization (GO:1904951)", 0.15222426365215072, 6.398255813953488, 12.044079474530164, ["TNF"], 0.26200205656031644, 0, 0], [816, "positive regulation of G protein-coupled receptor signaling pathway (GO:0045745)", 0.15222426365215072, 6.398255813953488, 12.044079474530164, ["C3"], 0.26200205656031644, 0, 0], [817, "positive regulation of oxidoreductase activity (GO:0051353)", 0.15222426365215072, 6.398255813953488, 12.044079474530164, ["TNF"], 0.26200205656031644, 0, 0], [818, "leukocyte adhesion to vascular endothelial cell (GO:0061756)", 0.15222426365215072, 6.398255813953488, 12.044079474530164, ["TNF"], 0.26200205656031644, 0, 0], [819, "mesenchymal cell development (GO:0014031)", 0.15222426365215072, 6.398255813953488, 12.044079474530164, ["HEY2"], 0.26200205656031644, 0, 0], [820, "myeloid cell activation involved in immune response (GO:0002275)", 0.15222426365215072, 6.398255813953488, 12.044079474530164, ["IFI35"], 0.26200205656031644, 0, 0], [821, "negative regulation of cellular component organization (GO:0051129)", 0.1523397226883993, 2.9613135402609085, 5.57213262661331, ["IRAK3", "TNF"], 0.26200205656031644, 0, 0], [822, "regulation of cell differentiation (GO:0045595)", 0.15312669002785764, 2.269204152249135, 4.258138130002176, ["CSF1", "HEY2", "TNF"], 0.2630351415077068, 0, 0], [823, "axonogenesis (GO:0007409)", 0.15503100751074184, 1.9647979139504563, 3.662638997856021, ["ACTBL2", "NEFH", "MYPN", "MAPK3"], 0.2659827249151488, 0, 0], [824, "activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919)", 0.15535558787026751, 2.923680509290103, 5.444006179407079, ["TNFRSF10A", "TNF"], 0.2660000550186239, 0, 0], [825, "positive regulation of nucleic acid-templated transcription (GO:1903508)", 0.1554178791716464, 1.6167168674698795, 3.0097412244285593, ["NCF1", "DTX3L", "NFYA", "IL1B", "HEY2", "TNF", "KLF2"], 0.2660000550186239, 0, 0], [826, "regulation of G protein-coupled receptor signaling pathway (GO:0008277)", 0.15838293728693437, 2.8869883040935673, 5.319967454872788, ["C3", "CNGB1"], 0.26790137286275445, 0, 0], [827, "ephrin receptor signaling pathway (GO:0048013)", 0.15838293728693437, 2.8869883040935673, 5.319967454872788, ["MMP9", "GRIN1"], 0.26790137286275445, 0, 0], [828, "positive regulation of cytoskeleton organization (GO:0051495)", 0.15838293728693437, 2.8869883040935673, 5.319967454872788, ["CSF3", "NES"], 0.26790137286275445, 0, 0], [829, "adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460)", 0.15956448624474256, 6.061199510403917, 11.124162714106953, ["EBI3"], 0.26790137286275445, 0, 0], [830, "negative regulation of lipid storage (GO:0010888)", 0.15956448624474256, 6.061199510403917, 11.124162714106953, ["TNF"], 0.26790137286275445, 0, 0], [831, "cardiac ventricle development (GO:0003231)", 0.15956448624474256, 6.061199510403917, 11.124162714106953, ["HEY2"], 0.26790137286275445, 0, 0], [832, "negative regulation of viral life cycle (GO:1903901)", 0.15956448624474256, 6.061199510403917, 11.124162714106953, ["IFITM3"], 0.26790137286275445, 0, 0], [833, "cortical actin cytoskeleton organization (GO:0030866)", 0.15956448624474256, 6.061199510403917, 11.124162714106953, ["TNF"], 0.26790137286275445, 0, 0], [834, "organic cation transport (GO:0015695)", 0.15956448624474256, 6.061199510403917, 11.124162714106953, ["SLC44A4"], 0.26790137286275445, 0, 0], [835, "embryonic digestive tract development (GO:0048566)", 0.15956448624474256, 6.061199510403917, 11.124162714106953, ["TNF"], 0.26790137286275445, 0, 0], [836, "positive regulation of activated T cell proliferation (GO:0042104)", 0.15956448624474256, 6.061199510403917, 11.124162714106953, ["IL23A"], 0.26790137286275445, 0, 0], [837, "regulation of T cell migration (GO:2000404)", 0.15956448624474256, 6.061199510403917, 11.124162714106953, ["CCL20"], 0.26790137286275445, 0, 0], [838, "regulation of tissue remodeling (GO:0034103)", 0.15956448624474256, 6.061199510403917, 11.124162714106953, ["IL23A"], 0.26790137286275445, 0, 0], [839, "granulocyte differentiation (GO:0030851)", 0.15956448624474256, 6.061199510403917, 11.124162714106953, ["CSF3"], 0.26790137286275445, 0, 0], [840, "growth hormone receptor signaling pathway (GO:0060396)", 0.15956448624474256, 6.061199510403917, 11.124162714106953, ["STAT5A"], 0.26790137286275445, 0, 0], [841, "positive regulation of natural killer cell mediated cytotoxicity (GO:0045954)", 0.15956448624474256, 6.061199510403917, 11.124162714106953, ["RASGRP1"], 0.26790137286275445, 0, 0], [842, "regulation of interleukin-1 beta production (GO:0032651)", 0.16142135015885548, 2.8512020792722548, 5.199843441700727, ["LGALS9", "TNF"], 0.2703759744060545, 0, 0], [843, "long-chain fatty acid metabolic process (GO:0001676)", 0.16142135015885548, 2.8512020792722548, 5.199843441700727, ["PLA2G4C", "ACSL5"], 0.2703759744060545, 0, 0], [844, "positive regulation of protein kinase B signaling (GO:0051897)", 0.16348592373112708, 2.196835443037975, 3.97853134613858, ["CSF3", "TNF", "HBEGF"], 0.2735096259577624, 0, 0], [845, "negative regulation of cell communication (GO:0010648)", 0.1668415199144423, 5.757848837209302, 10.310642671515755, ["IL1B"], 0.2761784596942468, 0, 0], [846, "negative regulation of ion transmembrane transporter activity (GO:0032413)", 0.1668415199144423, 5.757848837209302, 10.310642671515755, ["MMP9"], 0.2761784596942468, 0, 0], [847, "calcium ion transport into cytosol (GO:0060402)", 0.1668415199144423, 5.757848837209302, 10.310642671515755, ["GRIN1"], 0.2761784596942468, 0, 0], [848, "calcium-mediated signaling using intracellular calcium source (GO:0035584)", 0.1668415199144423, 5.757848837209302, 10.310642671515755, ["CCL20"], 0.2761784596942468, 0, 0], [849, "regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664)", 0.1668415199144423, 5.757848837209302, 10.310642671515755, ["LY96"], 0.2761784596942468, 0, 0], [850, "positive regulation of immune system process (GO:0002684)", 0.1668415199144423, 5.757848837209302, 10.310642671515755, ["LGALS9"], 0.2761784596942468, 0, 0], [851, "histone ubiquitination (GO:0016574)", 0.1668415199144423, 5.757848837209302, 10.310642671515755, ["DTX3L"], 0.2761784596942468, 0, 0], [852, "positive regulation of lipid storage (GO:0010884)", 0.1668415199144423, 5.757848837209302, 10.310642671515755, ["C3"], 0.2761784596942468, 0, 0], [853, "positive regulation of T cell cytokine production (GO:0002726)", 0.1668415199144423, 5.757848837209302, 10.310642671515755, ["IL1B"], 0.2761784596942468, 0, 0], [854, "positive regulation of protein catabolic process (GO:0045732)", 0.16752971488180962, 2.7822165856408088, 4.97069296426262, ["IL1B", "TNF"], 0.2769929243713293, 0, 0], [855, "protein ubiquitination (GO:0016567)", 0.17088730074260483, 1.5718821230869424, 2.7771243124368907, ["HERC5", "DTX3L", "TRIML2", "TRIM14", "UBE2L6", "DTX2", "RNF122"], 0.2822138814603018, 0, 0], [856, "protein targeting to membrane (GO:0006612)", 0.17367744137761687, 2.7164774681802544, 4.755344532725339, ["NCF1", "ZDHHC23"], 0.284123628310509, 0, 0], [857, "negative regulation of biomineral tissue development (GO:0070168)", 0.17405590544517727, 5.483388704318937, 9.587040210264009, ["HEY2"], 0.284123628310509, 0, 0], [858, "negative regulation of interleukin-2 production (GO:0032703)", 0.17405590544517727, 5.483388704318937, 9.587040210264009, ["CD34"], 0.284123628310509, 0, 0], [859, "cell projection assembly (GO:0030031)", 0.17405590544517727, 5.483388704318937, 9.587040210264009, ["NEFH"], 0.284123628310509, 0, 0], [860, "osteoclast differentiation (GO:0030316)", 0.17405590544517727, 5.483388704318937, 9.587040210264009, ["CSF1"], 0.284123628310509, 0, 0], [861, "regulation of platelet activation (GO:0010543)", 0.17405590544517727, 5.483388704318937, 9.587040210264009, ["C1QTNF1"], 0.284123628310509, 0, 0], [862, "positive regulation of amyloid precursor protein catabolic process (GO:1902993)", 0.17405590544517727, 5.483388704318937, 9.587040210264009, ["TNF"], 0.284123628310509, 0, 0], [863, "positive regulation of calcium ion transmembrane transporter activity (GO:1901021)", 0.17405590544517727, 5.483388704318937, 9.587040210264009, ["P2RY6"], 0.284123628310509, 0, 0], [864, "positive regulation of lipid catabolic process (GO:0050996)", 0.17405590544517727, 5.483388704318937, 9.587040210264009, ["IL1B"], 0.284123628310509, 0, 0], [865, "lipid droplet organization (GO:0034389)", 0.17405590544517727, 5.483388704318937, 9.587040210264009, ["PLA2G4C"], 0.284123628310509, 0, 0], [866, "positive regulation of neuron projection development (GO:0010976)", 0.17676507937952265, 2.6847545219638245, 4.652501488295007, ["ROR2", "TOX"], 0.2882128084109538, 0, 0], [867, "regulation of cation channel activity (GO:2001257)", 0.17986138675887012, 2.653760838878806, 4.552709293364653, ["MMP9", "GRIN1"], 0.289768911528844, 0, 0], [868, "regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281)", 0.17986138675887012, 2.653760838878806, 4.552709293364653, ["IFI6", "TNF"], 0.289768911528844, 0, 0], [869, "artery development (GO:0060840)", 0.18120817909346265, 5.233879492600423, 8.940035346802228, ["APLNR"], 0.289768911528844, 0, 0], [870, "regulation of cysteine-type endopeptidase activity (GO:2000116)", 0.18120817909346265, 5.233879492600423, 8.940035346802228, ["GRIN1"], 0.289768911528844, 0, 0], [871, "negative regulation of phosphoprotein phosphatase activity (GO:0032515)", 0.18120817909346265, 5.233879492600423, 8.940035346802228, ["TNF"], 0.289768911528844, 0, 0], [872, "regulation of interferon-gamma-mediated signaling pathway (GO:0060334)", 0.18120817909346265, 5.233879492600423, 8.940035346802228, ["PARP14"], 0.289768911528844, 0, 0], [873, "regulation of interleukin-4 production (GO:0032673)", 0.18120817909346265, 5.233879492600423, 8.940035346802228, ["LGALS9"], 0.289768911528844, 0, 0], [874, "peptidyl-L-cysteine S-palmitoylation (GO:0018230)", 0.18120817909346265, 5.233879492600423, 8.940035346802228, ["ZDHHC23"], 0.289768911528844, 0, 0], [875, "peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231)", 0.18120817909346265, 5.233879492600423, 8.940035346802228, ["ZDHHC23"], 0.289768911528844, 0, 0], [876, "regulation of protein export from nucleus (GO:0046825)", 0.18120817909346265, 5.233879492600423, 8.940035346802228, ["IL1B"], 0.289768911528844, 0, 0], [877, "regulation of telomere capping (GO:1904353)", 0.18120817909346265, 5.233879492600423, 8.940035346802228, ["MAPK3"], 0.289768911528844, 0, 0], [878, "regulation of toll-like receptor 4 signaling pathway (GO:0034143)", 0.18120817909346265, 5.233879492600423, 8.940035346802228, ["IFI35"], 0.289768911528844, 0, 0], [879, "positive regulation of epithelial cell apoptotic process (GO:1904037)", 0.18120817909346265, 5.233879492600423, 8.940035346802228, ["ECSCR"], 0.289768911528844, 0, 0], [880, "positive regulation of interleukin-17 production (GO:0032740)", 0.18120817909346265, 5.233879492600423, 8.940035346802228, ["IL23A"], 0.289768911528844, 0, 0], [881, "positive regulation of JUN kinase activity (GO:0043507)", 0.18120817909346265, 5.233879492600423, 8.940035346802228, ["TNF"], 0.289768911528844, 0, 0], [882, "hyaluronan metabolic process (GO:0030212)", 0.18120817909346265, 5.233879492600423, 8.940035346802228, ["IL1B"], 0.289768911528844, 0, 0], [883, "positive regulation of natural killer cell mediated immunity (GO:0002717)", 0.18120817909346265, 5.233879492600423, 8.940035346802228, ["RASGRP1"], 0.289768911528844, 0, 0], [884, "cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742)", 0.18263491798643253, 2.077492074674181, 3.5322893526811345, ["MILR1", "ITGB2", "MYPN"], 0.29172002737199404, 0, 0], [885, "cardiac muscle cell development (GO:0055013)", 0.18829887245255963, 5.006066734074823, 8.358753933401816, ["HEY2"], 0.29509212863819556, 0, 0], [886, "negative regulation of NIK/NF-kappaB signaling (GO:1901223)", 0.18829887245255963, 5.006066734074823, 8.358753933401816, ["IFI35"], 0.29509212863819556, 0, 0], [887, "regulation of cytokine production involved in immune response (GO:0002718)", 0.18829887245255963, 5.006066734074823, 8.358753933401816, ["TNF"], 0.29509212863819556, 0, 0], [888, "cellular response to catecholamine stimulus (GO:0071870)", 0.18829887245255963, 5.006066734074823, 8.358753933401816, ["MAPK3"], 0.29509212863819556, 0, 0], [889, "negative regulation of synaptic transmission (GO:0050805)", 0.18829887245255963, 5.006066734074823, 8.358753933401816, ["IL1B"], 0.29509212863819556, 0, 0], [890, "dendritic cell differentiation (GO:0097028)", 0.18829887245255963, 5.006066734074823, 8.358753933401816, ["LGALS9"], 0.29509212863819556, 0, 0], [891, "regulation of monooxygenase activity (GO:0032768)", 0.18829887245255963, 5.006066734074823, 8.358753933401816, ["IL1B"], 0.29509212863819556, 0, 0], [892, "peptidyl-glutamic acid modification (GO:0018200)", 0.18829887245255963, 5.006066734074823, 8.358753933401816, ["TPGS1"], 0.29509212863819556, 0, 0], [893, "phospholipid catabolic process (GO:0009395)", 0.18829887245255963, 5.006066734074823, 8.358753933401816, ["PLA2G4C"], 0.29509212863819556, 0, 0], [894, "regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947)", 0.18829887245255963, 5.006066734074823, 8.358753933401816, ["IL1B"], 0.29509212863819556, 0, 0], [895, "histone monoubiquitination (GO:0010390)", 0.18829887245255963, 5.006066734074823, 8.358753933401816, ["DTX3L"], 0.29509212863819556, 0, 0], [896, "positive regulation of neuron apoptotic process (GO:0043525)", 0.18829887245255963, 5.006066734074823, 8.358753933401816, ["TNF"], 0.29509212863819556, 0, 0], [897, "long-chain fatty-acyl-CoA metabolic process (GO:0035336)", 0.18829887245255963, 5.006066734074823, 8.358753933401816, ["ACSL5"], 0.29509212863819556, 0, 0], [898, "positive regulation of protein targeting to membrane (GO:0090314)", 0.18829887245255963, 5.006066734074823, 8.358753933401816, ["ITGB2"], 0.29509212863819556, 0, 0], [899, "positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003)", 0.18829887245255963, 5.006066734074823, 8.358753933401816, ["KLF2"], 0.29509212863819556, 0, 0], [900, "positive regulation of viral life cycle (GO:1903902)", 0.18829887245255963, 5.006066734074823, 8.358753933401816, ["LGALS9"], 0.29509212863819556, 0, 0], [901, "wound healing, spreading of cells (GO:0044319)", 0.18829887245255963, 5.006066734074823, 8.358753933401816, ["PDPN"], 0.29509212863819556, 0, 0], [902, "regulation of lipid metabolic process (GO:0019216)", 0.18919857450346186, 2.5649122807017544, 4.270471623050371, ["NFYA", "IL1B"], 0.2958453900319913, 0, 0], [903, "T cell activation (GO:0042110)", 0.18919857450346186, 2.5649122807017544, 4.270471623050371, ["TNFSF14", "RASGRP1"], 0.2958453900319913, 0, 0], [904, "cation transport (GO:0006812)", 0.19133241341973037, 2.028482972136223, 3.35458947370465, ["SLC11A2", "GRIN1", "CNGB1"], 0.2988510705184284, 0, 0], [905, "positive regulation of peptidyl-serine phosphorylation (GO:0033138)", 0.19232583755770416, 2.5365979050189575, 4.18174468559078, ["CSF3", "TNF"], 0.29966279255218453, 0, 0], [906, "receptor signaling pathway via STAT (GO:0097696)", 0.19532851270988713, 4.797238372093023, 7.834237856747159, ["STAT5A"], 0.29966279255218453, 0, 0], [907, "regulation of cAMP-mediated signaling (GO:0043949)", 0.19532851270988713, 4.797238372093023, 7.834237856747159, ["APLNR"], 0.29966279255218453, 0, 0], [908, "cardiac conduction system development (GO:0003161)", 0.19532851270988713, 4.797238372093023, 7.834237856747159, ["HEY2"], 0.29966279255218453, 0, 0], [909, "negative regulation of signaling (GO:0023057)", 0.19532851270988713, 4.797238372093023, 7.834237856747159, ["IL1B"], 0.29966279255218453, 0, 0], [910, "chemical synaptic transmission, postsynaptic (GO:0099565)", 0.19532851270988713, 4.797238372093023, 7.834237856747159, ["GRIN1"], 0.29966279255218453, 0, 0], [911, "organophosphate ester transport (GO:0015748)", 0.19532851270988713, 4.797238372093023, 7.834237856747159, ["SLC44A4"], 0.29966279255218453, 0, 0], [912, "divalent inorganic cation homeostasis (GO:0072507)", 0.19532851270988713, 4.797238372093023, 7.834237856747159, ["GRIN1"], 0.29966279255218453, 0, 0], [913, "regulation of rhodopsin mediated signaling pathway (GO:0022400)", 0.19532851270988713, 4.797238372093023, 7.834237856747159, ["CNGB1"], 0.29966279255218453, 0, 0], [914, "positive regulation of ERBB signaling pathway (GO:1901186)", 0.19532851270988713, 4.797238372093023, 7.834237856747159, ["MMP9"], 0.29966279255218453, 0, 0], [915, "positive regulation of lipid metabolic process (GO:0045834)", 0.19532851270988713, 4.797238372093023, 7.834237856747159, ["IL1B"], 0.29966279255218453, 0, 0], [916, "positive regulation of release of cytochrome c from mitochondria (GO:0090200)", 0.19532851270988713, 4.797238372093023, 7.834237856747159, ["MMP9"], 0.29966279255218453, 0, 0], [917, "positive regulation of T cell migration (GO:2000406)", 0.19532851270988713, 4.797238372093023, 7.834237856747159, ["CCL20"], 0.29966279255218453, 0, 0], [918, "ventricular cardiac muscle tissue development (GO:0003229)", 0.19532851270988713, 4.797238372093023, 7.834237856747159, ["ADAMTS9"], 0.29966279255218453, 0, 0], [919, "negative regulation of cell death (GO:0060548)", 0.1954599376349589, 2.508899059242309, 4.095526430760106, ["CSF1", "CD34"], 0.29966279255218453, 0, 0], [920, "negative regulation of MAPK cascade (GO:0043409)", 0.1954599376349589, 2.508899059242309, 4.095526430760106, ["IL1B", "IRAK3"], 0.29966279255218453, 0, 0], [921, "hemopoiesis (GO:0030097)", 0.1954599376349589, 2.508899059242309, 4.095526430760106, ["TOX", "CD34"], 0.29966279255218453, 0, 0], [922, "regulation of biomineral tissue development (GO:0070167)", 0.20229762247413866, 4.605116279069767, 7.359046213993185, ["HEY2"], 0.3074749654827597, 0, 0], [923, "cellular response to drug (GO:0035690)", 0.20229762247413866, 4.605116279069767, 7.359046213993185, ["IL1B"], 0.3074749654827597, 0, 0], [924, "negative regulation of signaling receptor activity (GO:2000272)", 0.20229762247413866, 4.605116279069767, 7.359046213993185, ["TNF"], 0.3074749654827597, 0, 0], [925, "organelle fission (GO:0048285)", 0.20229762247413866, 4.605116279069767, 7.359046213993185, ["MX2"], 0.3074749654827597, 0, 0], [926, "phosphatidylethanolamine acyl-chain remodeling (GO:0036152)", 0.20229762247413866, 4.605116279069767, 7.359046213993185, ["PLA2G4C"], 0.3074749654827597, 0, 0], [927, "regulation of synapse organization (GO:0050807)", 0.20229762247413866, 4.605116279069767, 7.359046213993185, ["TNF"], 0.3074749654827597, 0, 0], [928, "positive regulation of interleukin-2 production (GO:0032743)", 0.20229762247413866, 4.605116279069767, 7.359046213993185, ["IL1B"], 0.3074749654827597, 0, 0], [929, "positive regulation of T cell mediated cytotoxicity (GO:0001916)", 0.20229762247413866, 4.605116279069767, 7.359046213993185, ["IL23A"], 0.3074749654827597, 0, 0], [930, "central nervous system development (GO:0007417)", 0.20279338040603467, 1.7538999462076386, 2.7984660133899575, ["C3", "CTNS", "NES", "GRIN1"], 0.307897046379915, 0, 0], [931, "positive regulation of cellular biosynthetic process (GO:0031328)", 0.20456967858890965, 1.959122632103689, 3.1088271561831857, ["IL1B", "TNF", "KLF2"], 0.3102603503410746, 0, 0], [932, "negative regulation of neuron death (GO:1901215)", 0.20805779824281745, 2.403874269005848, 3.7739368355234104, ["CSF1", "CD34"], 0.31094725112899957, 0, 0], [933, "regulation of peptidyl-serine phosphorylation (GO:0033135)", 0.20805779824281745, 2.403874269005848, 3.7739368355234104, ["CSF3", "TNF"], 0.31094725112899957, 0, 0], [934, "acute inflammatory response (GO:0002526)", 0.20920671995223059, 4.427772808586762, 6.9269513530156175, ["VNN1"], 0.31094725112899957, 0, 0], [935, "negative regulation of catalytic activity (GO:0043086)", 0.20920671995223059, 4.427772808586762, 6.9269513530156175, ["NES"], 0.31094725112899957, 0, 0], [936, "negative regulation of cation channel activity (GO:2001258)", 0.20920671995223059, 4.427772808586762, 6.9269513530156175, ["MMP9"], 0.31094725112899957, 0, 0], [937, "regulation of blood coagulation (GO:0030193)", 0.20920671995223059, 4.427772808586762, 6.9269513530156175, ["CD34"], 0.31094725112899957, 0, 0], [938, "negative regulation of insulin receptor signaling pathway (GO:0046627)", 0.20920671995223059, 4.427772808586762, 6.9269513530156175, ["IL1B"], 0.31094725112899957, 0, 0], [939, "bile acid biosynthetic process (GO:0006699)", 0.20920671995223059, 4.427772808586762, 6.9269513530156175, ["CYP27A1"], 0.31094725112899957, 0, 0], [940, "regulation of cell junction assembly (GO:1901888)", 0.20920671995223059, 4.427772808586762, 6.9269513530156175, ["APLNR"], 0.31094725112899957, 0, 0], [941, "camera-type eye development (GO:0043010)", 0.20920671995223059, 4.427772808586762, 6.9269513530156175, ["NES"], 0.31094725112899957, 0, 0], [942, "positive regulation of calcium ion transmembrane transport (GO:1904427)", 0.20920671995223059, 4.427772808586762, 6.9269513530156175, ["APLNR"], 0.31094725112899957, 0, 0], [943, "positive regulation of cellular component movement (GO:0051272)", 0.20920671995223059, 4.427772808586762, 6.9269513530156175, ["PDPN"], 0.31094725112899957, 0, 0], [944, "regulation of toll-like receptor signaling pathway (GO:0034121)", 0.20920671995223059, 4.427772808586762, 6.9269513530156175, ["IRAK3"], 0.31094725112899957, 0, 0], [945, "regulation of transcription regulatory region DNA binding (GO:2000677)", 0.20920671995223059, 4.427772808586762, 6.9269513530156175, ["HEY2"], 0.31094725112899957, 0, 0], [946, "response to glucocorticoid (GO:0051384)", 0.20920671995223059, 4.427772808586762, 6.9269513530156175, ["TNF"], 0.31094725112899957, 0, 0], [947, "positive regulation of nuclear division (GO:0051785)", 0.20920671995223059, 4.427772808586762, 6.9269513530156175, ["IL1B"], 0.31094725112899957, 0, 0], [948, "stress-activated protein kinase signaling cascade (GO:0031098)", 0.20920671995223059, 4.427772808586762, 6.9269513530156175, ["MAPK3"], 0.31094725112899957, 0, 0], [949, "positive regulation of toll-like receptor signaling pathway (GO:0034123)", 0.20920671995223059, 4.427772808586762, 6.9269513530156175, ["IFI35"], 0.31094725112899957, 0, 0], [950, "modulation of excitatory postsynaptic potential (GO:0098815)", 0.20920671995223059, 4.427772808586762, 6.9269513530156175, ["GRIN1"], 0.31094725112899957, 0, 0], [951, "negative regulation of axonogenesis (GO:0050771)", 0.21605631892084193, 4.263565891472868, 6.532704598809649, ["LINGO1"], 0.31515653131841814, 0, 0], [952, "amide transport (GO:0042886)", 0.21605631892084193, 4.263565891472868, 6.532704598809649, ["PDPN"], 0.31515653131841814, 0, 0], [953, "negative regulation of cellular response to insulin stimulus (GO:1900077)", 0.21605631892084193, 4.263565891472868, 6.532704598809649, ["IL1B"], 0.31515653131841814, 0, 0], [954, "receptor clustering (GO:0043113)", 0.21605631892084193, 4.263565891472868, 6.532704598809649, ["ITGB2"], 0.31515653131841814, 0, 0], [955, "regulation of calcineurin-NFAT signaling cascade (GO:0070884)", 0.21605631892084193, 4.263565891472868, 6.532704598809649, ["TNF"], 0.31515653131841814, 0, 0], [956, "cellular response to acid chemical (GO:0071229)", 0.21605631892084193, 4.263565891472868, 6.532704598809649, ["KLF2"], 0.31515653131841814, 0, 0], [957, "neutral amino acid transport (GO:0015804)", 0.21605631892084193, 4.263565891472868, 6.532704598809649, ["CTNS"], 0.31515653131841814, 0, 0], [958, "regulation of protein transport (GO:0051223)", 0.21605631892084193, 4.263565891472868, 6.532704598809649, ["TNF"], 0.31515653131841814, 0, 0], [959, "regulation of reactive oxygen species biosynthetic process (GO:1903426)", 0.21605631892084193, 4.263565891472868, 6.532704598809649, ["GRIN1"], 0.31515653131841814, 0, 0], [960, "regulation of sodium ion transmembrane transport (GO:1902305)", 0.21605631892084193, 4.263565891472868, 6.532704598809649, ["FXYD5"], 0.31515653131841814, 0, 0], [961, "positive regulation of cell communication (GO:0010647)", 0.21605631892084193, 4.263565891472868, 6.532704598809649, ["TNF"], 0.31515653131841814, 0, 0], [962, "glycerophospholipid catabolic process (GO:0046475)", 0.21605631892084193, 4.263565891472868, 6.532704598809649, ["PLA2G4C"], 0.31515653131841814, 0, 0], [963, "response to interferon-beta (GO:0035456)", 0.21605631892084193, 4.263565891472868, 6.532704598809649, ["IFITM3"], 0.31515653131841814, 0, 0], [964, "sarcomere organization (GO:0045214)", 0.21605631892084193, 4.263565891472868, 6.532704598809649, ["MYPN"], 0.31515653131841814, 0, 0], [965, "L-amino acid transport (GO:0015807)", 0.21605631892084193, 4.263565891472868, 6.532704598809649, ["CTNS"], 0.31515653131841814, 0, 0], [966, "leukocyte cell-cell adhesion (GO:0007159)", 0.21605631892084193, 4.263565891472868, 6.532704598809649, ["ITGB2"], 0.31515653131841814, 0, 0], [967, "sulfur compound transport (GO:0072348)", 0.21605631892084193, 4.263565891472868, 6.532704598809649, ["SLC44A4"], 0.31515653131841814, 0, 0], [968, "positive regulation of response to wounding (GO:1903036)", 0.21605631892084193, 4.263565891472868, 6.532704598809649, ["HBEGF"], 0.31515653131841814, 0, 0], [969, "regulation of cell population proliferation (GO:0042127)", 0.21738136474544967, 1.3862703925052495, 2.115590055572091, ["STAT5A", "CSF3", "CSF1", "IL1B", "PDPN", "ROR2", "IFI35", "IFIT3", "HBEGF"], 0.316697612380577, 0, 0], [970, "positive regulation of protein localization to membrane (GO:1905477)", 0.21756139094133123, 2.330675172780436, 3.5549187354439638, ["ITGB2", "TNF"], 0.316697612380577, 0, 0], [971, "regulation of protein catabolic process (GO:0042176)", 0.22073805340247554, 2.307251461988304, 3.485746039419235, ["IRAK3", "TNF"], 0.3207541932021119, 0, 0], [972, "negative regulation of interferon-gamma production (GO:0032689)", 0.22284692884650978, 4.111088039867109, 6.171853803262898, ["LGALS9"], 0.3207541932021119, 0, 0], [973, "regulation of double-strand break repair via nonhomologous end joining (GO:2001032)", 0.22284692884650978, 4.111088039867109, 6.171853803262898, ["DTX3L"], 0.3207541932021119, 0, 0], [974, "negative regulation of transferase activity (GO:0051348)", 0.22284692884650978, 4.111088039867109, 6.171853803262898, ["DTX3L"], 0.3207541932021119, 0, 0], [975, "dicarboxylic acid transport (GO:0006835)", 0.22284692884650978, 4.111088039867109, 6.171853803262898, ["PDPN"], 0.3207541932021119, 0, 0], [976, "regulation of protein targeting to membrane (GO:0090313)", 0.22284692884650978, 4.111088039867109, 6.171853803262898, ["ITGB2"], 0.3207541932021119, 0, 0], [977, "regulation of response to biotic stimulus (GO:0002831)", 0.22284692884650978, 4.111088039867109, 6.171853803262898, ["HERC5"], 0.3207541932021119, 0, 0], [978, "regulation of T cell mediated cytotoxicity (GO:0001914)", 0.22284692884650978, 4.111088039867109, 6.171853803262898, ["IL23A"], 0.3207541932021119, 0, 0], [979, "regulation of ubiquitin-protein transferase activity (GO:0051438)", 0.22284692884650978, 4.111088039867109, 6.171853803262898, ["DTX3L"], 0.3207541932021119, 0, 0], [980, "positive regulation of extrinsic apoptotic signaling pathway (GO:2001238)", 0.22284692884650978, 4.111088039867109, 6.171853803262898, ["TNF"], 0.3207541932021119, 0, 0], [981, "protein ADP-ribosylation (GO:0006471)", 0.22284692884650978, 4.111088039867109, 6.171853803262898, ["PARP14"], 0.3207541932021119, 0, 0], [982, "regulation of GTPase activity (GO:0043087)", 0.22480148484480558, 1.863472485768501, 2.781302669214865, ["CCL22", "CCL20", "RASGRP1"], 0.3232379802452805, 0, 0], [983, "regulation of insulin secretion (GO:0050796)", 0.22710272202078732, 2.261781905744754, 3.352758840356458, ["IL1B", "TNF"], 0.3261223594923773, 0, 0], [984, "alpha-amino acid catabolic process (GO:1901606)", 0.2295790547701296, 3.9691259021651963, 5.8405998971400015, ["KMO"], 0.3261223594923773, 0, 0], [985, "cell projection organization (GO:0030030)", 0.2295790547701296, 3.9691259021651963, 5.8405998971400015, ["NEFH"], 0.3261223594923773, 0, 0], [986, "non-motile cilium assembly (GO:1905515)", 0.2295790547701296, 3.9691259021651963, 5.8405998971400015, ["RPGRIP1"], 0.3261223594923773, 0, 0], [987, "phosphatidylcholine acyl-chain remodeling (GO:0036151)", 0.2295790547701296, 3.9691259021651963, 5.8405998971400015, ["PLA2G4C"], 0.3261223594923773, 0, 0], [988, "fatty-acyl-CoA biosynthetic process (GO:0046949)", 0.2295790547701296, 3.9691259021651963, 5.8405998971400015, ["ACSL5"], 0.3261223594923773, 0, 0], [989, "regulation of type I interferon-mediated signaling pathway (GO:0060338)", 0.2295790547701296, 3.9691259021651963, 5.8405998971400015, ["OAS3"], 0.3261223594923773, 0, 0], [990, "positive regulation of endopeptidase activity (GO:0010950)", 0.2295790547701296, 3.9691259021651963, 5.8405998971400015, ["GRIN1"], 0.3261223594923773, 0, 0], [991, "respiratory tube development (GO:0030323)", 0.2295790547701296, 3.9691259021651963, 5.8405998971400015, ["PDPN"], 0.3261223594923773, 0, 0], [992, "response to alcohol (GO:0097305)", 0.2295790547701296, 3.9691259021651963, 5.8405998971400015, ["GRIN1"], 0.3261223594923773, 0, 0], [993, "heterotypic cell-cell adhesion (GO:0034113)", 0.2295790547701296, 3.9691259021651963, 5.8405998971400015, ["ITGB2"], 0.3261223594923773, 0, 0], [994, "positive regulation of small GTPase mediated signal transduction (GO:0051057)", 0.2295790547701296, 3.9691259021651963, 5.8405998971400015, ["RASGRP1"], 0.3261223594923773, 0, 0], [995, "negative regulation of cell population proliferation (GO:0008285)", 0.23161813275401674, 1.5480169340463459, 2.264230564907396, ["IL1B", "PDPN", "ROR2", "IFI35", "IFIT3"], 0.3286882446720318, 0, 0], [996, "positive regulation of programmed cell death (GO:0043068)", 0.23554175263465324, 1.6404381216165176, 2.3718554894125656, ["OLFM1", "TNFRSF10A", "TNF", "RNF122"], 0.33192986550252296, 0, 0], [997, "protein palmitoylation (GO:0018345)", 0.23625319747169657, 3.8366279069767444, 5.535683096771687, ["ZDHHC23"], 0.33192986550252296, 0, 0], [998, "receptor signaling pathway via JAK-STAT (GO:0007259)", 0.23625319747169657, 3.8366279069767444, 5.535683096771687, ["STAT5A"], 0.33192986550252296, 0, 0], [999, "negative regulation of DNA binding (GO:0043392)", 0.23625319747169657, 3.8366279069767444, 5.535683096771687, ["HEY2"], 0.33192986550252296, 0, 0], [1000, "negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732)", 0.23625319747169657, 3.8366279069767444, 5.535683096771687, ["PARP14"], 0.33192986550252296, 0, 0], [1001, "negative regulation of response to biotic stimulus (GO:0002832)", 0.23625319747169657, 3.8366279069767444, 5.535683096771687, ["IRAK3"], 0.33192986550252296, 0, 0], [1002, "regulation of macrophage derived foam cell differentiation (GO:0010743)", 0.23625319747169657, 3.8366279069767444, 5.535683096771687, ["CSF1"], 0.33192986550252296, 0, 0], [1003, "peptide cross-linking (GO:0018149)", 0.23625319747169657, 3.8366279069767444, 5.535683096771687, ["TGM5"], 0.33192986550252296, 0, 0], [1004, "positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052)", 0.23625319747169657, 3.8366279069767444, 5.535683096771687, ["ECSCR"], 0.33192986550252296, 0, 0], [1005, "vitamin transport (GO:0051180)", 0.23625319747169657, 3.8366279069767444, 5.535683096771687, ["PDPN"], 0.33192986550252296, 0, 0], [1006, "protein localization to membrane (GO:0072657)", 0.23850129544933535, 1.8046875, 2.586803937894429, ["ITGB2", "ZDHHC23", "TNF"], 0.3347552973901208, 0, 0], [1007, "activation of phospholipase C activity (GO:0007202)", 0.2428698534740808, 3.7126781695423854, 5.254291897977048, ["P2RY6"], 0.33648067560868966, 0, 0], [1008, "aortic valve morphogenesis (GO:0003180)", 0.2428698534740808, 3.7126781695423854, 5.254291897977048, ["HEY2"], 0.33648067560868966, 0, 0], [1009, "B cell proliferation (GO:0042100)", 0.2428698534740808, 3.7126781695423854, 5.254291897977048, ["RASGRP1"], 0.33648067560868966, 0, 0], [1010, "regulation of cell morphogenesis (GO:0022604)", 0.2428698534740808, 3.7126781695423854, 5.254291897977048, ["PDPN"], 0.33648067560868966, 0, 0], [1011, "regulation of chemotaxis (GO:0050920)", 0.2428698534740808, 3.7126781695423854, 5.254291897977048, ["ZSWIM4"], 0.33648067560868966, 0, 0], [1012, "regulation of NMDA receptor activity (GO:2000310)", 0.2428698534740808, 3.7126781695423854, 5.254291897977048, ["GRIN1"], 0.33648067560868966, 0, 0], [1013, "ERBB2 signaling pathway (GO:0038128)", 0.2428698534740808, 3.7126781695423854, 5.254291897977048, ["HBEGF"], 0.33648067560868966, 0, 0], [1014, "response to amino acid (GO:0043200)", 0.2428698534740808, 3.7126781695423854, 5.254291897977048, ["GRIN1"], 0.33648067560868966, 0, 0], [1015, "positive regulation of glucose transmembrane transport (GO:0010828)", 0.2428698534740808, 3.7126781695423854, 5.254291897977048, ["C3"], 0.33648067560868966, 0, 0], [1016, "superoxide metabolic process (GO:0006801)", 0.2428698534740808, 3.7126781695423854, 5.254291897977048, ["NCF1"], 0.33648067560868966, 0, 0], [1017, "positive regulation of receptor signaling pathway via STAT (GO:1904894)", 0.2428698534740808, 3.7126781695423854, 5.254291897977048, ["TNF"], 0.33648067560868966, 0, 0], [1018, "transcription initiation from RNA polymerase I promoter (GO:0006361)", 0.2428698534740808, 3.7126781695423854, 5.254291897977048, ["MAPK3"], 0.33648067560868966, 0, 0], [1019, "positive regulation of telomere maintenance (GO:0032206)", 0.2428698534740808, 3.7126781695423854, 5.254291897977048, ["MAPK3"], 0.33648067560868966, 0, 0], [1020, "modulation of chemical synaptic transmission (GO:0050804)", 0.24306677699777865, 2.15554462480188, 3.048843425566626, ["IL1B", "TNF"], 0.33648067560868966, 0, 0], [1021, "negative regulation of apoptotic process (GO:0043066)", 0.2438556354883503, 1.4512269823609565, 2.0479408772041294, ["PDPN", "IFI6", "TNF", "MMP9", "IFIT3", "MAPK3"], 0.33724207376057846, 0, 0], [1022, "regulation of protein kinase activity (GO:0045859)", 0.24626628990260246, 2.1354775828460038, 2.992534104932788, ["CSF1", "TNF"], 0.3399100697384895, 0, 0], [1023, "response to tumor necrosis factor (GO:0034612)", 0.24626628990260246, 2.1354775828460038, 2.992534104932788, ["CCL22", "CCL20"], 0.3399100697384895, 0, 0], [1024, "apoptotic mitochondrial changes (GO:0008637)", 0.2494295150978813, 3.5964752906976742, 4.993989732957624, ["IFI6"], 0.3416047287276512, 0, 0], [1025, "bile acid metabolic process (GO:0008206)", 0.2494295150978813, 3.5964752906976742, 4.993989732957624, ["CYP27A1"], 0.3416047287276512, 0, 0], [1026, "regulation of interleukin-17 production (GO:0032660)", 0.2494295150978813, 3.5964752906976742, 4.993989732957624, ["IL23A"], 0.3416047287276512, 0, 0], [1027, "phosphatidylcholine biosynthetic process (GO:0006656)", 0.2494295150978813, 3.5964752906976742, 4.993989732957624, ["SLC44A4"], 0.3416047287276512, 0, 0], [1028, "regulation of protein localization to cell surface (GO:2000008)", 0.2494295150978813, 3.5964752906976742, 4.993989732957624, ["TNF"], 0.3416047287276512, 0, 0], [1029, "positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427)", 0.2494295150978813, 3.5964752906976742, 4.993989732957624, ["TNF"], 0.3416047287276512, 0, 0], [1030, "positive regulation of telomere maintenance via telomerase (GO:0032212)", 0.2494295150978813, 3.5964752906976742, 4.993989732957624, ["MAPK3"], 0.3416047287276512, 0, 0], [1031, "muscle cell development (GO:0055001)", 0.2494295150978813, 3.5964752906976742, 4.993989732957624, ["HEY2"], 0.3416047287276512, 0, 0], [1032, "regulation of macromolecule metabolic process (GO:0060255)", 0.2500255183536518, 1.7584353538369664, 2.4375295350770436, ["TRIML2", "APLNR", "TRIM14"], 0.3420891782125546, 0, 0], [1033, "regulation of cytoskeleton organization (GO:0051493)", 0.2526698320362066, 2.0964380648591177, 2.8840104206934374, ["RHOF", "MAPK3"], 0.34537251000496, 0, 0], [1034, "generation of neurons (GO:0048699)", 0.2546591233762657, 1.7405852793378658, 2.3808237168455246, ["IL1B", "HEY2", "ASTN1"], 0.3468108739226676, 0, 0], [1035, "negative regulation of blood vessel endothelial cell migration (GO:0043537)", 0.2559326704160195, 3.4873150105708244, 4.752655441391066, ["TNF"], 0.3468108739226676, 0, 0], [1036, "regulation of amyloid-beta formation (GO:1902003)", 0.2559326704160195, 3.4873150105708244, 4.752655441391066, ["TNF"], 0.3468108739226676, 0, 0], [1037, "negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042)", 0.2559326704160195, 3.4873150105708244, 4.752655441391066, ["TNFRSF10A"], 0.3468108739226676, 0, 0], [1038, "central nervous system neuron differentiation (GO:0021953)", 0.2559326704160195, 3.4873150105708244, 4.752655441391066, ["TOX"], 0.3468108739226676, 0, 0], [1039, "positive regulation of DNA binding (GO:0043388)", 0.2559326704160195, 3.4873150105708244, 4.752655441391066, ["MMP9"], 0.3468108739226676, 0, 0], [1040, "positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895)", 0.2559326704160195, 3.4873150105708244, 4.752655441391066, ["TNF"], 0.3468108739226676, 0, 0], [1041, "transcription by RNA polymerase I (GO:0006360)", 0.2559326704160195, 3.4873150105708244, 4.752655441391066, ["MAPK3"], 0.3468108739226676, 0, 0], [1042, "positive regulation of telomerase activity (GO:0051973)", 0.2559326704160195, 3.4873150105708244, 4.752655441391066, ["MAPK3"], 0.3468108739226676, 0, 0], [1043, "extracellular matrix organization (GO:0030198)", 0.2618360442252519, 1.5617303694226772, 2.0927760987784736, ["COL24A1", "ITGB2", "MMP9", "ADAMTS9"], 0.35183312668577826, 0, 0], [1044, "negative regulation of epithelial cell migration (GO:0010633)", 0.2623798033995216, 3.384575923392613, 4.528434626957048, ["ADAMTS9"], 0.35183312668577826, 0, 0], [1045, "blood vessel diameter maintenance (GO:0097746)", 0.2623798033995216, 3.384575923392613, 4.528434626957048, ["KLF2"], 0.35183312668577826, 0, 0], [1046, "cellular response to amyloid-beta (GO:1904646)", 0.2623798033995216, 3.384575923392613, 4.528434626957048, ["GRIN1"], 0.35183312668577826, 0, 0], [1047, "negative regulation of T cell proliferation (GO:0042130)", 0.2623798033995216, 3.384575923392613, 4.528434626957048, ["LGALS9"], 0.35183312668577826, 0, 0], [1048, "regulation of JUN kinase activity (GO:0043506)", 0.2623798033995216, 3.384575923392613, 4.528434626957048, ["TNF"], 0.35183312668577826, 0, 0], [1049, "regulation of lipid biosynthetic process (GO:0046890)", 0.2623798033995216, 3.384575923392613, 4.528434626957048, ["C3"], 0.35183312668577826, 0, 0], [1050, "regulation of postsynaptic membrane potential (GO:0060078)", 0.2623798033995216, 3.384575923392613, 4.528434626957048, ["GRIN1"], 0.35183312668577826, 0, 0], [1051, "respiratory system development (GO:0060541)", 0.2623798033995216, 3.384575923392613, 4.528434626957048, ["PDPN"], 0.35183312668577826, 0, 0], [1052, "lung development (GO:0030324)", 0.2623798033995216, 3.384575923392613, 4.528434626957048, ["PDPN"], 0.35183312668577826, 0, 0], [1053, "muscle cell differentiation (GO:0042692)", 0.2623798033995216, 3.384575923392613, 4.528434626957048, ["HEY2"], 0.35183312668577826, 0, 0], [1054, "tumor necrosis factor-mediated signaling pathway (GO:0033209)", 0.2654877068264665, 2.0224684518313327, 2.6821708456052207, ["TNFSF14", "TNF"], 0.35566284823431754, 0, 0], [1055, "regulation of protein kinase B signaling (GO:0051896)", 0.2662950535400359, 1.697491349480969, 2.2460362920297534, ["CSF3", "TNF", "HBEGF"], 0.3560086379697673, 0, 0], [1056, "positive regulation of cell projection organization (GO:0031346)", 0.2686929584220566, 2.004780066107297, 2.634653835412695, ["ROR2", "TOX"], 0.3560086379697673, 0, 0], [1057, "aortic valve development (GO:0003176)", 0.2687713938213682, 3.2877076411960133, 4.319699665032603, ["HEY2"], 0.3560086379697673, 0, 0], [1058, "negative regulation of fat cell differentiation (GO:0045599)", 0.2687713938213682, 3.2877076411960133, 4.319699665032603, ["TNF"], 0.3560086379697673, 0, 0], [1059, "positive regulation of innate immune response (GO:0045089)", 0.2687713938213682, 3.2877076411960133, 4.319699665032603, ["IFI35"], 0.3560086379697673, 0, 0], [1060, "positive regulation of interferon-beta production (GO:0032728)", 0.2687713938213682, 3.2877076411960133, 4.319699665032603, ["OAS3"], 0.3560086379697673, 0, 0], [1061, "retina homeostasis (GO:0001895)", 0.2687713938213682, 3.2877076411960133, 4.319699665032603, ["CNGB1"], 0.3560086379697673, 0, 0], [1062, "positive regulation of mitotic nuclear division (GO:0045840)", 0.2687713938213682, 3.2877076411960133, 4.319699665032603, ["IL1B"], 0.3560086379697673, 0, 0], [1063, "membrane assembly (GO:0071709)", 0.2687713938213682, 3.2877076411960133, 4.319699665032603, ["TLCD1"], 0.3560086379697673, 0, 0], [1064, "membrane fusion (GO:0061025)", 0.2687713938213682, 3.2877076411960133, 4.319699665032603, ["MX2"], 0.3560086379697673, 0, 0], [1065, "transition metal ion transport (GO:0000041)", 0.2687713938213682, 3.2877076411960133, 4.319699665032603, ["SLC11A2"], 0.3560086379697673, 0, 0], [1066, "positive regulation of telomere maintenance via telomere lengthening (GO:1904358)", 0.2687713938213682, 3.2877076411960133, 4.319699665032603, ["MAPK3"], 0.3560086379697673, 0, 0], [1067, "regulation of actin cytoskeleton reorganization (GO:2000249)", 0.2751079175123721, 3.196220930232558, 4.1250166225568385, ["CSF3"], 0.3627006344794299, 0, 0], [1068, "positive regulation of calcium ion transport (GO:0051928)", 0.2751079175123721, 3.196220930232558, 4.1250166225568385, ["GRIN1"], 0.3627006344794299, 0, 0], [1069, "glutamate receptor signaling pathway (GO:0007215)", 0.2751079175123721, 3.196220930232558, 4.1250166225568385, ["GRIN1"], 0.3627006344794299, 0, 0], [1070, "positive regulation of myeloid cell differentiation (GO:0045639)", 0.2751079175123721, 3.196220930232558, 4.1250166225568385, ["CSF3"], 0.3627006344794299, 0, 0], [1071, "lysosome localization (GO:0032418)", 0.2751079175123721, 3.196220930232558, 4.1250166225568385, ["MILR1"], 0.3627006344794299, 0, 0], [1072, "protein modification by small protein conjugation (GO:0032446)", 0.2803976627348499, 1.430855139085337, 1.8193987859097491, ["HERC5", "DTX3L", "TRIML2", "TRIM14", "DTX2"], 0.3689159355740518, 0, 0], [1073, "positive regulation of apoptotic process (GO:0043065)", 0.28095461939584615, 1.5099199443090845, 1.916937164775898, ["OLFM1", "TNFRSF10A", "TNF", "RNF122"], 0.3689159355740518, 0, 0], [1074, "regulation of apoptotic signaling pathway (GO:2001233)", 0.28138984604338085, 3.1096794468887494, 3.9431177541455664, ["TNF"], 0.3689159355740518, 0, 0], [1075, "regulation of axon extension (GO:0030516)", 0.28138984604338085, 3.1096794468887494, 3.9431177541455664, ["OLFM1"], 0.3689159355740518, 0, 0], [1076, "synaptic vesicle endocytosis (GO:0048488)", 0.28138984604338085, 3.1096794468887494, 3.9431177541455664, ["MX2"], 0.3689159355740518, 0, 0], [1077, "positive regulation of signaling (GO:0023056)", 0.28138984604338085, 3.1096794468887494, 3.9431177541455664, ["TNF"], 0.3689159355740518, 0, 0], [1078, "positive regulation of GTPase activity (GO:0043547)", 0.282688563261048, 1.6405910231391134, 2.0727382358375213, ["CCL22", "CCL20", "RASGRP1"], 0.3702748156999998, 0, 0], [1079, "protein monoubiquitination (GO:0006513)", 0.28761764719454536, 3.0276927784577725, 3.772878500776779, ["DTX3L"], 0.3749917985583546, 0, 0], [1080, "negative regulation of protein secretion (GO:0050709)", 0.28761764719454536, 3.0276927784577725, 3.772878500776779, ["IL1B"], 0.3749917985583546, 0, 0], [1081, "regulation of ion transmembrane transporter activity (GO:0032412)", 0.28761764719454536, 3.0276927784577725, 3.772878500776779, ["FXYD5"], 0.3749917985583546, 0, 0], [1082, "regulation of receptor-mediated endocytosis (GO:0048259)", 0.28761764719454536, 3.0276927784577725, 3.772878500776779, ["C3"], 0.3749917985583546, 0, 0], [1083, "protein acylation (GO:0043543)", 0.28761764719454536, 3.0276927784577725, 3.772878500776779, ["ZDHHC23"], 0.3749917985583546, 0, 0], [1084, "fatty acid metabolic process (GO:0006631)", 0.29111198611016265, 1.8890806250599175, 2.331214757648495, ["PON3", "ACSL5"], 0.37847449583414716, 0, 0], [1085, "cellular protein metabolic process (GO:0044267)", 0.29375584522196624, 1.4024936430883033, 1.718063569662044, ["C3", "CSF1", "PAPPA", "UBE2L6", "TGM5"], 0.37847449583414716, 0, 0], [1086, "negative regulation of ERBB signaling pathway (GO:1901185)", 0.2937917846040341, 2.9499105545617175, 3.613298175344228, ["HBEGF"], 0.37847449583414716, 0, 0], [1087, "negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124)", 0.2937917846040341, 2.9499105545617175, 3.613298175344228, ["TNIP3"], 0.37847449583414716, 0, 0], [1088, "carboxylic acid metabolic process (GO:0019752)", 0.2937917846040341, 2.9499105545617175, 3.613298175344228, ["PON3"], 0.37847449583414716, 0, 0], [1089, "detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580)", 0.2937917846040341, 2.9499105545617175, 3.613298175344228, ["TAS2R4"], 0.37847449583414716, 0, 0], [1090, "digestive tract development (GO:0048565)", 0.2937917846040341, 2.9499105545617175, 3.613298175344228, ["TNF"], 0.37847449583414716, 0, 0], [1091, "positive regulation of catalytic activity (GO:0043085)", 0.2937917846040341, 2.9499105545617175, 3.613298175344228, ["MAPK3"], 0.37847449583414716, 0, 0], [1092, "positive regulation of cation channel activity (GO:2001259)", 0.2937917846040341, 2.9499105545617175, 3.613298175344228, ["P2RY6"], 0.37847449583414716, 0, 0], [1093, "regulation of sodium ion transmembrane transporter activity (GO:2000649)", 0.2937917846040341, 2.9499105545617175, 3.613298175344228, ["FXYD5"], 0.37847449583414716, 0, 0], [1094, "positive regulation of double-strand break repair (GO:2000781)", 0.2937917846040341, 2.9499105545617175, 3.613298175344228, ["DTX3L"], 0.37847449583414716, 0, 0], [1095, "response to organonitrogen compound (GO:0010243)", 0.2937917846040341, 2.9499105545617175, 3.613298175344228, ["IRAK3"], 0.37847449583414716, 0, 0], [1096, "positive regulation of wound healing (GO:0090303)", 0.2937917846040341, 2.9499105545617175, 3.613298175344228, ["HBEGF"], 0.37847449583414716, 0, 0], [1097, "protein targeting (GO:0006605)", 0.29430948755374897, 1.873627157324205, 2.291677193830204, ["NCF1", "ZDHHC23"], 0.37847449583414716, 0, 0], [1098, "regulation of protein secretion (GO:0050708)", 0.29430948755374897, 1.873627157324205, 2.291677193830204, ["IL1B", "TNF"], 0.37847449583414716, 0, 0], [1099, "circulatory system development (GO:0072359)", 0.29750504287960533, 1.8584229390681004, 2.2530109231287088, ["HEY2", "APLNR"], 0.38223577847679957, 0, 0], [1100, "transcription, DNA-templated (GO:0006351)", 0.2991697734790638, 1.587344846195359, 1.9155189682124132, ["NFYA", "IRF9", "PAX1"], 0.38254449676106034, 0, 0], [1101, "negative regulation of cell-cell adhesion (GO:0022408)", 0.29991271806975484, 2.876017441860465, 3.4634836543580896, ["FXYD5"], 0.38254449676106034, 0, 0], [1102, "nucleobase-containing compound catabolic process (GO:0034655)", 0.29991271806975484, 2.876017441860465, 3.4634836543580896, ["ENTPD3"], 0.38254449676106034, 0, 0], [1103, "regulation of mitochondrial membrane potential (GO:0051881)", 0.29991271806975484, 2.876017441860465, 3.4634836543580896, ["RNF122"], 0.38254449676106034, 0, 0], [1104, "regulation of release of cytochrome c from mitochondria (GO:0090199)", 0.29991271806975484, 2.876017441860465, 3.4634836543580896, ["MMP9"], 0.38254449676106034, 0, 0], [1105, "import into cell (GO:0098657)", 0.29991271806975484, 2.876017441860465, 3.4634836543580896, ["SLC11A2"], 0.38254449676106034, 0, 0], [1106, "sensory perception of bitter taste (GO:0050913)", 0.29991271806975484, 2.876017441860465, 3.4634836543580896, ["TAS2R4"], 0.38254449676106034, 0, 0], [1107, "visual system development (GO:0150063)", 0.29991271806975484, 2.876017441860465, 3.4634836543580896, ["C3"], 0.38254449676106034, 0, 0], [1108, "calcium ion transmembrane import into cytosol (GO:0097553)", 0.30598090333839384, 2.805728871242201, 3.322635557838656, ["GRIN1"], 0.3888794199044213, 0, 0], [1109, "negative regulation of protein catabolic process (GO:0042177)", 0.30598090333839384, 2.805728871242201, 3.322635557838656, ["IRAK3"], 0.3888794199044213, 0, 0], [1110, "regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041)", 0.30598090333839384, 2.805728871242201, 3.322635557838656, ["TNFRSF10A"], 0.3888794199044213, 0, 0], [1111, "translesion synthesis (GO:0019985)", 0.30598090333839384, 2.805728871242201, 3.322635557838656, ["UBE2L6"], 0.3888794199044213, 0, 0], [1112, "regulation of response to external stimulus (GO:0032101)", 0.31026376524146837, 1.799981725146199, 2.1065770901288396, ["HERC5", "CNGB1"], 0.39333881328967035, 0, 0], [1113, "anion transport (GO:0006820)", 0.31199679241107, 2.7387873754152823, 3.1900364796807583, ["SLC26A9"], 0.39333881328967035, 0, 0], [1114, "regulation of cell-substrate adhesion (GO:0010810)", 0.31199679241107, 2.7387873754152823, 3.1900364796807583, ["PDPN"], 0.39333881328967035, 0, 0], [1115, "DNA synthesis involved in DNA repair (GO:0000731)", 0.31199679241107, 2.7387873754152823, 3.1900364796807583, ["UBE2L6"], 0.39333881328967035, 0, 0], [1116, "glutathione metabolic process (GO:0006749)", 0.31199679241107, 2.7387873754152823, 3.1900364796807583, ["CTNS"], 0.39333881328967035, 0, 0], [1117, "heart looping (GO:0001947)", 0.31199679241107, 2.7387873754152823, 3.1900364796807583, ["APLNR"], 0.39333881328967035, 0, 0], [1118, "positive regulation of peptide hormone secretion (GO:0090277)", 0.31199679241107, 2.7387873754152823, 3.1900364796807583, ["UCN"], 0.39333881328967035, 0, 0], [1119, "positive regulation of phospholipase C activity (GO:0010863)", 0.31199679241107, 2.7387873754152823, 3.1900364796807583, ["P2RY6"], 0.39333881328967035, 0, 0], [1120, "myofibril assembly (GO:0030239)", 0.31199679241107, 2.7387873754152823, 3.1900364796807583, ["MYPN"], 0.39333881328967035, 0, 0], [1121, "regulation of apoptotic process (GO:0042981)", 0.3133041262056287, 1.261200561473041, 1.463725296548075, ["OLFM1", "PDPN", "IFI6", "TNFRSF10A", "TNF", "MMP9", "IFIT3", "RNF122"], 0.39463463532769644, 0, 0], [1122, "antibacterial humoral response (GO:0019731)", 0.31796083338704667, 2.674959437533802, 3.0650409326371726, ["WFDC5"], 0.397662264608069, 0, 0], [1123, "negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059)", 0.31796083338704667, 2.674959437533802, 3.0650409326371726, ["HBEGF"], 0.397662264608069, 0, 0], [1124, "cardiac ventricle morphogenesis (GO:0003208)", 0.31796083338704667, 2.674959437533802, 3.0650409326371726, ["HEY2"], 0.397662264608069, 0, 0], [1125, "cation transmembrane transport (GO:0098655)", 0.31796083338704667, 2.674959437533802, 3.0650409326371726, ["SLC44A4"], 0.397662264608069, 0, 0], [1126, "positive regulation of biosynthetic process (GO:0009891)", 0.31796083338704667, 2.674959437533802, 3.0650409326371726, ["GRIN1"], 0.397662264608069, 0, 0], [1127, "positive regulation of cell-matrix adhesion (GO:0001954)", 0.31796083338704667, 2.674959437533802, 3.0650409326371726, ["CSF1"], 0.397662264608069, 0, 0], [1128, "positive regulation of receptor-mediated endocytosis (GO:0048260)", 0.31796083338704667, 2.674959437533802, 3.0650409326371726, ["C3"], 0.397662264608069, 0, 0], [1129, "metal ion homeostasis (GO:0055065)", 0.31796083338704667, 2.674959437533802, 3.0650409326371726, ["GRIN1"], 0.397662264608069, 0, 0], [1130, "regulation of insulin receptor signaling pathway (GO:0046626)", 0.3238734704210352, 2.6140327695560255, 2.9470667209799353, ["IL1B"], 0.403626955193735, 0, 0], [1131, "regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893)", 0.3238734704210352, 2.6140327695560255, 2.9470667209799353, ["TNF"], 0.403626955193735, 0, 0], [1132, "regulation of receptor signaling pathway via JAK-STAT (GO:0046425)", 0.3238734704210352, 2.6140327695560255, 2.9470667209799353, ["TNF"], 0.403626955193735, 0, 0], [1133, "positive regulation of RNA metabolic process (GO:0051254)", 0.3238734704210352, 2.6140327695560255, 2.9470667209799353, ["IL1B"], 0.403626955193735, 0, 0], [1134, "positive regulation of transcription, DNA-templated (GO:0045893)", 0.32677918569448755, 1.187454583065915, 1.3281330510259393, ["CSF3", "NCF1", "DTX3L", "NFYA", "IL1B", "TNIP3", "HEY2", "TNF", "KLF2", "GRIN1", "NFKB2", "MAPK3"], 0.40688907425098453, 0, 0], [1135, "protein localization to plasma membrane (GO:0072659)", 0.32931031360649204, 1.7188618311949027, 1.9092339784886532, ["ZDHHC23", "TNF"], 0.4076935407859782, 0, 0], [1136, "alpha-amino acid metabolic process (GO:1901605)", 0.3297351441767614, 2.555813953488372, 2.8355875084960434, ["KMO"], 0.4076935407859782, 0, 0], [1137, "regulation of synaptic transmission, glutamatergic (GO:0051966)", 0.3297351441767614, 2.555813953488372, 2.8355875084960434, ["TNF"], 0.4076935407859782, 0, 0], [1138, "regulation of telomerase activity (GO:0051972)", 0.3297351441767614, 2.555813953488372, 2.8355875084960434, ["MAPK3"], 0.4076935407859782, 0, 0], [1139, "positive regulation of nucleocytoplasmic transport (GO:0046824)", 0.3297351441767614, 2.555813953488372, 2.8355875084960434, ["IL1B"], 0.4076935407859782, 0, 0], [1140, "positive regulation of organelle assembly (GO:1902117)", 0.3297351441767614, 2.555813953488372, 2.8355875084960434, ["TNF"], 0.4076935407859782, 0, 0], [1141, "postreplication repair (GO:0006301)", 0.3297351441767614, 2.555813953488372, 2.8355875084960434, ["UBE2L6"], 0.4076935407859782, 0, 0], [1142, "vesicle organization (GO:0016050)", 0.3297351441767614, 2.555813953488372, 2.8355875084960434, ["CD34"], 0.4076935407859782, 0, 0], [1143, "negative regulation of cold-induced thermogenesis (GO:0120163)", 0.3355462913229113, 2.5001263902932256, 2.730126405040359, ["PLCL1"], 0.4127102468187725, 0, 0], [1144, "regulation of DNA binding (GO:0051101)", 0.3355462913229113, 2.5001263902932256, 2.730126405040359, ["MMP9"], 0.4127102468187725, 0, 0], [1145, "determination of heart left/right asymmetry (GO:0061371)", 0.3355462913229113, 2.5001263902932256, 2.730126405040359, ["APLNR"], 0.4127102468187725, 0, 0], [1146, "embryonic heart tube morphogenesis (GO:0003143)", 0.3355462913229113, 2.5001263902932256, 2.730126405040359, ["APLNR"], 0.4127102468187725, 0, 0], [1147, "regulation of protein localization to nucleus (GO:1900180)", 0.3355462913229113, 2.5001263902932256, 2.730126405040359, ["DTX3L"], 0.4127102468187725, 0, 0], [1148, "regulation of wound healing (GO:0061041)", 0.3355462913229113, 2.5001263902932256, 2.730126405040359, ["HBEGF"], 0.4127102468187725, 0, 0], [1149, "regulation of cellular component organization (GO:0051128)", 0.33878190572380185, 1.6809664062833483, 1.8194758942312934, ["IRAK3", "TNF"], 0.41632728536293145, 0, 0], [1150, "regulation of protein metabolic process (GO:0051246)", 0.341307344829736, 2.4468085106382977, 2.6302504013087735, ["KLF2"], 0.41801352564103395, 0, 0], [1151, "positive regulation of blood vessel endothelial cell migration (GO:0043536)", 0.341307344829736, 2.4468085106382977, 2.6302504013087735, ["STAT5A"], 0.41801352564103395, 0, 0], [1152, "positive regulation of endocytosis (GO:0045807)", 0.341307344829736, 2.4468085106382977, 2.6302504013087735, ["C3"], 0.41801352564103395, 0, 0], [1153, "neuron projection morphogenesis (GO:0048812)", 0.34193032727719136, 1.6687007373506229, 1.7907633329396602, ["ACTBL2", "NEFH"], 0.41801352564103395, 0, 0], [1154, "enzyme linked receptor protein signaling pathway (GO:0007167)", 0.34193032727719136, 1.6687007373506229, 1.7907633329396602, ["CSF1", "ROR2"], 0.41801352564103395, 0, 0], [1155, "protein localization to cell periphery (GO:1990778)", 0.34193032727719136, 1.6687007373506229, 1.7907633329396602, ["ZDHHC23", "TNF"], 0.41801352564103395, 0, 0], [1156, "regulation of cellular protein metabolic process (GO:0032268)", 0.3470187341502088, 2.3957122093023258, 2.535565530848081, ["CSF1"], 0.42240556260353, 0, 0], [1157, "regulation of interferon-beta production (GO:0032648)", 0.3470187341502088, 2.3957122093023258, 2.535565530848081, ["OAS3"], 0.42240556260353, 0, 0], [1158, "positive regulation of actin filament polymerization (GO:0030838)", 0.3470187341502088, 2.3957122093023258, 2.535565530848081, ["CSF3"], 0.42240556260353, 0, 0], [1159, "regulation of smooth muscle cell proliferation (GO:0048660)", 0.3470187341502088, 2.3957122093023258, 2.535565530848081, ["TNF"], 0.42240556260353, 0, 0], [1160, "secondary alcohol metabolic process (GO:1902652)", 0.3470187341502088, 2.3957122093023258, 2.535565530848081, ["CYP27A1"], 0.42240556260353, 0, 0], [1161, "membrane organization (GO:0061024)", 0.3488034921959794, 1.4463204528673395, 1.5233320632882221, ["MX2", "TLCD1", "HBEGF"], 0.42421234365264676, 0, 0], [1162, "amino acid transport (GO:0006865)", 0.35268088478543624, 2.346701471286189, 2.4457126549922057, ["PDPN"], 0.4274552869674128, 0, 0], [1163, "neuron migration (GO:0001764)", 0.35268088478543624, 2.346701471286189, 2.4457126549922057, ["ASTN1"], 0.4274552869674128, 0, 0], [1164, "organic hydroxy compound biosynthetic process (GO:1901617)", 0.35268088478543624, 2.346701471286189, 2.4457126549922057, ["CYP27A1"], 0.4274552869674128, 0, 0], [1165, "iron ion transport (GO:0006826)", 0.35268088478543624, 2.346701471286189, 2.4457126549922057, ["SLC11A2"], 0.4274552869674128, 0, 0], [1166, "regulation of axonogenesis (GO:0050770)", 0.35829421894402896, 2.2996511627906977, 2.360363769020994, ["LINGO1"], 0.43240293773416144, 0, 0], [1167, "negative regulation of protein ubiquitination (GO:0031397)", 0.35829421894402896, 2.2996511627906977, 2.360363769020994, ["DTX3L"], 0.43240293773416144, 0, 0], [1168, "regulation of substrate adhesion-dependent cell spreading (GO:1900024)", 0.35829421894402896, 2.2996511627906977, 2.360363769020994, ["PDPN"], 0.43240293773416144, 0, 0], [1169, "inositol lipid-mediated signaling (GO:0048017)", 0.35829421894402896, 2.2996511627906977, 2.360363769020994, ["PLCL1"], 0.43240293773416144, 0, 0], [1170, "mesenchymal cell differentiation (GO:0048762)", 0.35829421894402896, 2.2996511627906977, 2.360363769020994, ["HEY2"], 0.43240293773416144, 0, 0], [1171, "positive regulation of cytosolic calcium ion concentration (GO:0007204)", 0.36383053307835783, 1.5875781407541842, 1.6051480080973792, ["C1QTNF1", "GRIN1"], 0.435766859067313, 0, 0], [1172, "negative regulation of cellular biosynthetic process (GO:0031327)", 0.36385915498609206, 2.2544459644322847, 2.2792187704918345, ["CD34"], 0.435766859067313, 0, 0], [1173, "negative regulation of protein metabolic process (GO:0051248)", 0.36385915498609206, 2.2544459644322847, 2.2792187704918345, ["IRAK3"], 0.435766859067313, 0, 0], [1174, "regulation of intrinsic apoptotic signaling pathway (GO:2001242)", 0.36385915498609206, 2.2544459644322847, 2.2792187704918345, ["MMP9"], 0.435766859067313, 0, 0], [1175, "regulation of release of sequestered calcium ion into cytosol (GO:0051279)", 0.36385915498609206, 2.2544459644322847, 2.2792187704918345, ["APLNR"], 0.435766859067313, 0, 0], [1176, "regulation of telomere maintenance via telomerase (GO:0032210)", 0.36385915498609206, 2.2544459644322847, 2.2792187704918345, ["MAPK3"], 0.435766859067313, 0, 0], [1177, "response to peptide hormone (GO:0043434)", 0.36385915498609206, 2.2544459644322847, 2.2792187704918345, ["STAT5A"], 0.435766859067313, 0, 0], [1178, "positive regulation of protein localization to cell periphery (GO:1904377)", 0.36385915498609206, 2.2544459644322847, 2.2792187704918345, ["TNF"], 0.435766859067313, 0, 0], [1179, "positive regulation of protein localization to plasma membrane (GO:1903078)", 0.36385915498609206, 2.2544459644322847, 2.2792187704918345, ["TNF"], 0.435766859067313, 0, 0], [1180, "negative regulation of cellular process (GO:0048523)", 0.36539902683201275, 1.2361206159110352, 1.2444833406578948, ["IL1B", "PDPN", "ROR2", "IFI35", "CD34", "IFIT3"], 0.4372401914294932, 0, 0], [1181, "positive regulation of intracellular protein transport (GO:0090316)", 0.36693756285138596, 1.576624208924137, 1.580666001551143, ["IL1B", "ITGB2"], 0.4387094316224869, 0, 0], [1182, "cellular macromolecule catabolic process (GO:0044265)", 0.3693761077617889, 2.210979427549195, 2.202002611866561, ["ADAMTS9"], 0.44087832980527975, 0, 0], [1183, "regulation of immune effector process (GO:0002697)", 0.3693761077617889, 2.210979427549195, 2.202002611866561, ["C3"], 0.44087832980527975, 0, 0], [1184, "regulation of cytokine production (GO:0001817)", 0.373134063709401, 1.5551604235814762, 1.533104366755372, ["LGALS9", "TNF"], 0.4449875827345221, 0, 0], [1185, "regulation of cyclin-dependent protein kinase activity (GO:1904029)", 0.37484548870499795, 2.169153137340939, 2.1284627919715216, ["HERC5"], 0.44552342596924, 0, 0], [1186, "regulation of humoral immune response (GO:0002920)", 0.37484548870499795, 2.169153137340939, 2.1284627919715216, ["C3"], 0.44552342596924, 0, 0], [1187, "regulation of proteasomal protein catabolic process (GO:0061136)", 0.37484548870499795, 2.169153137340939, 2.1284627919715216, ["ECSCR"], 0.44552342596924, 0, 0], [1188, "unsaturated fatty acid metabolic process (GO:0033559)", 0.37484548870499795, 2.169153137340939, 2.1284627919715216, ["PLA2G4C"], 0.44552342596924, 0, 0], [1189, "glycoprotein metabolic process (GO:0009100)", 0.3802677055871634, 2.128875968992248, 2.058367141127939, ["ADAMTS9"], 0.45158788922546234, 0, 0], [1190, "arachidonic acid metabolic process (GO:0019369)", 0.39097226129085055, 2.052637043189369, 1.9276697587104052, ["PLA2G4C"], 0.4627433637407217, 0, 0], [1191, "cellular response to peptide (GO:1901653)", 0.39097226129085055, 2.052637043189369, 1.9276697587104052, ["GRIN1"], 0.4627433637407217, 0, 0], [1192, "regulation of mitotic nuclear division (GO:0007088)", 0.39097226129085055, 2.052637043189369, 1.9276697587104052, ["IL1B"], 0.4627433637407217, 0, 0], [1193, "protein K48-linked ubiquitination (GO:0070936)", 0.39097226129085055, 2.052637043189369, 1.9276697587104052, ["DTX3L"], 0.4627433637407217, 0, 0], [1194, "negative regulation of neuron projection development (GO:0010977)", 0.39625539848161956, 2.0165238678090573, 1.8666887436976554, ["LINGO1"], 0.4666493933745178, 0, 0], [1195, "cellular iron ion homeostasis (GO:0006879)", 0.39625539848161956, 2.0165238678090573, 1.8666887436976554, ["SLC11A2"], 0.4666493933745178, 0, 0], [1196, "regulation of neurotransmitter receptor activity (GO:0099601)", 0.39625539848161956, 2.0165238678090573, 1.8666887436976554, ["GRIN1"], 0.4666493933745178, 0, 0], [1197, "regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803)", 0.39625539848161956, 2.0165238678090573, 1.8666887436976554, ["TNF"], 0.4666493933745178, 0, 0], [1198, "positive regulation of mitochondrion organization (GO:0010822)", 0.39625539848161956, 2.0165238678090573, 1.8666887436976554, ["MMP9"], 0.4666493933745178, 0, 0], [1199, "muscle organ development (GO:0007517)", 0.39625539848161956, 2.0165238678090573, 1.8666887436976554, ["HBEGF"], 0.4666493933745178, 0, 0], [1200, "organonitrogen compound biosynthetic process (GO:1901566)", 0.39766748893503273, 1.47480881691408, 1.359978842392579, ["SLC44A4", "PLA2G4C"], 0.46792207864688856, 0, 0], [1201, "positive regulation of apoptotic signaling pathway (GO:2001235)", 0.40149296855917643, 1.9816559743384121, 1.808390396831452, ["TNF"], 0.4720300346424289, 0, 0], [1202, "neutrophil degranulation (GO:0043312)", 0.403004487284263, 1.2099214685874349, 1.0995858047572227, ["C3", "VNN1", "ITGB2", "RHOF", "MMP9"], 0.4734129251625453, 0, 0], [1203, "homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156)", 0.4066853622292594, 1.9479700433582972, 1.752618760285087, ["MYPN"], 0.47733976015603846, 0, 0], [1204, "negative regulation of signal transduction (GO:0009968)", 0.407382817887809, 1.307687165775401, 1.1743056263222276, ["IL1B", "IRAK3", "TNF"], 0.4777612448983275, 0, 0], [1205, "neutrophil activation involved in immune response (GO:0002283)", 0.4098531860740348, 1.1995907738095237, 1.0699825075234999, ["C3", "VNN1", "ITGB2", "RHOF", "MMP9"], 0.48025950102617193, 0, 0], [1206, "negative regulation of response to stimulus (GO:0048585)", 0.41183296693540233, 1.9154069767441861, 1.6992292263869038, ["CD34"], 0.4805852473659406, 0, 0], [1207, "pattern recognition receptor signaling pathway (GO:0002221)", 0.41183296693540233, 1.9154069767441861, 1.6992292263869038, ["LY96"], 0.4805852473659406, 0, 0], [1208, "positive regulation of DNA biosynthetic process (GO:2000573)", 0.41183296693540233, 1.9154069767441861, 1.6992292263869038, ["MAPK3"], 0.4805852473659406, 0, 0], [1209, "iron ion homeostasis (GO:0055072)", 0.41183296693540233, 1.9154069767441861, 1.6992292263869038, ["SLC11A2"], 0.4805852473659406, 0, 0], [1210, "protein lipidation (GO:0006497)", 0.41183296693540233, 1.9154069767441861, 1.6992292263869038, ["ZDHHC23"], 0.4805852473659406, 0, 0], [1211, "neutrophil mediated immunity (GO:0002446)", 0.4149832695281581, 1.1919550428867198, 1.048344811604521, ["C3", "VNN1", "ITGB2", "RHOF", "MMP9"], 0.48386158263729084, 0, 0], [1212, "adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188)", 0.41876865792476803, 1.4109711907580813, 1.2281610232629074, ["MARCO", "GPR37L1"], 0.48747019372611083, 0, 0], [1213, "regulation of neuron projection development (GO:0010975)", 0.41876865792476803, 1.4109711907580813, 1.2281610232629074, ["ROR2", "TOX"], 0.48747019372611083, 0, 0], [1214, "negative regulation of programmed cell death (GO:0043069)", 0.4195921039584583, 1.2211008742328882, 1.0604921878923266, ["PDPN", "IFI6", "MMP9", "IFIT3"], 0.4880264009796896, 0, 0], [1215, "amyloid fibril formation (GO:1990000)", 0.42199534262323307, 1.8534321080270066, 1.5990689416314445, ["UBE2L6"], 0.4888083870254349, 0, 0], [1216, "anterior/posterior pattern specification (GO:0009952)", 0.42199534262323307, 1.8534321080270066, 1.5990689416314445, ["HEY2"], 0.4888083870254349, 0, 0], [1217, "positive regulation of DNA metabolic process (GO:0051054)", 0.42199534262323307, 1.8534321080270066, 1.5990689416314445, ["TOX"], 0.4888083870254349, 0, 0], [1218, "positive regulation of Ras protein signal transduction (GO:0046579)", 0.42199534262323307, 1.8534321080270066, 1.5990689416314445, ["RASGRP1"], 0.4888083870254349, 0, 0], [1219, "monocarboxylic acid biosynthetic process (GO:0072330)", 0.42199534262323307, 1.8534321080270066, 1.5990689416314445, ["CYP27A1"], 0.4888083870254349, 0, 0], [1220, "plasma membrane organization (GO:0007009)", 0.42701087203651533, 1.823920265780731, 1.5520572981527145, ["TLCD1"], 0.4930002872572033, 0, 0], [1221, "regulation of transcription initiation from RNA polymerase II promoter (GO:0060260)", 0.42701087203651533, 1.823920265780731, 1.5520572981527145, ["HEY2"], 0.4930002872572033, 0, 0], [1222, "lipid homeostasis (GO:0055088)", 0.42701087203651533, 1.823920265780731, 1.5520572981527145, ["TLCD1"], 0.4930002872572033, 0, 0], [1223, "protein catabolic process (GO:0030163)", 0.42701087203651533, 1.823920265780731, 1.5520572981527145, ["ADAMTS9"], 0.4930002872572033, 0, 0], [1224, "BMP signaling pathway (GO:0030509)", 0.4319831293730308, 1.795330668604651, 1.5069444481520382, ["MAPK3"], 0.49671024322045565, 0, 0], [1225, "regulation of cell-matrix adhesion (GO:0001952)", 0.4319831293730308, 1.795330668604651, 1.5069444481520382, ["CSF1"], 0.49671024322045565, 0, 0], [1226, "chemical homeostasis (GO:0048878)", 0.4319831293730308, 1.795330668604651, 1.5069444481520382, ["TLCD1"], 0.49671024322045565, 0, 0], [1227, "regulation of RNA metabolic process (GO:0051252)", 0.4319831293730308, 1.795330668604651, 1.5069444481520382, ["OAS3"], 0.49671024322045565, 0, 0], [1228, "steroid biosynthetic process (GO:0006694)", 0.4319831293730308, 1.795330668604651, 1.5069444481520382, ["CYP27A1"], 0.49671024322045565, 0, 0], [1229, "plasma membrane bounded cell projection assembly (GO:0120031)", 0.4327019605952038, 1.2546737967914439, 1.0510478939465167, ["NME8", "FXYD5", "CNGB1"], 0.4971319514730902, 0, 0], [1230, "cellular component disassembly (GO:0022411)", 0.43691248585776327, 1.7676207513416815, 1.4636295151903798, ["MMP9"], 0.5011538830472476, 0, 0], [1231, "extracellular matrix disassembly (GO:0022617)", 0.43691248585776327, 1.7676207513416815, 1.4636295151903798, ["MMP9"], 0.5011538830472476, 0, 0], [1232, "anion transmembrane transport (GO:0098656)", 0.44179930950693086, 1.7407505285412261, 1.4220183250048037, ["SLC44A4"], 0.5059372465724139, 0, 0], [1233, "vascular endothelial growth factor receptor signaling pathway (GO:0048010)", 0.44179930950693086, 1.7407505285412261, 1.4220183250048037, ["NCF1"], 0.5059372465724139, 0, 0], [1234, "regulation of myeloid cell differentiation (GO:0045637)", 0.4466439651725302, 1.7146824019437694, 1.3820228709382842, ["CSF3"], 0.5106569059300508, 0, 0], [1235, "positive regulation of protein localization to nucleus (GO:1900182)", 0.4466439651725302, 1.7146824019437694, 1.3820228709382842, ["DTX3L"], 0.5106569059300508, 0, 0], [1236, "peptidyl-tyrosine phosphorylation (GO:0018108)", 0.4514468146851317, 1.6893809849521204, 1.3435608286429652, ["MAPK3"], 0.5148973362967738, 0, 0], [1237, "positive regulation of protein polymerization (GO:0032273)", 0.4514468146851317, 1.6893809849521204, 1.3435608286429652, ["CSF3"], 0.5148973362967738, 0, 0], [1238, "positive regulation of protein transport (GO:0051222)", 0.4514468146851317, 1.6893809849521204, 1.3435608286429652, ["TNF"], 0.5148973362967738, 0, 0], [1239, "glycerophospholipid biosynthetic process (GO:0046474)", 0.4540480804845972, 1.3134168755221387, 1.0370111604657408, ["SLC44A4", "PLA2G4C"], 0.5174462386152149, 0, 0], [1240, "cellular response to light stimulus (GO:0071482)", 0.45620821657811794, 1.6648129423660263, 1.3065551167601677, ["CNGB1"], 0.5182349169817397, 0, 0], [1241, "defense response to Gram-positive bacterium (GO:0050830)", 0.45620821657811794, 1.6648129423660263, 1.3065551167601677, ["PGLYRP4"], 0.5182349169817397, 0, 0], [1242, "positive regulation of cell-substrate adhesion (GO:0010811)", 0.45620821657811794, 1.6648129423660263, 1.3065551167601677, ["CSF1"], 0.5182349169817397, 0, 0], [1243, "sterol metabolic process (GO:0016125)", 0.45620821657811794, 1.6648129423660263, 1.3065551167601677, ["CYP27A1"], 0.5182349169817397, 0, 0], [1244, "protein tetramerization (GO:0051262)", 0.4609285266405169, 1.6409468438538206, 1.270933494241867, ["GRIN1"], 0.5214992625131489, 0, 0], [1245, "cellular response to BMP stimulus (GO:0071773)", 0.4609285266405169, 1.6409468438538206, 1.270933494241867, ["MAPK3"], 0.5214992625131489, 0, 0], [1246, "phosphatidylinositol-mediated signaling (GO:0048015)", 0.4609285266405169, 1.6409468438538206, 1.270933494241867, ["PLCL1"], 0.5214992625131489, 0, 0], [1247, "Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096)", 0.4609285266405169, 1.6409468438538206, 1.270933494241867, ["MAPK3"], 0.5214992625131489, 0, 0], [1248, "response to metal ion (GO:0010038)", 0.4609285266405169, 1.6409468438538206, 1.270933494241867, ["SLC11A2"], 0.5214992625131489, 0, 0], [1249, "Fc-gamma receptor signaling pathway (GO:0038094)", 0.4656080973516879, 1.6177530298067475, 1.236628197511647, ["MAPK3"], 0.5259509067684667, 0, 0], [1250, "positive regulation of secretion by cell (GO:1903532)", 0.4656080973516879, 1.6177530298067475, 1.236628197511647, ["IL1B"], 0.5259509067684667, 0, 0], [1251, "antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)", 0.4702472783401561, 1.595203488372093, 1.2035756058997582, ["NCF1"], 0.5290750255109963, 0, 0], [1252, "regulation of actin filament polymerization (GO:0030833)", 0.4702472783401561, 1.595203488372093, 1.2035756058997582, ["CSF3"], 0.5290750255109963, 0, 0], [1253, "regulation of actin filament-based process (GO:0032970)", 0.4702472783401561, 1.595203488372093, 1.2035756058997582, ["RHOF"], 0.5290750255109963, 0, 0], [1254, "defense response to Gram-negative bacterium (GO:0050829)", 0.4702472783401561, 1.595203488372093, 1.2035756058997582, ["IL23A"], 0.5290750255109963, 0, 0], [1255, "positive regulation of synaptic transmission (GO:0050806)", 0.4702472783401561, 1.595203488372093, 1.2035756058997582, ["TNF"], 0.5290750255109963, 0, 0], [1256, "negative regulation of protein binding (GO:0032091)", 0.47484641618645673, 1.5732717425931826, 1.1717159383214986, ["NES"], 0.5329754687243854, 0, 0], [1257, "cellular response to amino acid starvation (GO:0034198)", 0.47484641618645673, 1.5732717425931826, 1.1717159383214986, ["MAPK3"], 0.5329754687243854, 0, 0], [1258, "Fc receptor mediated stimulatory signaling pathway (GO:0002431)", 0.47484641618645673, 1.5732717425931826, 1.1717159383214986, ["MAPK3"], 0.5329754687243854, 0, 0], [1259, "fibroblast growth factor receptor signaling pathway (GO:0008543)", 0.47940585452295725, 1.5519327467001887, 1.140992974888803, ["MAPK3"], 0.5368128997513208, 0, 0], [1260, "response to amino acid starvation (GO:1990928)", 0.47940585452295725, 1.5519327467001887, 1.140992974888803, ["MAPK3"], 0.5368128997513208, 0, 0], [1261, "integrin-mediated signaling pathway (GO:0007229)", 0.47940585452295725, 1.5519327467001887, 1.140992974888803, ["ITGB2"], 0.5368128997513208, 0, 0], [1262, "actomyosin structure organization (GO:0031032)", 0.48392593407689793, 1.5311627906976744, 1.1113538022082736, ["MYPN"], 0.5401608054676521, 0, 0], [1263, "phospholipid metabolic process (GO:0006644)", 0.48392593407689793, 1.5311627906976744, 1.1113538022082736, ["PLA2G4C"], 0.5401608054676521, 0, 0], [1264, "positive regulation of growth (GO:0045927)", 0.48392593407689793, 1.5311627906976744, 1.1113538022082736, ["SLC44A4"], 0.5401608054676521, 0, 0], [1265, "water-soluble vitamin metabolic process (GO:0006767)", 0.48392593407689793, 1.5311627906976744, 1.1113538022082736, ["VNN1"], 0.5401608054676521, 0, 0], [1266, "negative regulation of developmental process (GO:0051093)", 0.4884069926847284, 1.5109394124847002, 1.0827485799898282, ["HEY2"], 0.5438727710337827, 0, 0], [1267, "cellular response to UV (GO:0034644)", 0.4884069926847284, 1.5109394124847002, 1.0827485799898282, ["MMP9"], 0.5438727710337827, 0, 0], [1268, "cholesterol metabolic process (GO:0008203)", 0.4884069926847284, 1.5109394124847002, 1.0827485799898282, ["CYP27A1"], 0.5438727710337827, 0, 0], [1269, "negative regulation of blood vessel morphogenesis (GO:2000181)", 0.4928493651557242, 1.491241316822712, 1.055130327307115, ["ECSCR"], 0.5479553571652619, 0, 0], [1270, "antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590)", 0.4928493651557242, 1.491241316822712, 1.055130327307115, ["NCF1"], 0.5479553571652619, 0, 0], [1271, "negative regulation of NF-kappaB transcription factor activity (GO:0032088)", 0.4972533836140055, 1.4720483005366727, 1.0284547247794429, ["IRAK3"], 0.5524168195617433, 0, 0], [1272, "regulation of fat cell differentiation (GO:0045598)", 0.5016193773363116, 1.453341183397115, 1.0026799341307675, ["TNF"], 0.5544940043526231, 0, 0], [1273, "regulation of organelle organization (GO:0033043)", 0.5016193773363116, 1.453341183397115, 1.0026799341307675, ["MAPK3"], 0.5544940043526231, 0, 0], [1274, "regulation of protein localization to plasma membrane (GO:1903076)", 0.5016193773363116, 1.453341183397115, 1.0026799341307675, ["TNF"], 0.5544940043526231, 0, 0], [1275, "positive regulation of cell adhesion (GO:0045785)", 0.5016193773363116, 1.453341183397115, 1.0026799341307675, ["TNF"], 0.5544940043526231, 0, 0], [1276, "glycerophospholipid metabolic process (GO:0006650)", 0.5016193773363116, 1.453341183397115, 1.0026799341307675, ["PLA2G4C"], 0.5544940043526231, 0, 0], [1277, "lipid biosynthetic process (GO:0008610)", 0.5016193773363116, 1.453341183397115, 1.0026799341307675, ["ACSL5"], 0.5544940043526231, 0, 0], [1278, "regulation of programmed cell death (GO:0043067)", 0.5018720520981957, 1.1960891812865497, 0.824595923894898, ["TNFRSF10A", "TNF"], 0.5544940043526231, 0, 0], [1279, "organelle assembly (GO:0070925)", 0.5030033567972373, 1.0910061982599897, 0.749694112155134, ["NME8", "PLA2G4C", "CD34", "CNGB1"], 0.5553094134462072, 0, 0], [1280, "phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200)", 0.5059476726857004, 1.4351017441860465, 0.977766431749586, ["P2RY6"], 0.5576878328120288, 0, 0], [1281, "positive regulation of cellular amide metabolic process (GO:0034250)", 0.5059476726857004, 1.4351017441860465, 0.977766431749586, ["TNF"], 0.5576878328120288, 0, 0], [1282, "regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079)", 0.5102385932684737, 1.417312661498708, 0.953676854648716, ["HERC5"], 0.5619788562364155, 0, 0], [1283, "cilium assembly (GO:0060271)", 0.5124409201798574, 1.107395498392283, 0.7403712448115424, ["RPGRIP1", "NME8", "CNGB1"], 0.5639645980467332, 0, 0], [1284, "regulation of defense response (GO:0031347)", 0.5144924599694802, 1.3999574588769144, 0.9303758586909852, ["HERC5"], 0.564901519033364, 0, 0], [1285, "peptide metabolic process (GO:0006518)", 0.5144924599694802, 1.3999574588769144, 0.9303758586909852, ["CTNS"], 0.564901519033364, 0, 0], [1286, "epidermis development (GO:0008544)", 0.5144924599694802, 1.3999574588769144, 0.9303758586909852, ["TGM5"], 0.564901519033364, 0, 0], [1287, "lymphocyte differentiation (GO:0030098)", 0.5187095909586609, 1.383020453908658, 0.9078299877326373, ["TOX"], 0.5690893103602402, 0, 0], [1288, "modification-dependent protein catabolic process (GO:0019941)", 0.5207733783261302, 1.1536042787034588, 0.7526579289227425, ["DTX3L", "UBE2L6"], 0.5709099458047329, 0, 0], [1289, "negative regulation of defense response (GO:0031348)", 0.5228903016052368, 1.366486710963455, 0.8860075528950032, ["IRAK3"], 0.5718986102762156, 0, 0], [1290, "B cell activation (GO:0042113)", 0.5228903016052368, 1.366486710963455, 0.8860075528950032, ["RASGRP1"], 0.5718986102762156, 0, 0], [1291, "Wnt signaling pathway, planar cell polarity pathway (GO:0060071)", 0.5228903016052368, 1.366486710963455, 0.8860075528950032, ["ROR2"], 0.5718986102762156, 0, 0], [1292, "regulation of intracellular signal transduction (GO:1902531)", 0.5248795238264826, 1.0601145168563892, 0.6833355284415643, ["IL1B", "RHOF", "TNF", "MAPK3"], 0.5734983814532989, 0, 0], [1293, "transcription by RNA polymerase II (GO:0006366)", 0.5251653025631129, 1.0861013174986083, 0.6994950862067607, ["NFYA", "IRF9", "PAX1"], 0.5734983814532989, 0, 0], [1294, "axon guidance (GO:0007411)", 0.5260858008979419, 1.1420092519856857, 0.7335022187515285, ["MYPN", "MAPK3"], 0.5737650619919614, 0, 0], [1295, "regulation of Ras protein signal transduction (GO:0046578)", 0.5270349046767521, 1.3503419972640218, 0.8648785201132445, ["RASGRP1"], 0.5737650619919614, 0, 0], [1296, "positive regulation of endothelial cell migration (GO:0010595)", 0.5270349046767521, 1.3503419972640218, 0.8648785201132445, ["STAT5A"], 0.5737650619919614, 0, 0], [1297, "positive regulation of proteasomal protein catabolic process (GO:1901800)", 0.5270349046767521, 1.3503419972640218, 0.8648785201132445, ["ECSCR"], 0.5737650619919614, 0, 0], [1298, "positive regulation of transcription by RNA polymerase II (GO:0045944)", 0.5298418229779307, 1.0196363636363637, 0.6476493261066891, ["CSF3", "TNIP3", "HEY2", "TNF", "KLF2", "GRIN1", "NFKB2", "MAPK3"], 0.576376466906655, 0, 0], [1299, "calcium ion transmembrane transport (GO:0070588)", 0.5311437101997899, 1.334572742022715, 0.8444144068605514, ["GRIN1"], 0.5769037836939257, 0, 0], [1300, "regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618)", 0.5311437101997899, 1.334572742022715, 0.8444144068605514, ["KLF2"], 0.5769037836939257, 0, 0], [1301, "negative regulation of binding (GO:0051100)", 0.5352170255389179, 1.3191659983961508, 0.824588185859869, ["NES"], 0.5799895932931328, 0, 0], [1302, "regulation of establishment of planar polarity (GO:0090175)", 0.5352170255389179, 1.3191659983961508, 0.824588185859869, ["ROR2"], 0.5799895932931328, 0, 0], [1303, "retrograde transport, endosome to Golgi (GO:0042147)", 0.5352170255389179, 1.3191659983961508, 0.824588185859869, ["SNX32"], 0.5799895932931328, 0, 0], [1304, "regulation of endothelial cell migration (GO:0010594)", 0.5392551555940379, 1.3041094080338267, 0.805374195470075, ["ADAMTS9"], 0.5834699461293344, 0, 0], [1305, "collagen fibril organization (GO:0030199)", 0.5392551555940379, 1.3041094080338267, 0.805374195470075, ["COL24A1"], 0.5834699461293344, 0, 0], [1306, "cellular amino acid catabolic process (GO:0009063)", 0.5432584024445511, 1.2893911680167234, 0.7867480578039949, ["KMO"], 0.5873513508818577, 0, 0], [1307, "regulation of actin cytoskeleton organization (GO:0032956)", 0.5472270656912799, 1.275, 0.7686866009709118, ["RHOF"], 0.5907374745841646, 0, 0], [1308, "positive regulation of supramolecular fiber organization (GO:1902905)", 0.5472270656912799, 1.275, 0.7686866009709118, ["CSF3"], 0.5907374745841646, 0, 0], [1309, "phosphate-containing compound metabolic process (GO:0006796)", 0.5494991980355116, 1.092564745196324, 0.6541709173620384, ["PLA2G4C", "MAPK3"], 0.5927371028465565, 0, 0], [1310, "regulation of endothelial cell proliferation (GO:0001936)", 0.551161442394446, 1.2609251213902377, 0.7511677877092843, ["STAT5A"], 0.5931706986745104, 0, 0], [1311, "cellular response to fibroblast growth factor stimulus (GO:0044344)", 0.551161442394446, 1.2609251213902377, 0.7511677877092843, ["MAPK3"], 0.5931706986745104, 0, 0], [1312, "positive regulation of cellular component biogenesis (GO:0044089)", 0.551161442394446, 1.2609251213902377, 0.7511677877092843, ["TNF"], 0.5931706986745104, 0, 0], [1313, "visual perception (GO:0007601)", 0.5550618270572727, 1.2471562184024267, 0.7341706488458335, ["CNGB1"], 0.5969134042687503, 0, 0], [1314, "regulation of kinase activity (GO:0043549)", 0.5589285117392199, 1.2336834208552139, 0.7176752210199345, ["ROR2"], 0.6001574589929873, 0, 0], [1315, "positive regulation of epithelial cell migration (GO:0010634)", 0.5589285117392199, 1.2336834208552139, 0.7176752210199345, ["MMP9"], 0.6001574589929873, 0, 0], [1316, "sensory perception of light stimulus (GO:0050953)", 0.5627617858510764, 1.2204972785749628, 0.7016624893242105, ["CNGB1"], 0.6038143173417324, 0, 0], [1317, "cellular transition metal ion homeostasis (GO:0046916)", 0.5665619364091213, 1.2075887392900857, 0.6861143327944853, ["SLC11A2"], 0.6069692368813955, 0, 0], [1318, "regulation of vesicle-mediated transport (GO:0060627)", 0.5665619364091213, 1.2075887392900857, 0.6861143327944853, ["MAPK3"], 0.6069692368813955, 0, 0], [1319, "calcium ion homeostasis (GO:0055074)", 0.570329248060945, 1.1949491279069768, 0.671013474014342, ["GRIN1"], 0.6100794683803441, 0, 0], [1320, "glycosaminoglycan biosynthetic process (GO:0006024)", 0.570329248060945, 1.1949491279069768, 0.671013474014342, ["IL1B"], 0.6100794683803441, 0, 0], [1321, "regulation of neuron apoptotic process (GO:0043523)", 0.5740640028558807, 1.1825701270678495, 0.6563434325571089, ["TNF"], 0.6136096684576106, 0, 0], [1322, "organic acid transport (GO:0015849)", 0.5814369585683391, 1.1585623678646935, 0.6282336006501239, ["PDPN"], 0.6210204126312366, 0, 0], [1323, "cellular response to chemical stress (GO:0062197)", 0.5850757117850449, 1.1469186046511628, 0.6147644499074489, ["NCF1"], 0.6239629192148666, 0, 0], [1324, "positive regulation of cell cycle process (GO:0090068)", 0.5850757117850449, 1.1469186046511628, 0.6147644499074489, ["IL1B"], 0.6239629192148666, 0, 0], [1325, "supramolecular fiber organization (GO:0097435)", 0.5878780926155921, 0.9877789046653144, 0.524743396195313, ["COL24A1", "UBE2L6", "RHOF"], 0.6254180525213782, 0, 0], [1326, "calcium-mediated signaling (GO:0019722)", 0.5886830128411195, 1.1355054110062168, 0.6016673210935737, ["CCL20"], 0.6254180525213782, 0, 0], [1327, "positive regulation of cell growth (GO:0030307)", 0.5886830128411195, 1.1355054110062168, 0.6016673210935737, ["SLC44A4"], 0.6254180525213782, 0, 0], [1328, "positive regulation of cellular protein metabolic process (GO:0032270)", 0.5886830128411195, 1.1355054110062168, 0.6016673210935737, ["CSF1"], 0.6254180525213782, 0, 0], [1329, "intrinsic apoptotic signaling pathway (GO:0097193)", 0.5886830128411195, 1.1355054110062168, 0.6016673210935737, ["IFI6"], 0.6254180525213782, 0, 0], [1330, "cilium organization (GO:0044782)", 0.5890977406894, 1.0143869999482482, 0.5367762360889923, ["NME8", "CNGB1"], 0.6254180525213782, 0, 0], [1331, "cellular response to organonitrogen compound (GO:0071417)", 0.5922591320470021, 1.1243160054719563, 0.5889291100516374, ["P2RY6"], 0.6283019492489609, 0, 0], [1332, "ubiquitin-dependent protein catabolic process (GO:0006511)", 0.5936621575586646, 0.9791855203619909, 0.5105912759108592, ["DTX3L", "UBE2L6", "RNF122"], 0.6293175423970228, 0, 0], [1333, "steroid metabolic process (GO:0008202)", 0.5958043373752918, 1.1133438699480696, 0.5765372837882271, ["CYP27A1"], 0.6311145719234149, 0, 0], [1334, "activation of GTPase activity (GO:0090630)", 0.599318894592593, 1.1025827370304115, 0.5644798504496215, ["RASGRP1"], 0.6338863514342632, 0, 0], [1335, "positive regulation of cellular metabolic process (GO:0031325)", 0.599318894592593, 1.1025827370304115, 0.5644798504496215, ["CSF1"], 0.6338863514342632, 0, 0], [1336, "small GTPase mediated signal transduction (GO:0007264)", 0.6028030670486915, 1.0920265780730898, 0.5527453317519578, ["RASGRP1"], 0.6370942594855931, 0, 0], [1337, "regulation of protein serine/threonine kinase activity (GO:0071900)", 0.6197772215006038, 1.0421247357293868, 0.498547456445013, ["HERC5"], 0.6540548854699945, 0, 0], [1338, "Fc-epsilon receptor signaling pathway (GO:0038095)", 0.6197772215006038, 1.0421247357293868, 0.498547456445013, ["MAPK3"], 0.6540548854699945, 0, 0], [1339, "regulation of macroautophagy (GO:0016241)", 0.6230844926991146, 1.032683846637335, 0.4885349972680058, ["SNX32"], 0.6560740519695375, 0, 0], [1340, "phosphatidylinositol metabolic process (GO:0046488)", 0.6230844926991146, 1.032683846637335, 0.4885349972680058, ["PLA2G4C"], 0.6560740519695375, 0, 0], [1341, "Fc receptor signaling pathway (GO:0038093)", 0.6230844926991146, 1.032683846637335, 0.4885349972680058, ["MAPK3"], 0.6560740519695375, 0, 0], [1342, "anterograde trans-synaptic signaling (GO:0098916)", 0.6260722718224481, 0.9465468077908269, 0.44325789760284845, ["GABRR2", "GRIN1"], 0.6585441426274401, 0, 0], [1343, "positive regulation of metabolic process (GO:0009893)", 0.6263631611534363, 1.0234115448504983, 0.4787774511701996, ["TNF"], 0.6585441426274401, 0, 0], [1344, "activation of protein kinase activity (GO:0032147)", 0.6296134727649224, 1.0143033545997118, 0.4692666185024223, ["TNFRSF10A"], 0.6609771178766324, 0, 0], [1345, "positive regulation of cellular component organization (GO:0051130)", 0.6296134727649224, 1.0143033545997118, 0.4692666185024223, ["TNF"], 0.6609771178766324, 0, 0], [1346, "cellular amide metabolic process (GO:0043603)", 0.6328356714575899, 1.0053549571603426, 0.45999462445374684, ["VNN1"], 0.663866246729656, 0, 0], [1347, "cytosolic transport (GO:0016482)", 0.636029998891608, 0.9965621840242669, 0.4509539041301832, ["SNX32"], 0.6662272688686578, 0, 0], [1348, "regulation of protein-containing complex assembly (GO:0043254)", 0.636029998891608, 0.9965621840242669, 0.4509539041301832, ["TNF"], 0.6662272688686578, 0, 0], [1349, "regulation of cellular response to stress (GO:0080135)", 0.6423359969319238, 0.9794275491949911, 0.4335374856678098, ["MAPK3"], 0.6713385845062001, 0, 0], [1350, "negative regulation of response to external stimulus (GO:0032102)", 0.6423359969319238, 0.9794275491949911, 0.4335374856678098, ["IRAK3"], 0.6713385845062001, 0, 0], [1351, "positive regulation of protein-containing complex assembly (GO:0031334)", 0.6423359969319238, 0.9794275491949911, 0.4335374856678098, ["TNF"], 0.6713385845062001, 0, 0], [1352, "cytoskeleton organization (GO:0007010)", 0.6485333598950636, 0.9628688684776237, 0.41696250159461246, ["RHOF"], 0.6768138242216037, 0, 0], [1353, "macroautophagy (GO:0016236)", 0.6485333598950636, 0.9628688684776237, 0.41696250159461246, ["TMEM74"], 0.6768138242216037, 0, 0], [1354, "epithelium development (GO:0060429)", 0.6546239485961571, 0.9468575821641361, 0.4011781912476108, ["CD34"], 0.6826654471327726, 0, 0], [1355, "positive regulation of epithelial cell proliferation (GO:0050679)", 0.6576297754351735, 0.9390487990850171, 0.39356770706094496, ["STAT5A"], 0.6852939062099374, 0, 0], [1356, "non-canonical Wnt signaling pathway (GO:0035567)", 0.6606095921239404, 0.9313669880884855, 0.3861375312649346, ["ROR2"], 0.6878914041880559, 0, 0], [1357, "cellular component assembly (GO:0022607)", 0.6624949516993346, 0.8836505678610942, 0.36383635363793254, ["TLCD1", "NEFH"], 0.689346257774105, 0, 0], [1358, "cellular protein modification process (GO:0006464)", 0.6671153697560012, 0.8967551622418879, 0.36299956661254007, ["HERC5", "C3", "CSF1", "UBE2L6", "IRAK3", "PARP14", "TGM5", "MAPK3"], 0.6936427850482133, 0, 0], [1359, "positive regulation of macromolecule biosynthetic process (GO:0010557)", 0.6751262893772403, 0.8947583575581395, 0.35151075109649493, ["IL1B"], 0.7009399416181348, 0, 0], [1360, "muscle contraction (GO:0006936)", 0.6751262893772403, 0.8947583575581395, 0.35151075109649493, ["CLCN1"], 0.7009399416181348, 0, 0], [1361, "regulation of primary metabolic process (GO:0080090)", 0.6779546782897871, 0.8877771768523526, 0.3450566516860572, ["NFYA"], 0.7028428823386046, 0, 0], [1362, "G2/M transition of mitotic cell cycle (GO:0000086)", 0.6779546782897871, 0.8877771768523526, 0.3450566516860572, ["NES"], 0.7028428823386046, 0, 0], [1363, "cell cycle G2/M phase transition (GO:0044839)", 0.6807585838825325, 0.8809033989266547, 0.33874923332468176, ["NES"], 0.7052319298915157, 0, 0], [1364, "regulation of cell adhesion (GO:0030155)", 0.6862937860452122, 0.867468287526427, 0.32655798869832714, ["TNF"], 0.7094047041697216, 0, 0], [1365, "regulation of cell motility (GO:2000145)", 0.6862937860452122, 0.867468287526427, 0.32655798869832714, ["HBEGF"], 0.7094047041697216, 0, 0], [1366, "transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178)", 0.6862937860452122, 0.867468287526427, 0.32655798869832714, ["MAPK3"], 0.7094047041697216, 0, 0], [1367, "organic substance transport (GO:0071702)", 0.6944181739532311, 0.8480620155038759, 0.3092720562240515, ["ARRDC2"], 0.7172775871411575, 0, 0], [1368, "regulation of small GTPase mediated signal transduction (GO:0051056)", 0.7074965331018626, 0.8175664451827243, 0.2828964258999535, ["RHOF"], 0.7302522695466593, 0, 0], [1369, "negative regulation of DNA-binding transcription factor activity (GO:0043433)", 0.7125706764554125, 0.8059695381591877, 0.27312387565520524, ["IRAK3"], 0.7334266333776758, 0, 0], [1370, "neuron development (GO:0048666)", 0.7125706764554125, 0.8059695381591877, 0.27312387565520524, ["SLC44A4"], 0.7334266333776758, 0, 0], [1371, "monocarboxylic acid metabolic process (GO:0032787)", 0.7125706764554125, 0.8059695381591877, 0.27312387565520524, ["VNN1"], 0.7334266333776758, 0, 0], [1372, "proteolysis (GO:0006508)", 0.7126496749250504, 0.8019698368728839, 0.27167956748085736, ["MMP9", "ADAMTS9"], 0.7334266333776758, 0, 0], [1373, "regulation of cytosolic calcium ion concentration (GO:0051480)", 0.7248763973040372, 0.7783578547698149, 0.25043985060662693, ["C1QTNF1"], 0.7454664770526588, 0, 0], [1374, "actin filament organization (GO:0007015)", 0.7343426634343602, 0.7575850916371477, 0.23392675746188987, ["RHOF"], 0.7546519947374939, 0, 0], [1375, "chemical synaptic transmission (GO:0007268)", 0.7452533303308214, 0.7511157279162819, 0.22085136694973853, ["GABRR2", "GRIN1"], 0.7653074199469964, 0, 0], [1376, "cellular response to starvation (GO:0009267)", 0.7479382216738661, 0.7284106058361725, 0.21155585837913785, ["MAPK3"], 0.7669489970976754, 0, 0], [1377, "skeletal system development (GO:0001501)", 0.7479382216738661, 0.7284106058361725, 0.21155585837913785, ["PAX1"], 0.7669489970976754, 0, 0], [1378, "protein autophosphorylation (GO:0046777)", 0.7501359049482818, 0.7237636149543715, 0.20808267785430953, ["MAPK3"], 0.768644338016672, 0, 0], [1379, "double-strand break repair (GO:0006302)", 0.7608418105947083, 0.7013839349407904, 0.19170913989717392, ["DTX3L"], 0.7784845192461799, 0, 0], [1380, "heart development (GO:0007507)", 0.7608418105947083, 0.7013839349407904, 0.19170913989717392, ["APLNR"], 0.7784845192461799, 0, 0], [1381, "DNA-templated transcription, initiation (GO:0006352)", 0.7690771453976454, 0.6844450633616488, 0.17971063046492367, ["MAPK3"], 0.7863410060112058, 0, 0], [1382, "neuron projection development (GO:0031175)", 0.7750680529048297, 0.6722640218878249, 0.171295859837057, ["NEFH"], 0.7918929744584802, 0, 0], [1383, "mitochondrion organization (GO:0007005)", 0.7828162062683977, 0.6566760224538893, 0.16079194457633728, ["MX2"], 0.7992310074121312, 0, 0], [1384, "positive regulation of developmental process (GO:0051094)", 0.7865901816661274, 0.6491477272727273, 0.15582654940515214, ["TNF"], 0.8025038558616849, 0, 0], [1385, "negative regulation of immune response (GO:0050777)", 0.7884526458666168, 0.6454473787938511, 0.15341182438089698, ["IRAK3"], 0.8038232028618505, 0, 0], [1386, "post-translational protein modification (GO:0043687)", 0.8023752700904181, 0.6643820435442347, 0.14628288277015516, ["C3", "CSF1"], 0.817427042833817, 0, 0], [1387, "cellular response to DNA damage stimulus (GO:0006974)", 0.8088185766054491, 0.6546682798951402, 0.13890793686267863, ["DTX3L", "MAPK3"], 0.8233971378276093, 0, 0], [1388, "negative regulation of cell differentiation (GO:0045596)", 0.8112435980357982, 0.6008873929008568, 0.12569777245797273, ["TNF"], 0.8252708648606247, 0, 0], [1389, "endomembrane system organization (GO:0010256)", 0.8240374183394025, 0.5763742071881607, 0.11155108336266374, ["TLCD1"], 0.8376823863896589, 0, 0], [1390, "proteasomal protein catabolic process (GO:0010498)", 0.8330635400833791, 0.5592510259917921, 0.10214460559500842, ["RNF122"], 0.8462487184156341, 0, 0], [1391, "mitotic cell cycle phase transition (GO:0044772)", 0.8388236723931501, 0.5483843917710197, 0.096381166404176, ["NES"], 0.8514874373969289, 0, 0], [1392, "regulation of cell growth (GO:0001558)", 0.8497577420455482, 0.5278585271317829, 0.08593746881889318, ["SLC44A4"], 0.8619669050059727, 0, 0], [1393, "phosphorylation (GO:0016310)", 0.8636586885580029, 0.5709541861353551, 0.08368910836868843, ["IRAK3", "MAPK3"], 0.8754386706704237, 0, 0], [1394, "regulation of transcription by RNA polymerase II (GO:0006357)", 0.8701541097618815, 0.764173344348861, 0.10628500784677132, ["STAT5A", "CSF3", "NFYA", "DACH2", "TNF", "KLF2", "GRIN1", "NFKB2", "PAX1", "TAL2", "TNIP3", "HEY2", "TOX", "IRF9", "MAPK3"], 0.8813899590988354, 0, 0], [1395, "regulation of nucleic acid-templated transcription (GO:1903506)", 0.8892660684287914, 0.5301142263759087, 0.062213568768124526, ["NFYA", "NFKB2"], 0.900103002596024, 0, 0], [1396, "protein-containing complex assembly (GO:0065003)", 0.9032102211004609, 0.4275441510753628, 0.043523973060755464, ["TNF"], 0.9129082549705445, 0, 0], [1397, "protein deubiquitination (GO:0016579)", 0.9032102211004609, 0.4275441510753628, 0.043523973060755464, ["TNIP3"], 0.9129082549705445, 0, 0], [1398, "inorganic cation transmembrane transport (GO:0098662)", 0.9089969186676178, 0.41643240480449784, 0.03973330432791972, ["SLC11A2"], 0.9180998921020573, 0, 0], [1399, "protein modification by small protein removal (GO:0070646)", 0.9105861470453648, 0.4133615221987315, 0.03871823829334453, ["TNIP3"], 0.9190476337584381, 0, 0], [1400, "negative regulation of nucleic acid-templated transcription (GO:1903507)", 0.912885574720977, 0.49024075339864814, 0.04468286362049931, ["HEY2", "TNF"], 0.9207103082185855, 0, 0], [1401, "regulation of cellular macromolecule biosynthetic process (GO:2000112)", 0.9153327416446904, 0.485932284215546, 0.042989276427462655, ["NFYA", "NFKB2"], 0.9225195083528214, 0, 0], [1402, "regulation of cell cycle (GO:0051726)", 0.9250366047189539, 0.3849428458809618, 0.029995504728141456, ["MX2"], 0.9316345833546098, 0, 0], [1403, "DNA repair (GO:0006281)", 0.9263471727005281, 0.38231148696264977, 0.029249198348427388, ["DTX3L"], 0.9322895280492843, 0, 0], [1404, "regulation of transcription, DNA-templated (GO:0006355)", 0.9291536364956224, 0.6948077953577573, 0.05105529353741175, ["STAT5A", "NCF1", "DTX3L", "NFYA", "DACH2", "TNF", "KLF2", "NFKB2", "PAX1", "TAL2", "IL1B", "HEY2", "TOX", "IRF9"], 0.9344479592106971, 0, 0], [1405, "protein phosphorylation (GO:0006468)", 0.9307454223249452, 0.4577266377820394, 0.03285080483842096, ["IRAK3", "MAPK3"], 0.9353825881301228, 0, 0], [1406, "negative regulation of transcription by RNA polymerase II (GO:0000122)", 0.9381431231823728, 0.4961388960870692, 0.031679836997954756, ["HEY2", "TNF", "KLF2"], 0.9421465789000786, 0, 0], [1407, "proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161)", 0.939876315822321, 0.35441497093023255, 0.021976206014728474, ["RNF122"], 0.9432163169446461, 0, 0], [1408, "cellular protein localization (GO:0034613)", 0.9439774639740804, 0.3456288996029495, 0.019926538120515477, ["HEY2"], 0.9466592181330978, 0, 0], [1409, "negative regulation of cellular macromolecule biosynthetic process (GO:2000113)", 0.9522677336731213, 0.4137990235527657, 0.02023851749678803, ["HEY2", "TNF"], 0.9542952732054276, 0, 0], [1410, "protein transport (GO:0015031)", 0.9606665522784088, 0.3074285894843276, 0.012336466820221334, ["ARRDC2"], 0.962029199870293, 0, 0], [1411, "nervous system development (GO:0007399)", 0.9803054500174353, 0.25264626134112006, 0.005025405022751077, ["NES"], 0.981000209372515, 0, 0], [1412, "negative regulation of transcription, DNA-templated (GO:0045892)", 0.989790134692629, 0.3526050420168067, 0.0036185540555401124, ["HEY2", "TNF", "KLF2"], 0.989790134692629, 0, 0]]